Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Monographien, Kongreβberichte
American Institute Of Biological Sciences: Brain and behavoir, second conference. Brain Research Institute, University of California, Los Angeles. Washington Dc, (1962).
Baird, I. M., Howard, A. N.: Obesity, medical and scientific aspects. London: Livingstone 1969.
Blankart, R. (ed.): Adipositas — Kreislauf-Anorektika. Bern: Huber 1974.
Blix, G. (ed.): Occurence, causes and prevention of overnutrition. Second symposium of the Swedish Nutrition Foundation, Uppsala: Almqvist & Wiksells 1964.
Brai, G. A. (ed.): Obesity in perspective, DHEW Publication No. (NIH) 75–708, Superintendent of Documents, US Gov. Printing office, Washington Dc 1975.
Bray, G. A., Bethume, J. E.: Treatment and management of obesity. Hagerstown: Harper and Row 1974.
Brodoff, B. N. (ed.): Adipose tissue metabolism and obesity. Annals New York Adacemy of Sciences, (New York) Vol. 131, Art. 1 (1965).
Burland, W. L., Samuel, P. D., Yudiun, J. (ed.): Obesity. London: Churchill Livingstone 1974.
Collip, P. J. (ed.): Childhood obesity. Publishing Sciences Group (1975).
Craddock, D.: Obesity and it’s management, 2nd. ed. London: Churchill Livingstone 1973.
Galton, D. J.: The human adipose cell. London: Butterworths 1971.
Garrows, J. S.: Energy balance and obesity in man. Amsterdam: North Holland Publ. Co. New York: Amer. Elsevier Publ. 1974.
Greten, H., Levine, R., Pfeiffer, E., Renold, A. E. (ed.): Lipid metabolism, obesity, and diabetes mellitus: Impact upon atherosclerosis. Horm. metabol. Res. Suppl. 4. Stuttgart: Thieme 1974.
Grottner, R., Eckert, I. (ed.): Adipositas im Kindesalter. Stuttgart: Thieme 1974. Howard, A. (ed.): Recent advances in obesity research: I. Proc. 1st Int. Congr. on Obesity, London: Newman Publ. 1975.
Husemann, B.: Die chirurgische Therapie von Adipositas und Hyperlipaemie. Baden-Baden: Witzstrock 1975.
Jeanrenaud, B., Hepp, D. (ed.): Adipose tissue. Regulation and metabolic function. Horm. metabol. Res. Suppl. 2. Stuttgart: Thieme 1970.
Jequier, E. (ed.): Regulation of energy balance in man. Geneva: Ed. Med. Hyg. 1975.
Kasper, H., Zang, E.: Übergewicht. Grundlagen und Diätprogramme für Arzt und Patient. München: Urban und Schwarzenberg 1975.
Kiell, N.: The psychology of obesity: Dynamics and treatment. Springfield, Ill.: Charles C. Thomas 1973.
Mayer, J.: Overweight, causes, cost and control. Englewood Cliffs N. J.: Prentice Hall 1968.
Novin, D., Wyrwicka, W., Bray, G. A.: Hunger, basic mechanisms and clinical implications. New York: Raven Press 1976.
Reichsman, F. (ed.): Hunger and satiety in health and disease. Adv. psychosomat. Med. Vol. 7, Basel: Karger 1972.
Renold, A. E., Cahill, G. F. (ed.): Adipose tissue. Handbook of Physiology No. 5, Washington D. C.: American Physiological Society 1965.
Ries, W.: Fettsucht. Leipzig: J. A. Barth 1970.
Rodahl, K., Issekutz, B. (ed.): Fat as a tissue. Proceedings of a Conference held at the Lakeman Hospital, New York: McGraw-Hill Book Co. 1964.
Rossi, E. (ed.): Ernährung und Stoffwechsel. Die Adipositas im Kindesalter. Paediat. Fortbildk. Praxis, Vol. 42, Basel: Karger 1975.
Rynearson, E. H., Gastineau, C. F.: Obesity. Springfield: Thomas 1949.
Schettler, D., boecker, W. (ed.): Fettsucht — Gicht. Stuttgart: Thieme 1971.
Sektton gastroent/ dtsch. Klinik für diagnostik: Aktuelle Therapie der Adipositas. Stuttgart: Schattauer 1972.
Silverstone, J. T.: Obesity, pathogenesis and management. Medical & Technical Publ. Co. Lancaster 1975.
Vague, J. (ed.): Physiopathology of adipose tissue. Amsterdam: Excerpta Medica 1969. Vague, J., Boyer, J. (ed.): The regulation of the adipose tissue mass. Amsterdam: Excerpta Medica, New York: Amer. Elsevier Publ. 1974.
Whenlan, H., Silverstone, T. (ed.): Obesity, a bibliography 1964–1973. London: Information Retrieval Ltd. 1974.
Originalarbeiten
Abe, M.: The physiologic role of glucagon; Discussion. In: B. S. Leibel and G. S. Wrenshal (eds.): On the Nature and Treatment of Diabetes p. 283. Amsterdam: Excerpta Medica 1965.
Abramson, E., Arky, R. A.: Treatment of the obese diabetic. A. comparative study of placebo, sulfonylurea and phenformin. Metabolism 16, 204–212 (1967).
Acheson, R. M., O’brien, W. M.: Dependence of serum uric acid on haemoglobin and other factors in the general population. Lancet II, 777 (1966).
Actuar. Soc. America: (1913); O. a. Medico Actuarial Mortality Investigation (1913).
Adams, V. J.: AN 448: a double blind trial in obese mild to moderate hypertensive patients. In: A. Howard (Ed.), Recent Advances in Obesity Research: I, p. 393–395. London: Newman Publ. 1975.
Addington, W. W., Pfeffer, S. H., Gaensler, E. A.: Obesity and alveolarhypoventilation. Respiration 26, 214–225 (1969).
Adlersberg, D.: Obesity, fat metabolism and diabetes. Diabetes 7, 236–242 (1958).
Adlersberg, D., ColerH. R., Laval, J.: Effect of weight reduction on course of arterial hypertension. J. Mt. Sinai Hospital 12, 984 (1946).
Adlersberg, D., Eisler, L.: Circulating lipids in diabetes mellitus J. Am. Med. Ass. 170, 1261–1265 (1959).
Adlersberg, D., Mayer, M. E.: Results of prolonged medical treatment of obesity with diet alone, diet and thyroid preparations and diet and amphetamin. J. Clin. Endocrin. 9, 275–284 (1949).
Ahnefeld-Olbertz, S., Rudolfsky, G., Schultis, K.: Zur Behandlung der Adipositas. Schweiz. Rundschau für Medizin (Praxis) 62, 1065–1071 (1974).
Albrink, M.: Chorionic gonadotropin in obesity? Am. J. Clin. Nutr. 22, 681–685 (1969).
Albrink, M. J., Man, E. B.: Serumtriglycerides in health and diabetes. Diabetes 7,194–201, 1958.
Albrink, M. J., Meigs, J. W.: Interrelationship between skinf old thickness, serum lipids and blood sugar in normal men. Amer. J. clin. Nutr. 15, 255 (1964).
Albrink, M. J., Meigs, J. W.: The relationship between serum triglycerides and skin thickness in obese subjects. Ann. N. Y. Acad. Sci. 131, 673–683, (1965).
Albrink, M. J., Meigs, J. W., Grandee, M. A.: Weight gain and serum triglycerides in normal men. New Engl. J. Med. 266, 484 (1962).
Alexander, J. K.: Obesity and cardiac performance. Amer. J. Cardiol. 14, 860 (1964).
Alexander, J. K.: Chronic heart disease due to obesity. J. chron. Dis. 18, 895–898 (1965).
Alexander, J. K.: Gross obesity. The cardiovascular consequences. In: Blackburn H., Willis, J. (ed.): The Minnesota symposium on prevention in cardiology. Minn. Med. 52, 89–91 (1969).
Alexander, J. K.: Effects of weight reduction on the cardiovascular system. In: Bray, G. A. (ed.): Obesity in Perspective, DHEW Publication No. (NIH) 75–708, p. 233. Washington Dc, 1975.
Alexander, J. K., Amad, K. H., Cole, V. W.: Obervations on some clinical features of extreme obesity with particular reference to cardiorespiratory effects. Amer. J. Med. 32, 512–524 (1962a).
Alexander, J. K., Cruthrice, A. E., Sakaguchi, R., Crawford, H. W., Cole, V. W.: Lung volume changes with extreme obesity. Clin. Res. 7, 171 (1959).
Alexander, J. K., Dennis, E. W., Smith, W. G., Amad, K. H., Duncan, W. C., Austin, R. C.: Blood volume, cardiac output, and distribution of systemic blood flow in extreme,. obesity. Cardiovasc. Res. Ctr. Bull. 1, 39 (1962b).
Alexander, J. K., Peterson, K. L.: Cardiovascular effects of weight reduction. Circulation 45, 310–318 (1972).
Alexander, J. K., Pettigrove, J. R.: Obesity and congestive heart failure. Geriatrics 22, 101 (1967).
Allen, T. H., Peng, M. T., Chen, K. P., Hung, R. F., Chang, C., Fang, H. S.: Prediction of total adiposity from skinfolds and the curvilinear relationship between external and internal adiposity. Metabolism 5, 346–352 (1956).
Allison, R. S.: Carbohydrate tolerance in overweight and obesity. Lancet I, 537–540 (1927).
Allon, N.: Fat is a dirty word: fat as a sociological and social problem. In: Howard, A. (ed.): Recent advances in obesity research: I. p. 244. London: Newman Publ. 1975.
Amad, K. H., Brennan, J. C., Alexander, J. K.: The cardiac pathology of chronic exogenous obesity. Circulation 32, 740–745 (1965).
Anand, B. K.: Nervous regulation of food intake. Physiol. Rev. 41, 677 (1961).
Anand, B. K.: Effects of fenfluramine on the activity of feeding and satiety centers of hypothalamus. S. Afr. Med. J. 45, Suppl., 12–13, 1971.
Anderson, J.: Drugs and appetite. Practitioner 212, 536–544 (1974).
Anderson, J. W., Herman, R. H.: Effect of fasting, caloric restriction, and refeeding on glucose tolerance of normal men. Am. J. Clin. Nutr. 25, 41 (1972).
Anderson, J. W., Herman, R. H., Newcomer, K. L.: Improvement in glucose tolerance in fasting obese patients given oral potassium. Am. J. Clin. Nutr. 22, 1859 (1969).
Anderson, D. B., Kauffmann, R. G., Kastenschmidt, L. L.: Lipogenic enzyme activities and cellularity of porcine adipose tissue from various anatomical locations. J. Lipid Res. 13, 593–599, 1972.
Andres, R., Cader, G., Zierler, K L The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. Measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J. clin. Invest. 35, 671 (1956).
Angel, A.: Cholesterol and obesity. In: Bray G. A. (ed.): Obesity in Perspective, DHEW Publication No. (NIH) 75–708, p. 265. Washington 1975.
Angel, A., Desei, K., Halperin, M. L.: The effect of norepinephrenie (N), ACTH and dibutyryl — 3’, 5’ — cyclic AMP (DBC) on ATP metabolism. Clin. Res. 17, 544 (1969).
Antonetfi, V. W.: The equations governing weight change in human beings. Am. J. Clin. Nutr. 26, 64 (1973).
Apfelbaum, M., Boudon, P., Lacatis, E., Nillus, P.: Effects métaboliques de la diète protidique chez 41 sujets obèses. Presse Médicale 78, 1917–1920, (1970).
Archer, J. A., Gordon, P., Gavin, J. R., Lesniak, M. A., Rom, J.: Insulin receptor in human circulating lymphozytes: Application to the study of insulin resistance in man. J. clin. Endocrinol. Metab. 36, 627 (1973a).
Archer, J. A., Gordon, P., Kahn, R., Gavin, J. R., Neville, D. M., Martin, M. M., Rom, J.: Insulin receptor deficiency states in man: Two clinical forms. Amer. Soc. clin. Invest. 65. Ann. Meet. Abstr. 14, 4a, (1973b).
Arendt, E. C., Pattee, C. J.: Studies in obesity. I. The insulin glucose tolerance curve. J. clin. Endocrin. 16, 367–374 (1956a).
Arendt, E. C., Pattee, C. J.: Studies on obesity. II. Blood pyruvate and lactate curves in obese and normal subjects after ingestion of glucose. J. clin. Endocrin. 16, 375–379 (1956b).
Arky, R. A., Freinkel, N.: Alcohol hypoglycemia. V. Alcohol infusion to test gluconeoge-nesis in starvation with special reference to obesity. New Engl. J. Med. 274, 426 (1966).
Armatruda, J. M., Livingston, J. N., Lockwood, D. H.: Insulin receptor: Role in the resistance of human obesity to insulin. Science 188, 264 (1975).
Armstrong, D. B., Dublin, L. I., Wheatley, G. M.: Obesity and its relation to health and disease. J. Amer. Med. Assoc. 147, 1007–1014, (1951).
Arnoldi, W.: Untersuchungen über den Stoffwechsel bei der Fettsucht. Z. klin. Medizin 94, 268–316 (1921).
Arzneimittelkommission Der Deutschen Arzteschaft: Unerwünschte and gefährliche Kreislaufreaktionen beim längeren Gebrauch von sogenannten Appetitzüglern. Dtsch. Ärztebl. 67, 2568 (1970).
Asher, W. L., Dietz, R. E.: Effectiveness of weight reduction involving „diet pills“. Curr. Therapeut. Res. 14, 510–524 (1972).
Asher, W. L., Harper, H. W.: Effect of human chorionic gonadotropin on weight loss, hunger, and feeling of wellbeing. Am. J. clin. Nutr. 26, 211–218 (1973).
Ashmore, J.: The effects of glucocorticoids on insulin action. Diabetes 13,349–354 (1964).
Ashwell, M.: The relationship of the age of onset of obesity to the success of its treatment in the adult. Brit. J. Nutr. 34, 201–204 (1975).
Ashwell, M., Etchell, L.: Attitude of the individual to his own body weight. In: Howard, A. (ed.): Recent advances in obesity research: I. p. 232. London: Newman Publ. 1975.
Ashwell, M., Garrow, J. S.: Full and empty fat cells. Lancet II, 1036–1037 (1973).
Ashwell, M., Priest, P., Bondoux, M.: Adipose tissue cellularity in obese women. In: Howard, A., (ed.): Recent advances in obesity research: I. p. 74–77. London: Newman Publ. 1975.
Astrand, I.: Aerobic work capacity in men and women with special reference to age. Acta physiol. Scand. 49, Suppl. 169, (1960).
Astwood, E. B.: The heritage of corpulance. Endocrinology 71, 337 (1962).
Atkinson, R. M., Ringuetre, E. L.: A survey of biographical and psychological features in extraordinary fatness. Psychosom. Med. 29, (1967).
Aun, F., Soeldner, J. S., Meguid, M. M., Stolf, N. A. G.: Urinary insulin levels in health and disease: a concise review. Postgr. Med. J. 51, 622–626 (1975).
Axelsson, C., Andersen, J. A.: Lipohyperplasie of the ileocoecal region. Acta. Chir. Scand. 140, 649 (1974).
Azerad, E., Lubetzki, J., Duprey, J., Friedler, D.: Etude de la sécrétion insulinique au cours des perfusions de glucose chez des sujets normaux et diabétiques. Journées Diabétologie.Hotel Dieu: Flammarion Edit., p. 157–177 (1969).
Baader, O.: Gewichtskontrolle während der Schwangerschaft. Dtsch. Ärztebl. 69, 886 (1972).
Baber, J. C. Jr., Hayden, W. F., Thompson, B. W.: Intestinal bypass operations for obesity. Am. J. Surgery 126, 769–772 (1973).
Bagdade, J. D.: Basal insulin and obesity. Lancet II, 630–631 (1968).
Bagdade, J. D., Bierman, E. L., Porte, D.: Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia. Diabetes 20, 664 (1971).
Bagdade, J. D., Bierman, E. L., Porte, D.: Hyperinsulinism — A metabolic consequence of obesity. Diabetes 17, 315 (1968).
Bagdade, J. D., Bierman, E. L., Porte, D.: Basal and stimulated insulin levels: Comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects. Metabolism 20, 1000 (1971).
Bagdade, J. D., Bierman, E. L., Porte, D.: The significance of basal insulin in the evaluation of the insulin response to glucose in diabetic and non diabetic subjects. J. clin. Invest. 46, 1549–1557 (1967).
Bagdade, J. D., Porte, D., Bierman, E. L.: The interaction of diabetes and obesity on the regulation of fat mobilization in man. Diabetes 18, 759–772 (1969).
Bahner, F.: Fettsucht and Magersucht. In: Bergmann, G., Frey W., Schwiegk, H. (eds.): Handbuch der inneren Medizin, Band 7, 1. Teil, p. 978. Berlin-Heidelberg: Springer 1955.
Baier, H., Knick, B., Emden, A., Ruckes, J.: Fettleber, Fettsucht and latenter Diabetes. Med. Welt 15, 1813–1861, (1964).
Baier, H., Rother, F., Bauer, H., Knick, B.: Leberbioptische Befunde bei verschiedenen Formen von Diabetes mellitus. Munch. med. Wschr. 2, 89–94 (1965).
Baile, C. A.: Regulation of feed intake in ruminants. Fed. Proc. 27, 1361 (1968).
Baile, C. A., Forbes, J. M.: Control of feed intake and regulation of energy balance in ruminants. Physiol. Rev. 54, 160 (1974).
Baird, I. M.: Urinary corticosteroid excretion in obese adults. Lancet II, 1022 (1963).
Baird, I. M., Parsons, R. L., Howard, A. N.: Clinical and metabolic studies of chemically defined diets in the management of obesity. Metabolism 23, 645–657 (1974).
Balasse, E. O.: Influence of norepinephrine, growth hormone, and fasting on FFA mobilization and glucose metabolism in lean and obese subjects. Diabetologia 4, 20 (1968).
Balasse, E. O., Ooms, H. A.: Role of plasma free fatty acids in the control of insulin secretion in man. Diabetologia 9, 145–151 (1973).
Ball, E. G.: Some energy relationships in adipose tissue. Ann. NY. Acad. Sci. 131, 225 (1965).
Ball, E. G., Jungas, R. L.: On the action of hormones which accelerate the rate of oxygen consumption and fatty acid release in rat adipose tissue in vitro. Proc. Nat. Acad. Sci. 47, 932–941, (1961).
Ball, J. P., Donald, R. A., Espiner, E. A.: Pituitary response to insulininduced hypoglycemia in obese subjects before and after fasting. J. clin. Endocr. 31, 546 (1970).
Ball, M. F., Canary, J. J., Kyle, L. H.: Comparative effects of caloric restriction and total starvation on body composition in obesity. Am. Intern. Med. 67, 60–67 (1967a).
Ball, M. F., Canary, J. J., Kyle, L. H.: Tissue changes during intermittent starvation and caloric restrictions as treatment for severe obesity. Arch. Intern. Med. 125, 62–68 (1970a).
Ball, M. F., El-Khodary, A. Z., Canary, J. J.: Growth hormone response in the thinned obese. J. Clin. Endocr. Metab. 34, 498–511 (1972).
Ball, M. F., El-Khodary, A. Z., Canary, J. J., Aldige, C.: Growth hormone response to oral glucose in the thinned obese. Clin. Res. 18, 599 (1970a).
Ball, M. F., Kyle, L. H., Canary, J. J.: Comparative effects of caloric restriction and metabolic acceleration on body composition in obesity. J. Clin. Endocrin. 27, 273–278 (1967b).
Banting, W.: Letter on corpulence. 3. Aufl. London: Harrison 1864.
Barach, H. J.: Constitutional and hereditary traits in diabetes. Am. J. Med. Sci. 172, 243–248 (1926).
Barach, H. J.: Obesity, its associated diseases and treatment. Am. J. dig. diseases 19, 37–44 (1952).
Barrera, F., Reidenberg, M. M., Winters, W. L.: Pulmonary function in the obese patient. Amer. J. Med. Sci. 254, 785 (1967).
Barta, L., Rosta, J.: Juvenile obesity. Investigation of carbohydrate and fat metabolism. Ann. Paediat. 196, 189–203 (1961).
Basler, H. D., Schwoon, D. R.: Methoden der Verhaltenstherapie bei Adipösen. Med. Klin. 68, 1722–1728 (1973).
Bassas-Grau, E. U. M.: Klinische, aetiologische, pathologische und therapeutische Überlegungen zur Zellulitis (Pannikulose). Munch. med. Wschr. 108, 431 (1966).
Bauer, J.: Ober Fettansatz. Klin. Wschr. 1, 1977–1983 (1922).
Bauer, J.: Constitution and disease. New York: Grune and Stratton Inc. 1945.
Baum, J. D., Ounsted, M., Smith, M. A.: Weight gain in infancy and subsequent development of diabetes mellitus in childhood. Lancet II, 866 (1975).
Baxter, D., Gates, R. J., Lazarus, N. R.: Insulin receptor in the New Zealand obese mouse (NZO): Changes following the implantation of islets of Langerhans. Exerpta Medica (Amsterdam) Int. Congr. Series 280, 74 (1973).
Bayer, P. M., Grabl, F., Schnack, H., Zyman, H.: Vorsorgeuntersuchung Hyperlipidämie. Serumlipidwerte bei 3006 Erwachsenen aus dem Bereich von Wien. Wien. klin. Wschr. 87, 756–759 (1975).
Bayles, S.: Psychiatric contributions to the treatment of obesity. Am. J. Med. Sci. 219, 104–107 (1950).
Beck, P., Koumans, J. H. T., Winterling, C. H., Stein, M. F., Daughaday, W. H., Kipnis, D. M.: Studies of insulin and growth hormone secretion in human obesity. J. Lab. clin. Med. 64, 654–667 (1964).
Bedell, G. N., Wilson, W. R., Seesohn, P.: Pulmonary function in obese persons. J. clin. Invest. 37, 1049 (1958).
Behnke, A. R.: Physiologic studies pertaining to deep sea diving and aviation, especially in relation to the fat content and compositio of the body. Harvey Lectures NY 37,198–226 (1941).
Behnke, A. R.: The relation of lean body weight to metabolism and some consequent systematizations. Ann. NY Acad. Sci. 56, 1095 (1953).
Behnke, A. R., Feen, B. G., Welham, W. C.: The specific gravity of healthy men. J. Am. Med. Ass. 118, 495–501 (1942).
Bell, J. P., Donald, R. A., Espiner, E. A.: Pituitary response to insulin induced hypoglyce-mia in obese subjects before and after fasting. J. clin. Endocr. 31, 546 (1970).
Benedetti, A., Simpson, R. G., Grodsky, G. M., Forsham, P. H.: Exaggerated insulin response to glucagon in simple obesity. Diabetes 16, 666–669 (1967).
Benedict, F. G.: A study of prolonged fasting. Carnegie Institution of Washington Publication Nr. 203, Washington D. C. 1975.
Bengstsson, K., Karlberg, B., Lindgren, S.: Lactic acidosis in phenformintreated diabetics. Acta med. scand 191, 203–208 (1972).
Bennett, V., Cuatrecasas, P.: Insulin receptor in fat cells in insulin resistant metabolic states. Science 176, 805 (1972).
Bennion, L. J., Grundy, S. M.: Effects obesity and caloric intake on biliary lipid metabolism in man. J. clin. Invest. 56, 996–1011 (1975).
Benoit, F. L., Durrance, F. Y.: Radiothyroxine turnover in obesity. Am. J. Med. Sci. 249, 647–653 (1965).
Benoit, F. L., Martin, R. L., Watten, R. H.: Changes in body composition during weight reduction in obesity. Ann. intern. Med. 63, 604–612 (1965).
Benson-Cooper, D., Bird, D., Lanig, J. K., Hannah, E. E., Carell, R. W., Beanan, D. W.: Obesity in a New Zealand community. New Zealand Med. J. 82, 115–119 (1975).
Berchtold, P.: Glukosetoleranz, Plasmainsulin, Serumlipide und Fettgewebszellularität bei Männern verschiedenen Alters und Herzinfarktpatienten mit spezieller Berücksichti-gung des körperlichen Trainings. Habil. Schrift Düsseldorf (1974 a).
Berchtold, P.: Herzinfarkt und Diabetes mellitus. Therapiewoche 24, 2624 (1974b).
Berchtold, P., Berger, M., Dohse, M., Glawar, E., Potthoff, H., Gries, F. A., Zimmermann, H.: Ist der Adipöse ein Risikopatient für cardiovaskuläre Krankheiten? 10.Kongress Dtsch. Diabetes Ges. 1975.
Berchtold, P., Berger, M., Wiegelmann, W., Drost, H., Kley, H. K., Clippers, H. J., Schäfer, U., Gries, F. A., Zimmermann, H.: Hormonelle Reaktionen unter Muskelarbeit. Wiss. Arbeitstagung, Deutsche Diabetes Gesellschaft, Ausschuß Ernährung. Stuttgart: SchattauerVerlag 1976 im Druck.
Berchtold, P., Bjórntorp, P., Gustafson, A., Lindholm, B., Tibblin, G., Wilhelmsen, L.: Glucose tolerance, plasma insulin and lipids in relation to adipose tissue cellularity in men after myocardial infarction. Acta med. Scand. 191, 35 (1972).
Berchtold, P., Bow, P., Arbenz, U., Keiser, G.: Intestinale Absorptionsstörung infolge Metforminbehandlung (zur Frage der Wirkungsweise der Biguanide). Diabetologia 5, 405–412 (1969a).
Berchtold, P., Bolli, P., Keiser, G.: Mauriac-Syndrom und diabetische Enteropathie. Praxis 58, 1108–1115 (1969b).
Berchtold, P., Dahlqvist, A., Gustafson, A., Asp, N. G.: Effects of a biguanide (metformin) on vitamin B12 and folic acid absorption and intestinal enzyme activities. Scand. J. Gastroent. 6, 751–754 (1971).
Berchtold, P., Gries, F. A.: Kohlenhydratstoffwechsel. In: Buchbom, E., Jahrmärker, H., Karl, H. J., Martini, G. A., Müller, W., Riecker, G., Schwiegk, H., Siegenthaler, W., Stich, W. (eds.): Therapie innerer Krankheiten, p. 275. Berlin-Heidelberg: Springer 1974.
Berg, B. N., Simms, H. S.: Nutrition and longevity in the rat. II. Longevity and onset of disease with different levels of food intake. J. Nutr. 71, 255 (1960).
Berger, M.: Untersuchungen zur Lipolyse am menschlichen Fettgewebe in vitro. Inaugural Diss. Düsseldorf (1968).
Berger, M., Baumhoff, E., Gries, F. A.: Effect of weight reduction upon glucose tolerance in obesity. A follow up study of five years. In: Howard A. (ed.): Recent advances in obesity research: I. p. 128. London: Newman Publ. 1975.
Berger, M., Baumhoff, E., Gries, F. A.: Gewichtsreduktion und Glukose-Intoleranz bei Adipositas. Eine Verlaufsstudie über 5 Jahre. Dtsch. med. Wschr. 101, 307 (1976a).
Berger, M., Berchtold, P., Kroskemper, G. M., Zimmermann, H.: Therapie der Fettsucht. Internist im Druck (1976b).
Berger, M., Granz, M., Berchtold, P., Krüskemper, G. M., Zimmermann, H.: Verlaufsun-tersuchungen zum Langzeit-Effekt der Nulldiät. Dtsch. Med. Wschr. 101,601(1976e).
Berger, M., Gries, F. A., Berchtold, P.: Risikofaktoren bei Herzinfarkt: Adipositas. Therapiewoche 26, 455 (1976d).
Berger, M., Hagg, S. A., Goodman, M. N., Ruderman, N. B.: Glucose metabolism in perfused skeletal muscle. Effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J. in press (1976 e).
Berger, M., Herberg, L., Gries, F. A.: Fettmobilisation und Insulinempfindlichkeit des menschlichen Fettgewebes in vitro in Abhängigkeit von Alter, Übergewicht und Diabetes mellitus. In: Magyar, J., Beringer, A. (eds.): Diabetes mellitus. p. 409. Wien: Verl. Wien. Med. Akademie 1971a.
Berger, M., Preiss, H., Hesse-Wortmann, C., Gries, F. A.: Altersabhängigkeit der Fettzellgröße und der lipolytischen Aktivität im menschlichen Fettgewebe. Gerontologia 17, 312 (1971b).
Berger, W., Roten, L., Amrein, R., Christeller, M.: Aktion zur Früherfassung von Zuckerkranken in Basel 1972. Schweiz. med. Wschr. 106, 51–58 (1976).
Bergmann, von G.: Der Stoff-und Energieumsatz beim infantilen Myxödem und bei Adipositas universalis, mit einem Beitrag zur Schilddrüsenwirkung. Z. exper. Path. u. Ther. 5, 646–730 (1909).
Bergmann, von G.: Die Fettsucht. In: Oppenheimer, C. (ed.): Handbuch der Biochemie des Menschen und der Tiere. Band 4, 2. P. 208–237. Jena: G. Fischer 1910.
Beringer, A., Bänder, A., Glaninger, J., Mayerhofer, E.: Der Einfluß der Lipolyse und ihrer Hemmung auf die diabetische Stoffwechselstörung und den Cholesteringehalt des Blutes. Wiener Ztschr. Inn. Med. 52, 1–14 (1975).
Beringer, A., Thaler, H.: Zusammenhänge zwischen Diabetes und Fettleber. Dtsch. med. Wschr. 95, 836–838 (1970).
Berkowitz, D.: Metabolic changes associated with obesity before and after weight reduction. J. Am. Med. Ass. 187, 399–403 (1964).
Bernhardis, L. L., Frohman, L. A.: Effects of hypothalamic lesions at different loci on development of hyperinsulinemia and obesity in the weanling rat. J. Comp. Neuro1.141, 107–115 (1971).
Bernhardt, H.: Zur Behandlung der Fettleibigkeit. Dt. med. Journal 7, 226–229 (1956).
Bernstein, R. A., Gieeer, E. E., Rimm, A. A.: Gallbladder disease — I. Assessment of validity and reliability of data derived from a questionnaire. A study of 62739 weight conscious women. J. chron. Dis. 29, 51–58 (1976).
Bernstein, R. A., Grant, N., Kipnis, D. M.: Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus. Diabetes 24, 207–213 (1975).
Bernstein, R. A., Werner, L. H., Rimm, A. A.: Relationship of gallbladder disease to parity, obesity and age. Health service Rep. 88, 925–936 (1973).
Bertram, F.: Zur Pathogenese der Regulationskrankheiten. Dtsch. Med. Wschr. 75, 134–138 (1950).
Bierman, E. L., Bagdade, J. D., Porte, D. Jr.: Obesity and diabetes: the odd couple. Am. J. clin. Nutr. 21, 1434–1437 (1968).
Bierman, E. L., Glomset, J. A.: Disorders of lipid metabolism. In: Williams R. H.: Textbook of Endokrinology. p. 890. Philadelphia: Saunders 1974.
Bierman, E. L., Porte, D.: Carbohydrate intolerance and lipemia. Ann. intern. Med. 68, 926 (1968).
Billewicz, W. Z., Kemsley, W. F. F., Thomson, A. M.: Indices of adiposity. Brit. J. Prey. Soc. Med. 16 183–188, (1962).
Bismark, H. D.: Die Adipositas als schrittmachender and gemeinsamer Faktor der Polymorbidität im Alter. Ztschr. Altersforschung 21, 151–157, (1968).
Björntorp, P.: Studies on adipose tissue from obese patients with or without diabetes mellitus. II. Basal and insulin-stimulated glucose metabolism. Acta med. Scand. 179, 229 (1966).
Björntorp, P.: The effect of insulin in vitro on human adipose tissue from normal and diabetic subjects. Acta med. Scand. 181, 389 (1967).
Björntorp, P.: Disturbances in the regulation of food intake. Obesity: Anatomic and physiologic-biochemical observations. Adv. psychosom. Med. 7, 116 (1972a).
Björntorp, P.: Size, number and function of adipose tissue cells in human obesity. In: Greten, H., Levine, R., Pfeiffer, E. F., Renold, A. E. (eds.): Lipid metabolism, obesity, and diabetes mellitus: Impact upon atherosclerosis. Horm. metab. Res. Suppl. 4, p. 77, Stuttgart: Thieme 1972b.
Björntorp, P.: Effects of age, sex and clinical conditions on adipose tissue cellularity in man. Metabolism 23, 1091–1102 (1974a).
Björntorp, P.: Renaissance of a new frontier in obesity research. Acta. med. Scand. 196, 145–147 (1974b).
Björntorp, P.: Effects of physical conditioning in obesity. In: Bray, G. A. (ed.): Obesity in perspective. DHWE Publication No. (NIH) 75–708. p. 397. Washington, D. C. 1975.
Björntorp, P., Bengtsson, C., Blohme, G., Jonsson, A., Sjöstrom, L., Tibblin, E., Tibblin, G., Wilhelmsen, L.: Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism 20, 927–935 (1971a).
Björntorp, P., Berchtold, P., Tibblin, G.: Insulin secretion in relation to adipose tissue in men. Diabetes 20, 65–70 (1971b).
Björntorp, P., Bergman, H., Varnauskas, E.: Plasma free fatty acid turnover rate in obesity. Acta med. Scand. 185, 351 (1969a).
Björntorp, P., Bergman, H., Varnauskas, E., Lindholm, B.: Lipidmobilization in relation to body composition in man. Metabolism 18, 840 (1969b).
Björntorp, P., Carlgren, G., Isaaksson, B., Krotkieswski, M., Larsson, B., Sjöström, L.: Effect of an energy-reduced dietary regimen in relation to adipose tissue cellularity in obese women. Am. J. clin. Nutr. 28, 445–452 (1975).
Björntorp, P., Gustafson, A., Persson, B.: Adipose tissue fat cell size and number in relation to metabolism in endogenous hypertriglyceridemia. Acta med. Scand. 190, 363–367 (1971c).
Björntorp, P., Gustafson, A., Tibblin, G.: Relationship between adipose tissue cellularity and carbohydrate and lipid metabolism in a randomly selected population. In: R. J. Jones. (ed.): Atherosclerosis, Proc. of the second Intern. Symp., p. 374. Berlin-Heidelberg: Springer 1970a.
Björntorp, P., Hood, B., Martinsson, A., Persson, B.: The composition of human subcutaneous adipose tissue in obesity. Acta. med. Scand. 180, 117, 1966.
Björntorp, P., Jounge, De K., Krotkiewski, M., Sullivan, L., Sjöström, L., Steinberg, J.: Physical training in human obesity. III. Effects of long-term physical training on body composition. Metabolism 22, 1467–1475 (1973a).
Björntorp, P., Jounge, De K., Sjöström, L., Sullivan, L.: The effect of physical training on insulin production in obesity. Metabolism 19, 631–637 (1970b).
Björntorp, P., Jounge, De K., Sjöström, L., Sullivan, L.: Physical training in human obesity. II. Effects on plasma insulin in glucoseintolerant subjects without marked hyperinsulinemia. Scand. J. clin. Lab. Invest. 32, 41 (1973b).
Björntorp, P., Karlsson, M.: Triglyceride synthesis in human subcutaneous adipose tissue cells of different size. Europ. J. clin. Invest. 1, 112 (1970).
Björntorp, P., Lindholm, B., Cirndahl, G.: Adipose tissue cellularity in relation to metabolism in dystrophia myotonica. Zit. n. Bjömtorp et al. Acta med. Scand. 190, 363 (1971d).
Bjorntorp, P., Martinsson, A.: The composition of human subcutaneous adipose tissue in relation to its morphology. Acta. med. Scand. 17911, 475–481 (1966).
Björntorp, P., Sjöström, L.: The number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism 20, 703 (1971).
Björntorp, P., Sjöström, L.: The composition and metabolism in vitro of adipose tissue fat cells of different sizes. Europ. J. clin. Invest. 2, 78–84 (1972).
Björntorp, P., Sjöström, L., Berchtold, P. et al.: Diagnose and Behandlung der Adipositas. Schweiz. Rundschau Med. 60, (1971e).
Bjurulf, P.: Artherosclerosis and body build with special reference to size and number of subcutaneous fat cells. Acta med Scand. 66, Suppl. 349, 29–53 (1959).
Black, M., Botroms, E., Shuster, S.: Skin collagen and thickness in simple obesity. Brit. med. J. 4, 149–150 (1971).
Blackburn, H.: Progress in the epidemiology and prevention of coronary heart disease. In: Yn P. N., Groodwin J. F.: Progress in cardiology. p. 1 Lea and Febiger, Philadelphia: 1974.
Blackburn, L., Bistrian, B. R., Flatr, J. P.: Role of a protein sparing fast in a weight reduction programm. In: A. Howard (ed.): Recent Advances in obesity research: I. p. 279–281 London: Newman Pbl. Ltd. 1975.
Blecket, R. B., Woodhill, J. M., Leelarthaepin, B., Palmer, A. J.: Typ IV hyperlipidaernia and weight-gain after maturity. Lancet II, 517 (1975).
Bleuler, M.: „Psychosomatik“ der Fettsucht. HeIv. Med. Acta. 19, 293–308 (1952).
Blodget, F. M., Iezzoni, L., Gribetz, D., Talbot, N. B.: Effects of prolonged cortisone treatment on the statural growth, skeletal maturation and metabolic status of children. New. Engl. J. Med. 254, 636 (1956).
Bloem, W. L., Azar, G., Clark, J., Mackar, H. J.: Comparison of metabolic changes in fasting obese and lean patients. Ann. N.Y. Acad. Sci. 131, 623–631 (1965).
Blondheim, S. H., Kaufmann, N., Poznanski, R.: The treatment of obesity in an outpatient diabetic unit. J. Am. Med. Ass. 186, 1043–1046 (1963).
Bloom, W. L.: Fasting as an introduction to the treatment of obesity. Metabolism 8, 214–220 (1959).
Bloom, W. L.: Fasting ketosis in obese men and women. J. lab. clin. Med. 59, 605 (1962).
Bloom, W. L.: To fast or exercise. Am. J. clin. Nutr. 21, 1475–1479 (1968
Bloom, W. L., Azar, G., Clark, J., Mackay, J. H: Comparison of metabolic changes in fasting obese and lean patients. Ann. NY Acad. Sci. 131, 623 (1965).
Bloom, W. L., Eidex, M.: Inactivity as a major factor in adult obesity. Metabolism 16, 679–684 (1967a).
Bloom, W. L., Eidex, M. F.: The comparison of energy expenditure in the obese and lean. Metabolism 16, 685–692 (1967b).
Boeuf, G., Vague, Ph.: Le dosage radio-immunologique de l’insuline plasmatique dans le diabète et les obésités. Le Diabète 15, 185–195 (1967).
Börjeson, M.: Oberweight children. Acta paediat. 51, Suppl. 132 (1962).
Boileau, J. G., Lizoa, E. P.: Dépistage du numbre d’enfants obèses et étude sommaire dú status socioéconomique de leur famille. Vie médicale du Canada Francaise 1, 572 (1972).
Bollinger, R. E., Brown, R. W., Lukert, B. P., Monroe, M. L.: Insulin-like activity in urine of normal and obese subjects. Metabolism 14, 568–577 (1965).
Bollinger, R. E. Lukert, B. P., Brown, R. W., Guevara, L., Steinberg, R.: Metabolic balance of obese subjects during fasting. Arch. Intern. Med. 118, 3–8 (1964).
Boller, R Die Fettsucht als Gegenwartsproblem. Med. Welt 51, 570–577 (1956).
Bolodeoku, J. O., Abadevoh, B. K. Palmer, E. D.: Therapeutic effect of fenfluramine (ponderax) in obese nigerians-weight reducing and hypotensive properties. Nigerian Med. J. 2, 199–202 (1972).
Bolte, R., Gleiss, J.: Fettsucht im Kindesalter. Kinderärztl. Praxis 37, 123–137 (1969).
Bolzano, K., Lisch, H.-J., Aigner, A., Sandhofer, F., Sailer, S ’ Der Einfluß einer Null-Caloriendiät auf die Herzleistung von kreislaufgesunden,übergewichtigen Frauen. Wiener klin. Wschr. 85, 657–6661 (1973).
Bonnet, F., Gosselin, L., Chad Raine, J., Seuterre, J.: Subcutaneous adipose cell size and number in normal and obese children. Proc. XIII int. Congr. Pediatr. p. 231. Wien. med. Akad. Vol. 7 (1971).
Booyens, J., Mccane, R. A.: Individual variations in expenditure of energy. Lancet I, 223–229 (1957).
Bornhardt, A.: Die Körperwägungen der Einberufenen als Mittel zur Bestimmung der Tauglichkeit zum Militärdienst. Sankt Petersburger Medizinische Wochenschrift 11, 108–109 (1886).
Bornstein, J., Lawrence, R. D.: Plasma insulin in human diabetes mellitus. Brit. Med. J. 2, 1541 (1951).
Bortz, W. M.: Glucose tumover and oxidation in lean and obese humans. Fed. Proc. 27, 807 (1968).
Bortz, W. M.: Metabolic consequences of obesity. Ann. intern. Med. 71, 833–843 (1969).
Bortz, W. M.: The pathogenesis of hypercholesterolemia. Ann. intern. Med. 80, 738–746 (1974).
Bortz, W., Holmes, W. L.: Plasma FFA response to starvation in lean and obese subjects. Zit. Bortz: Ann. intern. Med. 71, 833 (1969).
Bory, R., Pardon, N.: Contribution a l’évaluation du facteur alimentaire dans l’obesité. Presse Medicale 60, 333–334 (1962).
Boshell, B. R., Chandalia, H. B., Kreisberg, R., Roddam, R. F.: Serum insulin in obesity and diabetes mellitus. Am. J. clin. Nutr. 21, 1419L-1428 (1968).
Botrermann, P., Schulze-Sölde, R., Dammbacher, M.: Untersuchungen über den Fettstoffwechsel bei der Fettsucht. Diabetologia 1, 180–186 (1965/66).
Bouchardat, A.: De la glycosurie au diabete sucré. Gercer-Bailliere, Paris 1875.
Boyer, J., Clement, M., Vague, P., Vague, J.: Le taux de production de cortisol dans les obésités feminines In: Atti: XII Congresso Nazionale della Sociéta Italiana di Endocrinologia: Componenti Endocrine nelle Obesità, Catania 1968, p. 197. Milan: La Pigraf 1968.
Boyer, J., Girodengo, M., Dzieniszewski, J., Vague, J.: La reponse sécrétoire corticosurrénale des sujets obèses à l’injection de 1–24 corticotrophine. Ann. Endocr. (Paris) 31, 869 (1970).
Bram, J.: Psychich factors in obesity; observation in over 2000 cases. Arch. Paediatr. 67, 543–552 (1950).
Braunstein, J. J.: Management of the obese patient. Med. Clin. North. America 55, 391–401 (1971).
Braunsteiner, H., Sailer, S., Sandhofer, F., Di Pauli, R., Gable, E., Jung, A.: Lipidwerte bei gesunden Personen and Patienten mit Myokardinfarkt. Wien. Klin. Wschr. 77, 859–862 (1965).
Bräutigam, W.: Psychosomatische Gesichtspunkte zur Genese and Therapie der Übergewichtigkeit. Therapiewoche 26, 1206–1212 (1976).
Bray, G. A.: Effect of diet and triiodothyronine on the activity of sn-glycerol-3-phosphate dehydrogenase and on the metabolism of glucose and pyruvate by adipose tissue of obese patients. J. clin. Invest. 48, 1413–1422 (1969a).
Bray, G. A.: Effect of caloric restriction on energy expenditure in obese patients. Lancet II, 397–398 (1969b).
Bray, G. A.: Measurement of subcutaneous fat cells from obese patients. Ann. intern. Med. 73, 565–569 (1970).
Bray, G. A.: Obesity: A serious symptom. Ann. intern. Med. 77, 779–795 (1972).
Bray, G. A.: Lipogenesis in human adipose tissue: some effects of nibbling and gorging. J. clin. Invest. 51, 537–548 (1972).
Bray, G. A.: Genetic and regulatory aspects in obesity of animals and man. Horm. metab. Res. Suppl. 4, 63–69 (1974).
Bray, G. A.: Metabolic responses of human adipose tissue in obesity. In: Bray G. A. (ed.): Obesity in perspective, DHEW Publication No. (NIH) 75–708, p. 253, Washington 1975 b.
Bray, G. A., (ed.): Obesity in perspective. DHEW Publication No. (NIH) 75–708, Washington 1975 a.
Bray G. A., Campfield, L. A.: Metabolic factors in the control of energy stores. Metabolism 24, 99 (1975).
Bray, G. A., Davidson, M. B., Drenick, E. J.: Obesity: A Serious Symptom. Ann. Intern. Med. 77, 779–805 (1972).
Bray, G. A., Gallagher, T. F.: Effect of nutritional state and triiodithyronine on the metabolism of adipose tissue in obesity. Clin. Res. 16, 331 (1968).
Bray, G. A., Gallagher, T. F.: Hypothalamic obesity in man. Clin. Res. 20, 190 (1972).
Bray, G. A., Gallagher, T. F.: Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine 54, 301 1975).
Bray, G. A., Glennon, J. A., Ruedi, B., Cheifetz, P., Cassidy, C. E.: Triiodothyronine and mercurial diuretics. Effects on excretion of a water load and on plasma free fatty acids in obese patients. Am. J. Clin. Nutr. 22, 1420–1422 (1969).
Bray, G. A., Kenneth, E. W., Chopra, M., Chopra, J.: Effect of triiodothyronine on some metabolite responses of obese patients. Ann. J. Clin. Nutr. 26, 715–721 (1973).
Bray, G. A., Londono, J., Gallagher, T. F.: Effect of weight loss and triiodothyronine on plasma growth hormone and insulin in obesity. Ann. Intern. Med. 70, 1100 (1969).
Bray, G. A., York, D. A.: Genetically transmitted obesity in rodents. Physiol. Rev. 51, 598 (1971).
Brech, W. J., Gordon, E. S., Glennon, J. A.: Kinetische Studien des Glukosestoffwechsels bei der Adipositas. Verh. dtsch. Ges. inn. Med. 77, 908 (1969).
Brobeck, J. R., Tepperman, J., Long, C. N. H.: Experimental hypothalamic hyperphagia in albino rat. Yale J. biol. Med. 15, 893 (1943).
Brook, C. G. D.: Evidence for a sensitive period in adipose-cell replication in man. Lancet II, 624–627 (1972).
Brook, C. G. D., Lloyd, J. K.: Adipose cell size and glucose tolerance in obese children and effects of diet. Arch. disease childhood 48, 301–304 (1973).
Brook, C. G. D., Lloyd, J. K., Wolf O. H.: Relation between age of onset of obesity and size and number of adipose cells. Brit. Med. J. II, 25–27 (1972).
Brown, D. F., Doyle, J. T.: Pre-beta-lipoproteinemia. Its bearing on the dietary management of serum lipid disorders as related to ischemic heart desease. Am. J. clin. Nutr. 20, 324 (1967).
Brown, R. G., O’leary, J. P., Woodward, E. R.: Hepatic effects of jejunoileal bypass for morbid obesity. Am. J. Surgery 127, 53–58 (1974).
Brozek, J., Keys, A.: Relative body weight, age and fatness. Geriatrics 8, 70–75 (1953).
Bruch, H.: Obesity in childhood. 4. Energy expenditure of obese children. Amer. J. dis. child. 60, 1082 (1940).
Bruch, H.: The importance of overweight. New York: Norton 1957.
Bruch, H.: Developmental obesity and schizophrenia. Psychiatry 21, 65 (1958).
Bruch, H.: Über die psychologischen Aspekte der Fettleibigkeit. Med. Klin. 295–300 (1964).
Bruch, H.: Eating disorders: obesity, anorexia nervosa and the person within. London: Routledge and Kejan, 1974.
Brügel, H.: Die Behandlung der Adipositas mit Schilddrüsenhormon-Analogen. Münch. Med. Wschr. 106, 214–217 (1964).
Brugsch, T.: Fettsucht. In: Kraus, F., Brugsch, T. (eds.): Spezielle Pathologie und Therapie innerer Krankheiten. 1. Band, p. 297. Berlin: Urban + Schwarzenberg, 1919.
Buchwald, H., Lober, P. H., Varco, R. L.: Liver biopsy findings in serenty = seven consecutive patients undergoing jejunoileal bypass for morbid obesity. Am. J. Surgery 127, 48–52 (1974).
Buchwald, H., Varco, R.: A bypass operation for obese hyperlipidemia patients. Surgery 70, 62–70 (1971).
Bugyi, B.: Hautfalten Untersuchungen an der heranwachsenden Jugend. Z. Morph. Anthropolog. 61, 207–216 (1969).
Bühlmann, A. A.: Atmung. In: Siegenthaler W. (ed.): Klinische Pathophysiologie p. 656. Stuttgart: Thieme 1973.
Bürger, M.: Verdauungs-und Stoffwechselkrankheiten. Berlin VEB Volk und Gesundheit. 1953.
Bullen, B. A., Quaade, F., Olesen, E., Lund, S. A.: Ultrasound reflections used or measuring subcutaneous fat in humans. Human Biol. 37, 375–384 (1965).
Burcher, S. K., Sorell, V. F. Intestinal bypass for obesity. N. Z. Med. J. 73, 128–135(1971).
Bürger, M., Ries, U.: Zum Problem der Fettsucht. Münch. Med. Wschr. 100, 258–265 (1958).
Burmeister, W.: Eine neue Methode zur Bestimmung der Körperzellmasse. Klin. Wschr. 43, 750–751 (1965).
Burns, Th. W., Hales, C. N.: Regulation of lipolysis in isolated human adipose tissue cells. Lancet I, 796 (1966).
Burt, V., Stunkard, A.: Body weight and achilles reflex time. Ann. Intern. Med 60, 900–902 (1964).
Burwell, C. S., Robin, E. D., Whaley, R. D., Bichelmann, A. G.: Extreme obesity associated with alveolar hypoventilation — a pickwickian syndrome. Amer. J. med. 21, 811 (1956).
Buschmann, G., Fritze, E., Marsch, A.: Verlaufsbeobachtungen an 1500 Zuckerkranken. Dtsch. Med. Wschr. 83, 1284–1289 (1958).
Buskirk, R. R., Thompson, R. H., Lutwak, L., Whedon, G. D.: Energy balance of obese patients during weight reduction: influence of diet restriction and exercise. Ann N Y Acad Sci 110, 918 (1963).
Butterfield, W. J. H., Hanley, T., Whichelow, M. J.: Peripheral metabolism of glucose and free fatty acids during oral glucose tolerance tests. Metabolism 14, 851 (1965).
Butterfield, W. J. H., Whichelow, M. J.: Fenfluramine and muscle glucose uptake in man. Lancet 2, 109 (1968).
Cahill, G. F.: Starvation in man. N. Engl. J. Med. 282, 668–675 (1970).
Cahill, G. F.,: Obesity and insulin levels. N. Engl. J. Med. 284, 1268 (1971).
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, B. A., Kipnis, D. M.: Hormone-fuel interrelationship during fasting. J. clin. Invest. 45, 1751 (1966).
Cahill, G. F., Owen, O. E., Felig, P., Morgan, A. P.: The endocrine control of metabolism during fasting. Excerpta medica Intern. Cong. Ser. 184, 148–151 (1968a).
Cahill, G. F. Jr., Owen, O., Morgan, A. P.: The consumption of fuels during prolonged starvation. In: G. Weber, (ed.): Advances in enzyme regulation 6, 143 (1968b).
Caldwell, A. B., Watson, P., Green, D. B., Florin, A., Braun, P., Bierenbaum, M. L.: Weight reduction and serum cholesterol levels. Amer. J. clin. Nutr. 12, 401–405 (1963).
Canzler, H.: Energiemessungen unter KH- bzw. Fettreicher Kost. In: Jahnke, K., Mehnert, H. and Drost, H., (eds.): Metabolische and klinische Aspekte der Kohlenhydrate in der Ernährung. p. 136. Mainz: Kirchheim 1975.
Cargille, C. M.: Human chorionic gonadotropin not indicated for obesity. J. Amer. med. Ass. 219, 1485 (1972).
Carlson, L. A.: Obesitas; steady state. In: Melin H. (ed.): Nordisk Symposium om obesitas, p. 63 (1967).
Carne, S.: The action of chorionic gonadotropin in the obese. Lancet II,1282–1284 (1961).
Carter, J. E. L., Phillips, W. H.: Structural changes in exercising middle-aged males during a 2 year period. J. appl. Physiol. 27, 787 (1969).
Castelnuovo-Tedesco, P., Schiebel, D.: Studies of superobesity: II. Psychiatric appraisal of jejuno-ileal bypass surgery. Amer. J. Psychiatry 133, 26–31 (1976).
Catenacci, A. J., Anderson, J. D., Boersma, D.: Anesthetic hazards of obesity. J. Amer. med. Ass. 175, 657 (1961).
Ceresa, F., Angeli, A., Boccuzzi, G., Perotti, L.: Impulsive and basal ACTH secretion phases in normal subjects, in obese subjects with signs of adrenocortical hyperfunction and in hyperthyroid patients. J. Clin. Endocrinol. 31, 491–501 (1970).
Cermak, J.: Das Herzvolumen bei Fettleibigen. Das Herzvolumen and seine Beziehung zur Körpermasse, zum Gewicht and zur Körpermasse bei obesen and proportional entwikkelten Knaben. Arch. Kreisl. Forsch. 47, 234 (1965).
Challoner, D. R.: Hypothesis: Hypermetabolic states, Lancet II, 681 (1966).
Chapman, J. M., Massey, F. J.: The interrelationship of serum cholesterol, hypertension, body weight and risk of coronary heart disease: results of the first ten years follow-up in the Los Angeles heart study. J. chron. Dis. 17, 933–949 (1964).
Chetwynd, S. J., Stewart, R. A., Powell, G. E.: Social attitudes toward the obese physique. In: Howard A. (ed.): Recent advances of obesity research: I. p. 223. London: Newman Publ. 1975.
Chiang, B. N., Perlman, L. V., Epstein, F. H.: Overweight and hypertension. A review. Circulation 39, 403 (1969).
Chief medical officer of the Ministry of Education (1962): Report on the Health of the School Child (1960/1961). London, HMSO (1962).
Chiles, R., Tzagournis, M.: Excessive serum insulin response to oral glucose in obesity and mild diabetes. Diabetes 19, 458–464 (1970).
Chiumello, G., Del Guercio, M. J., Carnelutti, M., Bidone, G.: Relationship between obesity, chemical diabetes and beta pancreatic function in children. Diabetes 18, 238 (1969).
Chlouverakis, C., Hoinicki, D.: Effect of fat cell size on its sensitivity to insulin measured by a new method. Steroids Lipid Res. 5, 351–358 (1974).
Christakos, G.: Community programs for weight reduction: Experience of the bureau of nutrition, New York City. Canad. J. Publ. Health. 58, 499 (1967).
Cianoli, A. C.: Die Behandlung der Adipositas mit 500 Kalorien-Diät and humanem Choriongonadotropin. Gynäkolog. Rundschau 12, 279–290 (1972).
Cioffi, L. A., Speranza, A.: Physiological and psychological components of the body weight control system in the obese. Bibl. Nutr. Dieta 77, 154 (1972).
Claussen, F., Jahnke, K., Daweke, H., Liebermeister, H., Oberdisse, K.: Diabetesmorbidität in einer soziologisch definierten Bevölkerungsgruppe (Bäckermeister einer Großstadt). Dtsch. med. Wschr. 95, 431 (1970).
Clive, D., Ball, M. F., Melon, C. R., Werdein, E. J., Canary, J. J., Kyle, L. H.: Modifications of the helium dilution method of measuring human body volume. J. Lab. clin. Med. 66, 841 (1965).
Cogate, A. N., Prunty, F. T. G.: Adrenocortical function in “obesity with pink striae” in the young adult. J. clin. Endocrinol. 23, 747 (1963).
Cohen, J.: 17 -Ketogenic steroid excretion in obese children before and after weight reduction. Brit. Med. J. 5072, 686 (1958).
Cohn, C., Joseph, D.: Influence of body weight and body fat on appetite of normal, lean and obese rats. Yale J. biol. Med. 34, 598 (1962).
Coleman, D. L., Hummel, K. P.: Effects of parabiosis of normal with genetically diabetic mice. Amer. J. Physiol. 217, 1298 (1969).
Colwell, J. A., Lein, A.: Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes 16, 560–565 (1967).
Comstocx, G. W., Kendrick, M. A., Livesay, V. T.: Subcutaneous fatness and mortality. Amer. J. epidemiol. 83, 548 (1966).
Conradi, M.-L., Conradi, E.: Zur Indikation klinischer Fastenbehandlung. Ztschr. ärztl. Fortbild. 63, 1284–1288 (1969).
Cope, C. L.: Studies on urea excretion. The effects on the urea clearance of changes in protein and salt content of the diet. J. clin. invest. 12, 967 (1933).
Copinschi, G., Cornie, A., Leclercq, R., Frankson, J. R. M.: Cortisol secretion rate and urinary corticoid excretion in normal and obese subjects. Acta endocr. (Kbh) 51, 186 (1966).
Copinischi, G., Wegienka, L. C., Hane, S., Forsham, P. H.: Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism 16, 485–491 (1967).
Corvilain, J., Loeb, H., Champenois, A., Abramow, M.: Effect of fasting on levels of plasmanonesterified fatty acids in normal children, normal adults and obese adults. Lancet I, 534–535 (1961).
Court, J. M.: The management of obesity. Drugs 4, 411–418 (1972).
Court, J. M., Hill, G. J., Dunlop, M., Boulton, T. J. C.: Hypertension in childhood obesity. Aust. paediat. J. 10, 296–300 (1974).
Craddock, D.: Obesity and its management. II. Edit. London, New York, Edinburgh: Churchill Livingstone. 1973.
Craddock, D.: Psychological and personality factors associated with succesfull weight reduction: a 10-year follow up of 134 personal cases. In: Howard A. (ed.): Recent advances in obesity research: I, p. 220. London: Newman Publ. 1975.
Cramer, M.: Statistische Untersuchung der Metabolite des Fett-and KH-Stoffwechsels im Serum bei Normalpersonen and Personen mit Adipositas, Arteriosklerose and Diabetes mellitus. Dissertation, Düsseldorf 1970.
Crane, M. G., Harris, J. J., Herber, R., Shankel, S., Specht, N.: Excessive fluid retention related to cellulose ingestion: studies on two patients. Metabolism 18,945–960 (1969).
Creutzfeldt, W.: The relationship between aetiological and promoting factors in the pathogenesis of diabetes mellitus in man and animals. In: Luft, R., Randle, J. (eds.): On the pathogenesis of diabetes mellitus. Acta diabet. lat. 7, Suppl. 1, 341–359, (1970).
Creutzfeld, W., Sickinger, K., Frerichs, F.: Diabetes and Lebererkrankungen. In: Pfeiffer, E. F. (ed.). Handbuch des Diabetes mellitus Band II, p. 807. München: Lehmanns 1971.
Crisp, A. H., Mcguiness, B.: Jolly fat, relation between obesity and psychoneurosis in general population. Brit. med. J. 1, 7–9 (1976).
Crisp, A. H., Stonehill, E., Koval, J.: The pycnic habitus in psychiatric illness. In: Howard A. (ed.): Recent advances in obesity research: I p. 199. London: Newman Publ. 1975.
Crockford, P. M., Hazzard, W. R., Williams, R. H.: Insulin response to glucagon; the opposing effects of diabetes and obesity. Diabetes 18, 216–224 (1969).
Crockford, P. M., Salmon, P. A.: Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss. Canad. Med. Ass. J. 103, 147–150 (1970).
Crofford, O. B.: The uptake and inactivaton of native insulin by isolated fat cells. J. biol. Chem. 243, 362 (1968).
Croughs, W., Schopman, W., Tiddens, H. A.: Helv. Paediat. Acta 23, 464 (1968) 1. c. Rabinowitz (1970).
Cuatrecasas, P.: Interaction of insulin with the cell membrane: The primary action of insulin. Proc. Nat. Acad. Sci (USA) 63, 450 (1969).
Cuatrecasas, P.: Perturbation of the insulin receptor of isolated fat cells with proteolytic enzymes: Direct measurement of insulin-receptor interactions. J. biol. Chem. 246, 6522 1971).
Cuatrecasas, P.: Insulin receptor interractions in adipose tissue: Direct Measurement and Properties. Proc. Nat. Acad. Sci. (USA) 68, 1264 (1971).
Cuatrecasas, P.: Membrane Receptors. Ann. Rev. Biochem. 43, 169 (1974).
Cubberley, P. T., Polster, C. S. A., Schulman, C. L.: Lactic acidosis and death after the treatment of obesity by fasting. N. Engl. J. Med. 272, 628–630 (1965).
Cullen, J. H., Formel, P. F.: The respiratory defects in extreme obesity. Amer. J. Med. 32, 525 (1962).
Cunningham, G. L. W.: Diethylpropion in the treatment of obesity. J. coll. Gen. Praet. 347–349 (1963).
Cutillo, S., Ansanelli, V., Stoppoloni, G., Pacelli, V., D’onofrio, F.: Insulin response to lucagon in obese children. Lancet.II, 1188 (1968).
Czyzyk, A., Tawecki, J., Sadowski, J., Ponikowska, L, Szczepanik, Z.: Effects of biguani-des on intestinal absorption of glucose. Diabetes 17, 492–498 (1968).
Dahr, P.: Fettleibigkeit and Zuckerkrankheit. Inaugural - Diss. Köln, 1930.
Dalén, N., Hallberg, D., Lamke, B.: Bone mass in obese subjects. Acta med. Scand. 197, 353 (1975).
Damon, A., Goldman, R. F.: Predicting fat from body measurements. Densitometric validation of ten anthropometric equations. Human Biology 36, 32–44 (1964).
Damp P., Christiansen, C., Lenz, K., Jakobsen, E., Justesen, T.: Bile acid metabolism, intestinal bacterial flora and calcium metabolism after three types of intestinal shunt operation for obesity. In: A. Howard (ed.): Recent Advances in obesity Research I. p. 341 London: Newman Publ. 1975.
Danowski, T. S., Morgan, C. R., Simder, J. H., Moses, C., Sabeh, G.: Immuno assayable insulin and glucose tolerance in non-obese and obese subjects. Exp. Med. Surg. 25, 122 (1967).
Danowski, T. S., Tsai, C. T., Morgan, C. R., Sieracki, J. C., Alley, R. A., Robbins, T. J., Sabeh, G., Sunder, J. H.: Serum growth hormone and insulin in females without glucose intolerance. Metabolism 18, 811–820 (1969).
Davidoff, E., Reifenstein, E. C.: The stimulating action of benzedrine sulfate: a comparative study of the responses of normal persons and of depressed patients. J. Am. Med. Ass. 108, 1770–1776 (1937).
Davidoff, L. M.: Studies in Acromegaly III. The anamnesis and sympomatology in one hundred cases. Endocrinology 10, 461–467 (1926).
Davidson, M. B.: Effect of obesity on insulin sensitivity of human adipose tissue. Diabetes 21, 6–12 (1972).
Davidson, M. B., Kaplan, S. A.: Increased insulin binding by hepatic plasma membranes of diabetic rats:Normalization by insulin therapy. Clin. Res. 23, 419A (1975).
Davies, C. T. M., Drysdale, H. C., Passmore, R.: Does exercise promote health? Lancet II, 930 (1963).
Daweke, H., Van Landeghem, H., Bach, I., Zimmermann, H., Breitbach, A.: Bestimmung der insulinähnlichen Aktivität und der physiologischen Insulinreserve bei schwerer Adipositas. Klin. Wschr. 43, 185 (1965).
Daweke, H., Liebermeister, H., Gruneklee, D., Oberdisse, K.: Die Insulinsekretion bei Adipositas und Diabetes. Med. Welt 20, 1872–1876 (1969).
Daweke, H., Rüenauver, R., Schilling, W., Grüneklee, D., Jahnke, K, Liebermeister, H., Gries, F. A., Oberdisse, K.: Untersuchungen des Kohlenhydrat-und Fettstoffwechsels bei Praediabetes. Diabetologia 4, 349–357 (1968).
Daweke, H., Van Landeghem, H., Winkelmann, W., Bach, I.: Der Einfluß der Adipositas auf die insulinähnliche Aktivität und physiologische Insulinreserve beim Altersdiabetes. Klin. Wschr. 43, 190–196 (1965).
Debeus, A. F., Krimsky, I., Fran, A.: Rapid effects of insulin on the hyptothalamic satiety center. Am. J. Physiol. 217, 1114 (1969).
Deckert, T., Hagerup, L.: Serum insulin in normal and obese persons. Acta Med. Scand. 182, 225–232 (1967).
Deeths, T. M., Dodds, W. J.: Lipoma of the colon. Amer. J. Gastroent. 58, 326 (1972).
Deeths, T. M., Madden, P. N., Dodds, W. J.: Multiple Lipomas of the stomach and duodenum. Dig. Dis. 20, 771 (1975).
Defelice, E.A., Chaykin, L. B., Cohen, A.: Double blind clinical evaluation of mazindol, dextroamphetamin and placebo in treatment of exogenous obesity. Current. therapeut. Res. 15, 358–366 (1973).
De Meyts, P., Roth, J. Neville, D. M., Gavin, J. R., Lesniak, M. A.: Insulin interaction with its receptors: Experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 55, 154 (1973).
Delso Blanco, A. E.: Obesity in rural environment. I. c. Ries, W. (1970).
De Ramos, E. C.: The use of diethylpropion in the treatment of obesity. Brit. J. Clin. Practice 18, 210 (1964).
Dercum, F. X.: A subcutaneous connective tissue dystrophy of the arm and neck, associated with symptoms resembling myxedema. Univ. Med. Mag. 1, 140–150 (1888).
Deutsche Gesellschaft für Ernährung: Ernährungsbericht 1976. Frankfurt 1976.
Dietze, G., Wicklmayr, M., Heft, K. D., Mehnert, H.: Kohlenhydratverwertung des Zentralnervensystems und des Skelettmuskels während längerem Fasten. In: K. Jahnke, H. Mehnert, H. Drost (eds.): Metabolische und klinische Aspekte der Kohlenhydrate in der Ernährung. p. 110–113. Mainz: Verlag Kirchheim & Co., 1975.
Di Girolamo, M., Mendlinger, S., Fertig, J. W.: A simple method to determine fat cell size and number in four mammalian species. Am. J. Physiol. 221, 850–858 (1971).
Di Natale, B. Devetta, M., Rossi, L., Garlaschi, C., Caccamo, A., Del Guercio, M. J., Chimuello, G.: Circadian rhythm of plasma growth hormone, cortisol and insulin in obese and diabetic children. Heiv. paediat. Acta 28, 591 (1973).
Ditschuneit, H.: Obesity and diabetes mellitus. In: Rodriguez, R. R., Vallance-Owen, J., (eds.): Diabetes. p. 526, Amsterdam, Exerpta Medica 1971.
Ditschuneit, H.: Erfahrungen mit ambulanter Nulldiät. Verhdlg. IV. Internat. Donau-Symposiums über Diabetes mellitus, Dubrovnik (1975).
Ditschuneit, H., Faulhaber, J.-D., Beil, J., Pfeiffer, E. F.: Veränderungen des Stoffwechsels bei Null-Diät. Internist 11, 176–183 (1970).
Dole, V. P.: Relation between non-esterified fatty acids in plasma and metabolism of glucose. J. clin. Invest. 35, 150 (1956).
Drenick, E. J.: Weight reduction by prolonged fasting. In: Bray, G. A. (ed.): Obesity in perspective, DHEW Publication No. (IH) 75–708 p. 341, Washington DC (1975).
Drenick, E. J., Alvarez, L. C.: Neutropenia in prolonged fasting. Am. J. Clin. Nutr. 24,859–863 (1971).
Drenick, E. J., Brickman, A. S., Gold, E. M.: Dissociation of the obesity-hyperinsulinism relationship following dietary restriction and hyperalimentation. Amer. J. Clin. Nutr. 25,746 (1972).
Drenick, E. J. Hunt, J. E., Swendseid, M. E.: Magnesium depletion during prolonged fasting of obese males. J. Clin. Endocrin. 29, 1341–1348 (1969).
Drenick, E. J., Johnson, D.: Evolution of diabetic ketoacidosis in gross obesity. Amer. J. Clin. Nutr. 28, 264–272 (1975).
Drenick, E. J., Joven, C. B., Swendseid, M. E.: Occurance of acute Wemicke’s encephalopathy during prolonged starvation for the treatment of obesity. New Engl. J. Med. 274, 937–939 (1966).
Drenick, E. J., Simmons, F., Murphy, J. F.: Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small bowel bypass. New Engl. J. Med. 282, 829–834 (1970).
Drenick, E. J., Swendseid, M. E., Bland, W. H., Tuttle, S. G.: Prolonged starvation as treatment for obesity. J. Am. Med. Ass. 187, 100–105 (1964).
Dressler, D.: Die sogenannte Zellulitis (Pannikulose) Fortsch. Med. 88, 1294 (1970).
Drost, H., Grüneklee, D., Grips, F. A.: Das Verhalten von Blutglucose, Seruminsulin and Plasmaglucagon im sukzessiven Glucose-Tolbutamid-Test and deren differential-diagnostische and differential-therapeutische Bedeutung bei Diabetes mellitus. IV. Internat. Donau-Symposium über Diabetes mellitus, Dubrovnik (1975).
Drost, H., Jahnke, K.: Zur Frage der Nährstoffaufnahme Fettleibiger. In: Jahnke, K., Mehnert, H. U., Drost, H., (eds.): Metabolische and klinische Aspekte der Kohlenhydrate in der Ernährung. p. 114 Mainz: Kirchheim 1975.
Dublin, L.J.: The influence of weight on certain causes of death. Human Biol. (Baltimore) 2, 159 (1930).
Dublin, L.J., Lotka, A.J.: Length of life. New York, Ronald Press Co. 1936.
Dublin, L.J., Marks, H.H.: The build of women and its relation to their mortality. Trans. Ass. Life. Insur.Med. Dir. Amer. 24, 47 (1937).
Dublin, L.J., Marks, H.H.: Mortality among insured overweights in recent years. Trans. Ass. Life Insurance Med. Dir. Amer. 35, 235 (1951).
Duboff, G.S., Luby, E.D.: Adrenocortical, anterior pituitary and gonadal activity in an extremely obese male. Metabolism 13, 60–62 (1964).
Duchosal, F., Allemann, H., Widmer, L.K., Breil, H., Leu, H.J.: Varikosis — Alter — Körpergewicht. Z. Kreisl. Forsch. 57, 380 (1968).
Duddleston, A.K., Bennion, M.H.: Effect of diet and/or exercise on obese college women. J. Am. Diet, Ass. 56, 126–129 (1970).
Du Florey, C.V.: The use and interpretation of ponderai index and other weight — height ratios in epidemiological studies. J. Chron. Dis. 23, 93–103 (1970).
Duncan, G.C., Duncan, T.G., Schatanoff, J.: Refractory obesity and diabetes. Ann. N.Y. Acad. Sci. 148, 906–913 (1968).
Dunkelman, S.S., Fairhurst, B., Plager, J., Waterhouse, C.: Cortisol metabolism in obesity. J. Clin. Endocrin. Metab. 24, 832 (1964).
Durnin, J.V.G.A.: Age, physical activity and energy expenditure. Proc. Nutr. Soc. 25, 107–113 (1966).
Durnin, J.V.G.A., Rahaman, M.M.: The assessment of the amount of fat in the human body from measurements of skinfold thickness. Brit. J. Nutr. 21,681–689 (1967).
Durnin, J.V.G.A., Womersley, J.: The metabolic effects, and the composition of tissue lost, in reduction by obese patients on treatment with fenfluramine. Brit. J. Pharmacol. 49, 115–120 (1973).
Durnin, J.V.G.A., Womersley, J.: Body fat assessed from total body density and its extimation from skinf old thickness; measurements on 481 men and women aged from 16 to 72 years. Brit. J. Nutr. 32, 77–97 (1974).
Dyer, A.R., Stamler, J., Berkson, D.M., Lindberg, H.A.: Relationship of relative weight and body mass index to 14-year mortality in the Chicago Peoples Gas Company study. J. chron. Dis. 28, 109–123 (1975).
Dykes, M.H.M.: Evaluation of three anorexiants. J. Am. Med. Ass. 230, 270–272 (1974).
Eastman, N.J., Jackson, E.: Weight relationships in pregnancy 1. The bearing of maternal weight gain and the pre-pregnancy weight on birth weight in full term pregnancies. Obstet. Gynecol. Surv. 23, 1003–1025 (1968).
Ebstein, W.: Die Fettleibigkeit (Korpulenz) and ihre Behandlung nach physiologischen Grundsätzen. Wiesbaden, Bergman (1882).
Edholm, O.G.: Energy expenditure and calorie intake in young men. Proc. Nutr. Soc. 20, 71–76 (1961).
Edholm, O. G., Fletcher, J.G., Widdowson, E.M., Mccane, R.A.: The energy expenditure and food intake of individual men. Brit. J. Nutr. 9, 286–300 (1955).
Editorial: Effects of meal eating versus nibbling on body composition. Nutr. Rev. 19, 9–11 (1961).
Editorial: Drugs and obesity. J. Am. Med. Ass. 204, 328–329 (1968a).
Editorial: Reducing pills and digitalis intoxication. J. Am. Med. Ass. 206, 1078–1079 (1968b).
Editorial: The measurement of obesity. S. Afr. Med. J. 43, 1273 (1969).
Editorial: Drastic cures for obesity. Lancet I, 1094 (1970).
Editorial: Effects of meal frequency during weight reduction. Nutr. Rev. 30, 158–162 (1972).
Editorial: Effects of bypass on liver remain unclear. J. Am. Med. Ass. 225, 13–14 (1973).
Edwards, D.A.W.: Observations on the distribution of fat. Clin.Sci. 9, 259–270 (1950).
Edwards, D.A.W.: Estimation of the proportion of fat in the body by measurement of skinfold thickness. Am. J. Clin. Nutr. 4, 35–36 (1956).
Edwards, D.A.W., Hammond, W.H., Healty, M.J.R., Tanner, J.M.,Whitehouse, R.H.:Design and accuracy of calipers for measuring subcutaneous tissue thickness. Brit. J. Nutr. 9, 133–143 (1955
Edwards, K.D.G., Whyte, H.M.: The simple measurement of obesity. Clin. Sci. 22, 347–352 (1962).
Egert, H., Rarrls, S., Jahn, O.: Zur lipolytischen Wirkung von Adrenalin bei Adipositas vor and nach Trijodthyronin. Wien. Klin. Wschr. 80, 405–409 (1968).
Eid, E.E.: Follow up study of physical growth of children who had exessive weight gain in first six months of life. Brit. Med. J. 2, 74–76, 1970.
Eitner, S., Achterberg, J.: Zum Problem des Ober-and Untergewichts im Alter aus arbeitshygienischer Sicht. Dtsch. Gesundheitswesen 20, 1240–1247 (1965
El-Khodary, A.Z., Ball, M.F., Ball, J.J.: Plasma insulin levels and body composition in obesity. Clin. Res. 16, 341 (1968).
El-Khodary, A.Z., Ball, M.F., Oweiss, I.M., Canary, J.J.: Insulin secretion and body composition in obesity. Metabolism 21, 641–655 (1972).
El-Khodary, A.Z., Ball, M.F., Stein, B., Canary, J.J.: Effect of weight loss on the growth hormone response to arginine infusion in obesity. J. Clin. Endocrinol. 32, 42–51 (1971
Elliotr, B.W.: A collaborative investigation of fenfluramine: anorexigenic with sedative properties. CUIT. Therapeut. Res. 12, 502–515 (1970).
Emerson, K., Saxeny, B.N., Poindexter, E.L.: Calorie cost of normal pregnancy. Obstet. Gynecol. 40, 786–794, 1972.
Ende, N.: Starvation studies with special reference to cholesterol. Amer. J. Clin. Nutr. 11, 270–280 (1962).
Englhardt, A., Gries, F.A., Liebermeister, H., Jahnke, K.: Size, lipid and enzyme content of isolated human adipozytes in relation to nutritional state. Diabetologia 7, 51–58 (1971).
Englhardt, A., Gries, F.A., Preiss, H., Jahnke, K.: Vergleichende Untersuchungen über Protein-und Lipidgehalt und die Aktivitäten von Enzymen der Glykolyse und des Pentosephosphatshunt im Fettgewebe und in isolierten Fettzellen Stoffwechselgesunder. Horm. Metab. Res. 1, 228 (1969).
Englhardt, A., Hagemann, K., Jahnke, K.: Enzyme des energieliefernden Stoffwechsels im menschlichen Fettgewebe. Enzym. biol. clin. 9, 287 (1968).
Englhardt, A., Jahnke, K.: Moderne Behandlung der Fettsucht. Dtsch. Med. J. 15, 292–298, 1964.
Englhardt, A., Jahnke, K., Pilger, H.: Ernährungsgewohnheiten Fettsüchtiger und Wege zu ihrer therapeutischen Beeinflussung. Med. Klinik 58, 1754–1759 (1963).
Epriglir, E.S. et al: 1956, 1. c. Luhanova 1969.
Eriksen, M., Deckert, T., Hansen, P.F.: Glukosetolerans hos 70 öarige personer. Nordisk Medicin 83, 748–753 (1970).
Evans, E., Miller, D.S.: Bulking agents in the treatment of obesity. Nutr. Metabol. 18, 199–203 (1975).
Fabry, P., Fodor, J., Hejl, Z., Braun, T., Zvolankova, K.: The frequency of meals: its relation to overweight, hypercholesterolemia and decreased glucose tolerance. Lancet II, 614 (1964).
Fahlen, M., Stenberg, J., Björntorp, P.: Insulin secretion in obesity after exercise. Diabetologia 8, 141 (1972).
Fahrner, H.: Erfahrungen mit der strengen Nahrungskarenz bei der Behandlung der essentiellen Adipositas. Therapiewoche: 2068–2069 (1968).
Farrant, P.C., Neville, R.W.J., Stewart, G.A.: Insulin release in response to oral glucose in obesity: the effect of reduction of body weight. Diabetologia 5, 198–200 (1969).
Fain, J.N., Liken, S C Response of trypsin-treated brown and white fat cells to hormones. J. biol. Chem. 244, 3500 (1969).
Faloon, W.W.: An evaluation of risks — bypass versus obesity. N. Engl. J. Med. 294, 159–160 (1976).
Falta, W., Högler, F.: Die Zuckerkrankheit. 4. Aufl., Halle: Markhold Verl. 1953.
Fankhauser, S.: Zur Indikation und praktischen Verwendung der oralen Anti-Diabetika. Schweiz. med. Wschr. 103, 856 (1972).
Farebrother, M.J.B., Mchardy, G.J.R., Munro, J.F.: Relation between pulmonary gas exchange and closing volume before and after substantial weight loss in obese subjects. Brit. Med. J. 3, 391–393 (1974).
Farquhar, J.W., Olefsky, J., Stern, M., Reaven, G.M.: Obesity, insulin and triglycerides. In: Bray, G.A. (ed.): Obesity in Perspective, DHEW Publication No. (NIH) 75–708, p. 313, Washington DC 1975.
Faulhaber, J.D., Petruzzi, E.N., Eble, H., Ditschuneit, H.: In-vitro-Untersuchungen über den Fettstoffwechsel isolierter menschlicher Fettzellen in Abhängigkeit von der Zellgröße: Die durch Adrenalin induzierte Lipolyse. Horm. Metab. Res. 1, 80 (1969).
Favre, H., Busset, R., Quoidbach, A., Dayer, A., Charlier, B.: Evaluation des modifications de la composition corporelle de l’obèse au cours de l’amaigrissement. Praxis 38, 1202–1205 (1969).
Fazekas, F.: Current concepts in therapy: Anorexigenic agents. N. Engl. J. Med. 264, 501–503 (1961).
Fda Drug Bulletin: Food and Drug Administration. Rockville, Md. Dezember 1972.
Feinberg, Cr.: Obesity: class IV anesthesia risk. N.Y. State J. Med. 71, 2200–2101 (1971).
Feinstein, A.R.: The measurement of success in weight reduction. J. Chron. Dis. 10,440–456 (1959).
Feinstein, A.R.: The treatment of obesity: an analysis of methods, results, and factors which influence success. J. Chron. Dis. 11, 349–393 (1960).
Felber, J.P., Vanotti, A.: Effects of fat infusion on glucose tolerance and insulin plasma levels. Exptl. Med. 10, 153 (1964).
Feldman, E.B., Benkel, P., Nayak, R.V.: Physiologic factors influencing circulating triglycerides in women: Age, weight gain and ovarian function. J. lab. clin. Med. 62, 437–448 (1963).
Feldman, R., Sender, H.J., Siegelaub, A.B.: Difference in diabetic and non-diabetic fat distribution patterns by skinfold measurements. Diabetes 18, 478 (1969).
Felig, P., Marliss, E., Cahill, G.F.: Plasma amino acid levels and insulin secretion in obesity. N. Engl. J. Med. 281, 811–816 (1969).
Felig, P., Marliss, E., Cahill, G.F.: The plasma amino acid levels elevated in obesity. N. Engl. J. Med. 282, 166 (1970).
Felig, P., Wahren, J.: Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J.clin.Invest. 50, 1702 (1971).
Felig, P., Wahren, J.: The liver as site of insulin and glucagon action in normal, diabetic and obese humans. Israel J. med. Sci. 11, 528 (1975).
Felig, P., Wahren, J., Hendler, R.: Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes 24, 468 (1975).
Felig, P., Wahren, J., Hendler, R., Brundin, T.: Splanchnic glucose and amino acid metabolism in obesity. J. clin. Invest. 53, 582 (1974).
Fergel, P.P., Fernandes, J., Haverkamp Begemann, P Plasma triglyceride clearing in obese children. Amer. J. clin. Nutr. 28, 858 (1975).
Fernandez, N.A., Burgos, J.C., Roberts, L.J., Asenjo, C.F.: Nutritional status in Puerto Rican slum area. Amer. J. clin. Nutr. 21, 646–656 (1968).
Ferner, H.: Das Inselsystem des Pankreas. Entwicklung, Histologie und Pathophysiologie, mit besonderer Berücksichtigung des Diabetes mellitus. Stuttgart: Thieme Verlag 1952.
Ferstl, R., RICHTER: Abnehmen per Post. Psychologie Heute 3, 23–26 (1976).
Fetter, F., Durkin, J.K., Duncan, G.G.: Dietary versus insulin treatment of the obese diabetic patient. Amer. J. Med. Sci. 195, 781–787 (1938).
Fineberg, S.E., Merimee, T.J.: The effects of hyperinsulism upon insulin sensitivity. Clin. Res. 22, 467A (1974).
Fineberg, S.K.: The obesity-diabetes clinic. J. Amer. med. Ass. 181, 862–865 (1962).
Fineberg, S.K.: combinations of oral hypglycemic drugs in obese, insulin resistant diabetics. Geriatrics 137–146 (1968).
Finkelstein, B., Fryer, B.A.: Meal frequency and weight reduction of young women. Am. J. clin. Nutr. 24, 465–468 (1971).
Fisch, H.P., Reutter, F.W.: Spätresultate der Nullkalorien-Diätbehandlung bei Adipositas. Schweiz. med. Wschr. 106, 339–343 (1976).
Fiser, R.H. Jr., Bray, G.A.: Effects of carbohydrate and calories on hormonal-metabolic parameters in obesity. Clin. Res. 22, 467 A (1974).
Fiser, R.H., Fisher, D.A.: Current understanding of pathogenesis of obesity. South. Med. J. 68, 931 (1975).
Fitch, C.D.: Muscle wasting disease of endocrine origin. Med. Clin. N. Am. 52, 243 (1968).
Flau, J.P.: Role of the increased adipose tissue mass in the apparent insulin insensitivity of obesity. Am. J. clin. Nutr. 25, 1189 (1972).
Fleisch, A., Ries, W.: Grundumsatz bei Fettleibigkeit. Schweiz. Med. Wschr. 95, 1092–1096 (1965).
Fletcher, A.P.: The effect of weight reduction upon blood pressure of obese hypertensive women. Quart. J. Med. 23, 331–345 (1953).
Fletcher, R.F.: The measurement of total body fat with skinfold calipers. clin. sci. 22, 333–346 (1962).
Floyd, J.C., Fajans, S.S., Conn, J.W.: Stimulation of insulin secretion by amino acids. J. clin. Invest. 45, 1487 (1966).
Floyd, J.C., Fajans, S.S., Knopf, R.F., Rull, J., Conn, J.W.: Stimulation of insulin-secretion by amino acids. Clin. Res. 12, 322 (1964).
Floyd, J.C., Pek, S., Fajans, S.S., Schteingart, D.E., Conn, J.W.: Effect upon plasma glucagon of severe and prolonged restriction of food intake in obese and nonobese subjects. Diabetes 21, 331 (1972).
Flury, A.: Endokrinologie und Fettsucht. In: Boecker, W. (ed.): Fettsucht-Gicht. p 48. Stuttgart: Thieme 1971.
Folix, O., Dennis, W.: On starvation and obesity. J. biol. Chem. 21, 183–192 (1915).
Ford, S., Bozian, R.C., Knowles, H.C.: Interactions of obesity, and glucose and insulin levels in hypertriglyceridemia. Amer. J. clin. Nutr. 21,904–910 (1968).
Foreyt, J.P., Kennedy, W.A.: Treatment of overweight by aversion therapy. Behay. Res. Ther. 9, 29–34 (1971).
Förster, H., Mehnert, H.: Biochemische und klinische Überlegungen zur Diättherapie der Fettsucht. Dtsch. med. Wschr. 98,26–29,742–743 (1973).
Forget, P.P., Fernandes, J., Haverkamp Begemann, P.: Plasma triglyceride clearing in obese children. Am. J. clin. Nutr. 28, 858 (1975).
Frank, G.W.: The use of chorionic gonadotropin hormone in the treatment of obesity. Am. J. clin. Nutr. 14, 133–136 (1964).
Franken, F.H., Irmscher, K.: Aldosteronausscheidung bei Adipositas. Ärztl. Wschr. 14, 325 (1959).
Franckson, J.R.M., Malaisse, W., Arnould, Y., Rasio, E., Ooms, H.A., Balasse, E., Conard, V., Bastenie, P.A.: Glucose kinetics in human obesity. Diabetologia 2, 96–103 (1966).
Fraser, R., Joplin, G.F., Opie, L.H., Rabinowitz, D.: The augmented insulin tolerance test for detecting insulin resistance. J. Endocrinol. 25, 299 (1962).
Frayn, K.N., Hedges, A., Kirby, M.J.: Stimulation by fenfluramine of glucose uptake into skeletal muscle in vitro. Horm. Metab. Res. 6,86 (1974).
Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N. Engl. J. Med. 276, 43 (1967).
Frerichs, F.T. v.: Über den Diabetes. Berlin 1884.
Frerichs, H., Daweke, H., Gries, F.A., Grüneklee, D., Hessing, J., Jahnke, K., Keup, U., Miss, H., Otto, H., Puls, W., Schmidt, D., Zumfelde, C.: A novel pancreatic amylase inhibitor (BAY d 7791). Experimental studies on rats and clinical observations in normal and obese diabetic and non-diabetic subjects. Diabetologia 9, 68 (1973).
Freyberger, H., Strube, K.: Zur Psychosomatik und Psychotherapie der Fettsucht. Dtsch. med. Wschr. 87, 2199–2203 (1962).
Freyberger, H., Strube, K.: Zur Psychodynamik und Psychotherapie gesteigerter Eßbedürfnisse bei Fettsuchtkranken. Schweiz. Med. Wschr. 93, 550 (1963).
Freychet, P., Luadat, M.H., Luadat, P. et al.: Impairment of insulin binding to the fat cell membrane in the obese hyperglycemic mouse. FEES Letters 25, 339 (1972).
Friedman, G.D., Kaunel, W.B., Dawker, T.R.: The epidemiology of gallbladder disease: Observations in the Framingham — study. J. chron. Dis. 19, 273–292 (1967).
Fröhlich, A.: Ein Fall von Tumor der Hypophysis cerebri ohne Akromegalie. Wien. klin. Rdsch. 15,883–886,906–908 (1901).
Gabe, D., Irmscher, K.: Beitrag zur Frage einer gestörten Nierenfunktion bei exogen alimentärer Fettsucht. Klin. Wschr. 45, 707 (1967).
Gadermann, E., Jungmann, H.: Der Kreislauf bei freiwilliger befristeter Nahrungskarenz und bei Anorexia nervosa. Med. Klinik 61, 204–208 (1966).
Galbraith, W.B., Connor, W.E., Stone, D.B.: Weigth loss and serum lipid changes in obese subjects given low calorie diets of varied cholesterol content. Ann. int. Med. 64, 268–275 (1966).
Galton, D.J.: Lipogenesis in human adipose tissue. J. Lipid Res. 9, 16–26 (1968).
Galton, D.J.: The human adipose cell. London: Butterworths 1971.
Galton, D.J., Bray, G.A.: Effects of epinephrine on isolated adipose cells from normal and overweight patients. J. clin. Invest. 45, 1010 (1966).
Galton, D.J., Bray, G.A.: Metabolism of a-glycerol phosphate in human adipose tissue in obesity. J. clin. Endocrinol. Metab. 27, 1573–1580 (1967).
Galton, D.J., Wilson, J.P.D.: The effect of starvation and diabetes on glycolytic enzymes in human adipose tissue. Clin. Sci. 41,545 (1971).
Garattini, S., Bizzi, A., De Gaetano, G., Jori, A., Samanin, R.: Recent advances in the pharmacology of anorectic agents. In: Howard A. (ed.): Recent advances in obesity research: I. p. 354, London: I. Newman Publ. 1975.
Garb, J.R., Stunkard, A.J.: Effectiveness of a self-help group in obesity control. Arch. intern. Med. 134,716–720 (1974).
Garland, P.B., Newsholme, E.A., Randle, P.J.: Regulation of glucose uptake by muscle, part. 9. Effects of fatty acids and ketone bodies, and of alloxan-diabetes and starvation, on pyruvate metabolism and on lactate/pyruvate and 1-glycerol 3-phosphate/dihydroxyacetone phosphate concentration ratios in rat heart and rat diaphragm muscles. Biochem. J. 93, 665–678 (1964).
Garn, S.M.: Radiographic analysis of body composition. In: J. Brozek, A. Henschel, (eds.): Techniques for Measuring body composition. pp. 36–58. Nat. Ac. Sci.-Nat. Res. Council, Washington, 1961.
Garn, S.M., Gorman, E.L.: Comparison of pinch-caliper and teleroentgenogrammetrie measurements of subcutaneous fat. Human Biol. 28, 407 (1956).
Garnett, E.S., Barnard, D.L., Ford, J., Goodbory, R.A., Woodhouse, M.A.: Gross fragmentation of cardiac myofibrils after therapeutic starvation. Lancet I, 914–916 (1969).
Garrow, F.S.: Energy balance and obesity in man. Amsterdam, North-Holland Publishing. Company (1974).
Gavin, J.R., Gordon, P., Rom, J.: Characteristics of the human lymphocyte insulin receptor. J. biol. Chem. 248, 2202 (1973).
Gavin, J.R., Rom, J., Jen, P., Freychet, P.: Insulin receptors in human circulating cells and fibroblasts. Proc. Nat. Acad. Sci. (USA) 69, 747 (1972).
Geisler, L.S.: Das Pickwick-Syndrom. Dtsch. med. Wschr. 96, 212–216 (1971).
Genuth, S.M.: Effects of prolonged fasting on insulin secretion. Diabetes 15, 798–806 (1966).
Genuth, S., Vertes, V.: Weight reduction by supplemented fasting: In: Howard A. (ed.): Recent Advances in Obesity Research I. p. 277 London: Newman Publ. Ltd. 1975.
Gercke, W.: Das Fettsuchtproblem aus der Sicht der Versicherungsträger. In: Cremer, H.D., Heilmeyer, L., Holtmeier, H.J., Hötzel, D., Kühnau, J., Schretzenmeyer, A. (eds.): Fettsucht, Gefahren, Prophylax, Therapie. München: J.F. Lehmann Verlag 1968.
Gerson, A.C., Martin, D.G., Hawryluk, G.A.: Field-dependence in two different populations of obese and normal weight-subjects. In: Howard A. (ed.): Recent Advances in Obesity Research: I. p. 194. London: Newman Publ. Ltd. 1975.
Gibson, T.C., Horton, E.S., Whorton, E.B.: Interrelationships of insulin, glucose, lipid and anthropometric data in a natural population. Am. J. clin. Nutr. 28, 1387 (1975).
Gilbert, R., Sipple, J.H., Auchincloss, J.W.: Respiratory control and work of breathing in obese subjects. J. appl. Physiol. 16, 21 (1961).
Girard, J.: Kindliche Adipositas: Differentialdiagnose and Hypothese zur Pathophysiologie. In: Rossi, E. (ed.): Ernährung and Stoffwechsel. Die Adipositas im Kindesalter. Pädiat. Fortbild. K. Praxis 42,69 (1975).
Glenister, T.W., Hytren, F.E., Kerr, M.G.: Human reproduction. In: Passmore R., Robson, J.S. (eds.): A companion to medical studies. Vol. 1. p. 37, 47. Oxford: Blackwell 1971.
Glennon, J.A., Brech, W.J.: Serum protein-bound iodine in obesity. J. Clin. Endocr. 25, 1673 (1965).
Glennon, J.A., Brech, W.J., Gordon, E.S.: Effect of a short period of cold exposure on plasma FFA level in lean and obese humans. Metabolism 16, 503 (1967).
Glick, S.M.: Normal and abnormal secretion of growth hormone. Ann. N.Y. Acad. Sci. 148, 471 (1968).
Glieman, J., Vinten, J.: Glucose metabolism and insulin sensitivity of single fat cells. Israel J. med. Sci. 8, 34 (1972).
Glucksman, M.L.: Psychiatric observations in obesity. In: Reichsman, F. (ed.): Hunger and satiety in health and disease. Adv. psychosom. Med. 7, 194–216 (1972).
Glucksman, M.L., Hirsch, J.: The response of obese patients to weight reduction. III. The perception of body size. Psychosom. Med. 31, 1 (1969).
Glueck, C.J., Tsang, R., Fallat, R., Buncher, C.R., Evans, G., Steiner, P.: Familial hypertriglyceridemia: studies in 130 children and 45 siblings of 36 index cases. Metabolism 22, 1287 (1973).
Godlowsky, Z.: Carbohydrate metabolism in obesity. Edinburgh Med. J. 53, 574–582 (1946).
Goldberg, E.M., Gordon, E.S.: Free fatty acid metabolism in human obesity. J. lab. clin. Med. 60, 877 (1962).
Goldberg, M., Gordon, E.S.: Energy metabolism in human obesity. J. Amer. med. Ass. 189, 616 (1964).
Goldblatr, P.B., Moore, M.E., Stunkard, A.J.: Social factors in obesity. J. Amer. Med. Ass. 192, 1039 (1965).
Goldfine, I.D., Kirstein, L., Lawrence, A.M.: Exessive glucagon responses to arginine in active acromegaly. Horm. Metab. Res. 4, 97–100 (1972).
Goldfine, D., Kahn, C.R., Neville, D.M. et al.: Decreased binding of insulin to its receptors in rats with hormone induced insulin resistance. Biochem. Biophys. Res. Comm. 53, 852 (1973).
Goldman, A.G., Vabady, P.D., Franklin, S.S.: Body habitus and serum cholesterol in essential hypertension and renovascular hypertension. J. Amer. med. Ass, 221, 378–383 (1972).
Goldrick, R.B.: Effects of insulin on glucose metabolism in isolated Human Fat Cells. J. Lipid Res. 8, 581 (1967).
Goldrick, R.B., Hirsch, J.: Serial studies on the metabolism of human adipose tissue. II. Effects of caloric restriction and ref eeding on lipogenesis and the uptake and release of free fatty acids in obese and nonobese individuals. J. clin. Invest. 43, 1793 (1964).
Goldrick, R.B., Mcloughlin, G.M.: Lipolysis and lipogenesis from glucose in human fat cells of different sizes. Effects of insulin, epinephrine and theophylline. J. clin. Invest. 49, 1213–1223 (1970).
Goldrick, R.B., Havenstein, N., Carroll, K.F., Peardon, M.: Effect of overfeeding on lipid and carbohydrate metabolism in lean young adults. Metabolism 21, 761 (1972).
Goldstein, M.S., Mullick, V., Hudlestun, B., Levine, R.: Action of muscular work on transfer of sugars across cell barriers: comparison with action of insulin. Amer. J. Physiol. 173, 212 (1953).
Gomez-Perez F.J., Ryan J.R., Staub, R.: Influence of phenformin on gastric emptying rate. J. clin. Pharmacol. 14, 261–263 (1974).
Goodman, L.S., Gilman, A.: The pharmacological basis of therapeutics. London: Macmillan 1971.
Goodner, C.J., Werrbach, J.H., Conway, M.J.: Studies of the regulation of insulin, glucose and FFA in hyperglycemic adult onset diabetes. Diabetes 18, 357 (1969).
Gordon, E.S.: Non-esterified fatty acids in the blood of obese and lean subjects. Am. J. clin. Nutr. 8, 740–747 (1960).
Gordon, E.S.: Relationship between obesity and diabetes mellitus. Metabolism 11, 819–832 (1962).
Gordon, E.S.: New concepts of the biochemistry and physiology of obesity. Med. Clin. N. Amer. 48, 1285 (1964).
Gordon, E.S., Goldberg, M., Chosy, J.: A new concept in the treatment of obesity. J. Amer. med. Ass. 186, 50 (1963).
Gordon, T., Kannel, W.B.: The effects of overweight on cardiovascular diseases. Geriatrics 28, 80–88 (1973).
Gordon, P., Rom, J.: Circulating insulin „Big“ and „Little”. Arch. Intern. Med. 123, 237–247 (1969).
Gordon, P., Roth, J., Freychet, P., Kahn, R.: The circulating proinsulin-like components. Diabetes 21, 673 (1972).
Göschke, H.: Zur Behandlung der Adipositas mit prolongiertem Fasten. Schweiz. med. Wschr. 25, 940–944 (1971).
Gossain, V., Matute, M., Kalkhoff, R.K.: Plasma glucagon in obesity and diabetes. Clin. Res. 21, 625 (1973).
Gossain, V.V., Matute, M.L., Kalkhofe, R.K.: Relative influence of obesity and diabetes on plasma alpha-cell glucagon. J. Clin. Endocrinol. Metab. 38, 238–243, (1974).
Goto, Y., Nakayama, Y., Yagi, T.: Influence of the world war II food shortage on the incidence of diabetes mellitus in Japan. Diabetes 7, 133 (1958).
Gotzsche, H., Petersen, V.P.: Obesity associated with cardiopulmonary failure - the Pickwickian syndrome. Acta med. Scand. 161, 383–390 (1958).
Grab, W., Oberdisse, K.: Die medikamentöse Behandlung der Schilddrüsenerkrankungen. Stuttgart: Georg Thieme Verlag 1959.
Grafe, E.: Ernährungs-und Stoffwechselkrankheiten und ihre Behandlung. p. 368 ff. Berlin-Göttingen-Heidelberg: Springer 1958.
Grafe, E., Koch, R.: Über den Einfluß langdauernder Überernährung auf die Intensität der Verbrennung im menschlichen Organismus (Untersuchungen bei Mastkuren). Dtsch. Arch. klin. Med. 56, 564–584 (1912).
Grahame, R., Scott, J.T.: Clinical survey of 354 patients with gout. Ann. rheum. Dis 29, 461–468 (1970).
Grant, D.B.: Fasting serum insulin levels in childhood. Arch. Dis. Childhood 42, 375–378 (1967).
Grauhan, M.: Über die Altersadipositas der Frau. Zschft. f. Altersforschung 2, 277–300 (1940).
Gray, H., Lunnon, J.B., Pond, M.H., Simpson, S.L.: Steroid studies in normal and adipose children. J. clin. Endocrinol. 16, 473–482 (1956).
Green, M.B., Beckman, M.: Obesity and hypertension. N.Y. State J. Med. 48,1250–1253 (1948).
Greiser, E.: Epidemiologische Untersuchungen zum Zusammenhang zwischen Appetitzüglereinnahme und primär vasculärer pulmonaler Hypertonie. Internist 14, 437–442 (1973).
Grey, N., Kipnis, D.M.: Effect of diet composition on hyperinsulinemia of obesity. N. Engl. J. Med. 285, 827–831 (1971).
Gries, F.A.: Wechselbeziehungen zwischen Fett-und Kohlenhydratstoffwechsel. Habil. Schrift. Düsseldorf 1967.
Gries, F.A.: Hormonal control of human adipose tissue metabolism in vitro. In: Jeanrenaud, B., Hepp, D. (eds.): Adipose Tissue. Horm. Metab. Res. Suppl. 2, p. 167. Stuttgart: Thieme 1970.
Gries, F.A.: Biguanid-Therapie bei Adipositas? Dtsch. Med. Wschr. 98, 1823–1824 (1973).
Gries, F.A., Berger, M., Herberg, L., Preiss, H., Hesse-Wortmann, Ch., Jahnke, K.: Pathologische Reaktionen des menschlichen Fettgewebes auf lipolytisch und antilipolytisch wirksame Substanzen in vitro bei Adipositas mit und ohne Diabetes mellitus. Medizin, Ernährung 10, 99 (1969).
Gries, F.A., Berger, M., Neumann, M., Preiss, H., Liebermeister, H., Hesse-Wortmann, C., Jahnke, K.: Effect of norepinephrine, theophylline and dibutyryl cyclic AMP on in vitro lipolysis of human adipose tissue in obesity. Diabetologia 8, 75–83 (1972).
Gries, F.A., Berger, M., Oberdisse, K.: Untersuchungen zum antilipolytischen Effekt des Insulins am menschlichen Fettgewebe in vitro. Diabetologia 4, 262 (1968).
Gries, F.A., Daweke, H., Liebermeister, H.: Diabetes mellitus bei Fettsucht. Verh. dtsch. Ges. inn. Med. 76, 51 (1970a).
Gries, F.A., Englhardt, A., Cramer, M., Jahnke, K.: Metabolite des Fett-und Kohlenhydratstoffwechsels bei normgewichtigen Stoffwechselgesunden sowie bei Adipösen und Diabetikern. Verh. dtsch. Ges. inn. Med. 76, 371 (1970b).
Gries, F.A., Jahnke, K., Preiss, H., Canzler, H, Miss, H.D.: Diättherapie essentieller Hyperlipämien. Dtsch. med. Wschr. 94, 2307 (1969).
Gries, F.A., Koschinsky, A., Herberg, L.: Increased glucose metabolism and insulin sensitivity in large adipozytes. In: Vague, J., Boyer, J., (eds.): The regulation of the adipose tissue mass. p. 89. Amsterdam: Exerpta Medica 1974.
Gries, F.A., Oberdisse, K.: Fettstoffwechselstörungen und Diabetes mellitus. Dtsch. med. Wschr. 95, 727 (1970).
Gries, F.A., Steinke, J.: Insulin and human adipose tissue in vitro: A brief review. Metabolism 16, 693 (1967).
Glues, F.A., Zimmer, G., Jahnke, K.: Fettstoffwechselstudien bei Adipositas. Verh. dtsch. Ges. inn. Med. 70, 424–427 (1964).
Griesener, R.D., Thomas, R.W.: Lipogenesis in human skin. V. Effect of dietary changes in an obese male. J. Invest. Derm. 50, 358 (1968).
Griffith, J.D., Nutr, J.G., Jasinski, D.R.: A comparison of fenfluramine and amphetamine in man. Clin. Pharm. Therapeut. 18, 563–570 (1975).
Grinker, J.: Behavioral and metabolic consequences weight reduction. J. Am. Diet. Ass. 62, 30–34 (1973).
Grivaux, M., Gentilini, M., Soulie, J., Badonal, P.: Adénolipomatose symétrique de Launois et Bensaude et troubles du métabolisme lipidique. Sem Hôp. Paris 45, 1958 (1966).
Grodsky, G.M., Benoit, F.L.: Effect of massive weight reduction on insulin secretion in obese subjects. In: Ostman, J. (ed.): Diabetes. Proc. VI. Congr. internat. Diabetes Fed. p. 540. Amsterdam, Excerpts Med. Found. 1969.
Grodskv, G.M., Karam, J.H., Pavlatos, F.Ch., Forsham, P.H.: Reduction by phenformin of excessive insulin levels after glucose loading in obese and diabetic subjects. Metabolism 12, 278–286 (1963).
Grönberg, A., Larsson, T., Jung, J.: Diabetes in Sweden. A clinico — statistical epidemiological and genetic study of hospital patients and death certificates. Acta med. Scand. Suppl. 477 (1967).
Groothof, G., Du Plessis, J.P., Versluis, E.E., Louw, M.E.J., Alberts, A., Visagie, M.E., Laubscher, N.F., Galpin, J.S., Markham, R.: Biochemical aspects of a study of 100 obese white subjects. S. Afr. Med. J. 49, 893–897 (1975).
Grosse-Brockhoff, F.: Obesitas als Stoffwechselproblem. Heiv. Med. Acta 19, 271–290 (1952).
Grosse-Brockhoff, F.: Die Bedeutung der Adipositas als Krankheitsursache, ihre Therapie und Prophylaxe. Dtsch. med. Wschr. 78, 399–402,435–439 (1953).
Grott, J.W., Marzec, L., Grincowt-Dziwill, W., Korzon, J., Pieter, R., Poskuta, W., Zurkowski, J.W.: La fréquence du diabète et de l’ état prédiabétique chez 1000 personnes à 40 ans passés obèses ou prédisposés à l’obésité. Diabète 10, 5–13 (1962).
Grubner, R., Ungerleider, H.E.: Electrocardiographic criteria of left ventricular hypertrophy. Arch. intern. Med. 72, 196 (1943).
Grüneklee, D., Gries, F. A., Preiss, H., Jahnke, K., Daweke, H.: Seruminsulin bei essentiellen und alkoholinduzierten Hyperlipämien. Verh. dtsch. Ges. inn. Med. 75, 875 (1969).
Gulick, A.: A study of weight regulation in the adult human body during overnutrition. Amer. J. Physiol. 60, 371–395 (1922).
Günther, H.: Die Lipomatosis und ihre klinischen Formen. Ein Beitrag zur Physiologie und Pathologie des Fettgewebes. Jena: Gustav Fischer 1920.
Gurtner, H.P.: Pulmonale Hypertonie nach Appetitzüglern. Med. Welt 23, 1036–1041 (1972).
Gustafson, A., Elmfeldt, D., Wilhelmsen, L., Tibblin, G.: Serum lipids and lipoproteins in men after myocordial infarction compared with representative population sample. Circulation 46, 709 (1972).
Gwinup, G.: Effect of exercise alone on the weight of obese women. Arch. intern. Med. 135, 676 (1975).
Gwinup, G., Chelvam, R., Steinberg, T.: Thickness of subcutaneous fat and activity of underlying muscles. Ann. intern. Med. 74, 408 (1971).
Gwinup, G., Poucher, R.: A controlled study of thyroid analogs in the therapy of obesity. Am. J. Med.Sci. 50, 416–420 (1967).
Haase, K.-E., Hosenfeld, H.: Zur Fettsucht im Kindesalter. Zeitschrift Kinderheilk. 78, 1–27 (1956).
Hackenberg, K., Zimmermann, H., Dressel, R., Daweke, H., Grüneklee, D., Liebermeister, H.: Der Einfluß von 6-Dehydro-16-Methylenhydrocortison auf Cortisol-und Corticosteronsekretionsraten, Glukosetoleranz und Insulinspiegel bei Adipösen. Acta. endocr. (Kbh.), Suppl. 152, 45 (1971).
Hadden, D. R., Lucey, C.: Diethylpropion in the treatment of obesity. Ulster med. J. 30, 109 (1961).
Haefs, K.: Untersuchungen über das Blutvolumen, die extracelluläre Flüssigkeit und das Gesamtkörperwasser bei Fettsüchtigen. Dissertation, Düsseldorf (1972).
Hall, A. P., Barry, P. E., Dawher, T. R., Mcnamara, P. M.: Epidemiology of gout and hyperuricemia: a long-term population study. Amer. J. Med. 42, 27 (1967).
Hales, C. N., Greenwood, F. C., Mitchell, F. L., Strauss, W. T.: Blood glucose, plasma insulin and growth hormone concentrations of individuals with minor abnormalities of glucose tolerance. Diabetologia 4, 73 (1968).
Hales, C. N., Randle, P. J.: Effects of low carbohydrate diet and diabetes mellitus on plasma concentrations of non-esterified fatty acids, glucose and insulin during oral glucose-tolerance tests. Lancet I, 790–794 (1963).
Hallberg, D., Backman, L., Espmark, S.: Surgical treatment of obesity. Progr. Surg. 14,46–83 (1975).
Hallberg, L.: Kaloriintaget vid obesitas. In: Melin H. (ed.): Nordisk symposium om obesitas Umea (1967).
Hallenberg, L., Svanborg, A.: Cholesterol, phospholipids, and triglycerides in plasma in 50 year old women. Influence of menopause, body-weight, skinfold thickness, weight gain, and diet in a random population sample. Acta med. Scand. 181, 185 (1967).
Hamburger, W. W.: Emotional aspects of obesity. Med. Clin. N. Amer. 35,483 (1951).
Hamilton, C. I.: Physiologic control of food intake. J. Amer. Diet. Ass. 62, 35 (1973).
Hammermüller, B., Leonhardt, W., Hanefeld, M.: Vorläufige Mitteilung über die elektronische Messung der Volumenverteilungskurven menschlicher Fettzellen bei Adiposi-tas und ihre Beziehung zum Diabetes mellitus. Dtsch. Gesundheitswesen 25, 2020–2022 (1970).
Hammond, E. C., Garfinkel, L.: Coronary heart disease, stroke and aortic aneurysm. Factors in etiology. Arch. environ. Health 19, 167–182 (1969).
Hanefeld, M., Naumann, H. J., Renger, F.: Statistische Untersuchungen zur Pathogenese der Fettleber. II. Pathogenetische Faktoren der Steatosis hepatis. Dtsch. Gesundheitswesen 23, 2467 (1968).
Hanley, T., Lewis, J. G., Knight, G. J.: The influence of fatness in the plasma NEFA response to glucose ingestion. Metabolism 16, 324 (1969).
Hansen, Aa. P.: Serum growth hormone response to exercise in non-obese and obese normal subjects. Scand. J. clin. Lab. Invest. 31, 175 (1973).
Hanzlickova, L., Krizek, V., Stepanek, P.: Dermatologische Befunde bei Fettleibigkeit. Munch. med. Wschr. 199, 586–591 (1967).
Harding, T.: Depression following fenfluramine withdrawal. Brit. J. Psychiatry 121, 338 (1972).
Harger, B. S., Miller, J. B., Thomas, J. C.: The caloric cost of running. Its impact on weight reduction. J. Am. Med. Ass. 228, 482 (1974).
Harlan, W. R., Oberman, A., Mitchell, R. E., Graybiel, A.: Constitutional and environmental factors related to serum lipid and lipoprotein levels. Ann. intern. Med. 66, 540 (1967).
Harris, J. M., Warsaw, E.: Obesity: a problem with many facts: observations on treatment with chorionic gonadotropin as an adjunct to dietary measures. J. Amer. Geriatric Soc. 12, 987–995 (1964).
Harris, S. C., Joy A. C., Searle, L. M.: The mechanism of amphetamine induced loss of weight. J. Amer. Med. Ass. 134, 1468–1475 (1947).
Harrison, L. C., King-Roach, A. P., Sandy, K. C.: Effects of mazindol on carbohydrate and insulin metabolism in obesity. Metabolism 24, 1353–1361 (1975a).
Harrison, L. C., King-Roach, A., Martin, F. J. R., Melick, R. A.: The effect of fenfluramine on insulin binding and on basal and insulin-stimulated oxidation of 1-C74-glucose by human adipose tissue. Postgrad. Med. J. 51, (Suppl. 1) 110–114 (1975b).
Harrison, M. T., Harden, R. M.: The long term value of fasting in the treatment of obesity. Lancet II, 1340 (1966).
Hart, A., Cohen, H.: Treatment of obese non-diabetic patients with phenformin. A double-blind crossover trial. Brit. med. J. 1, 22–24 (1970).
Hartmann, G., Schmid, R.: Prolongiertes Fasten als Behandlungsform der Adipositas. Dtsch. med. Wschr. 92, 163–168 (1967).
Hartmann, G.: Calorie consumption and plasma lipid levels. In: Schettler, G., Weigel, A. (eds.): Atherosclerosis III, p. 761 Berlin — Heidelberg: Springer 1974.
Hartmann, G.: Ernährung und Serumlipide. In: Rossi, E. (ed.) Ernährung und Stoffwechsel. Die Adipositas im Kindesalter. Pädiat. Fortbild K. Praxis 42, 29 (1975).
Hashim, S. A., Van Itallie, T. B.: Studies in normal and obese subjects with a monitored food dispensing device. Ann. N. Y. Acad. Sci. 131, 654–661 (1965).
Hasik, J., Tyc, M.: Leberfunktion bei Adipositas unter Hungertherapie. Dt. Z. Verdauungsund Stoffwechselkrankheiten 32, 101–103 (1972).
Hausberger, F. X.: Composition of adipose tissue in several forms of obesity. Anat. Rec. 127, 305 (1957).
Havel, R. J., Naimark, A., Borchgrevink, C. F.: Turnover rate and oxidation of free fatty acids of blood plasma in man during exercise: studies during continuous infusion of palmitate-1-C14. J. clin. Invest. 42, 1054 (1963).
Hayward, J. S., Lyman, C. P., Taylor, C. R.: The possible role of brown fat as a source of heat during hibernation. Ann. NY Acad. Sci. 131, 441 (1965).
Heald, F. P., Mueller, P. S., Daugela, M. Z.: Glucose and free fatty acid metabolism in obese adolescents. Amer. J. Clin. Nutr. 16, 256–264 (1965).
Hedderich, G., Weidlich, S.: Das nicht bewußte Eigenurteil adipöser Patienten. Dtsch. med. Wschr. 96, 784 (1971).
Hedhammar, A., Fu-Ming W., Krook, L., Schryven, H., Lahunta, A., Wahlen, J. P., KallJelty, F. A., Nuney, E. A., Hintry, H. F., Sheffey, B. E., Ryan, G. D.: Overnutrition and skeletal disease, an experimental study in growing great Dane dogs. The Carmel Veterinarian Suppl. 5 (1974).
Heessen, H., Geissler, D., Jöns, P., Petersen, H.: Verhalten des Thiamin und Thiaminpyrophosphats bei Fettsüchtigen unter Reduktionskost und Nulldiät. Dtsch. med. Wschr. 100, 544–548 (1975).
Hegglin, R.: Differentialdiagnose innerer Krankheiten p. 63. Stuttgart: Thieme 1975.
Hejda, S.: Das frühere und gegenwärtige Körpergewicht hochbetagter Personen. Zschft. Altersforschung 16, 129–134 (1962).
Helbig, W.: Wasserhaushaltsstörungen bei Adipositas und ihre Erfassung durch den Volhardschen Versuch. Dtsch. Gesundheitswesen 19, 340 (1964).
Hellier, M. D.: The effects of prolonged starvation and refeeding on 24-hours urinary insulin levels in obese subjects. J. Endocrinology 47, 73 (1970).
Helmreich, E., Cori, C. F.: Studies of tissue permeability. II. The distribution of pentoses between plasma and muscle. J. biol. Chem. 224, 663 (1957).
Hendrix, R. C., Fox, J. E.: Relation of obesity and abnormalities of lipid metabolism to lipid embolization of lungs. Amer. J. clin. Pathol. 44, 55 (1964).
Henneman, P. H.: Plasma growth hormone during prolonged starvation in obesity. Internat. Symp. Growth Hormone. Amsterdam. Excerpta Med. International Congr. Series 142, 52 (1967).
Henschen, F.: Morgagni’s Syndrom. Jena: Gustav Fischer 1937.
Hepp, D., Challoner, D. R., Williams, R. H.: Respiration in isolated fat cells and the effect of epinephrine. J. biol. Chem. 243, 2321 (1968).
Herberg, L.: Die spontan-diabetischen Tiere. In Oberdisse, K., (ed.): Handbuch der Inneren Medizin, Bd. 7 A, Diabetes mellitus. p. 561. Berlin - Heidelberg: Springer 1975.
Herberg, L., Döppen, W., Major, E., Gries, F. A.: Dietary — induced hypertrophie-hyper-plastic obesity in mice. J. Lip. Res. 15, 580–585 (1974).
Herberg, L., Frohn, C., Solbach, H. G., Zimmermann, H.: Der Einfluß der Metopirondosis auf die Corticosteroidausscheidung in Abhängigkeit vom Körpergewicht. Symp. Dtsch. Ges. Endokrin. 15, 356–358 (1969).
Herberg, L., Gries, F. A., Hessewortmann, C.: Effect of weight and cell size on hormone induced lipolysis in New Zealand obese mice. Diabetologia 6, 300 (1970).
Hermann, L. S., Nathan, E., Ebbersen, I.: The influence of phenformin on lactate metabolism in diabetic patients in relation to hypoxia and exercise. Acta med. Scand. 194, 111–116 (1973).
Hermansen, L., Döbeln, W. V.: Body fat and skinfold measurements. J. clin. Lab. Invest. 27, 315–319 (1971).
Hesse, R., Döll, G.: Zur Nahrungsaufnahme Fettsüchtiger. Dtsch. Gesundheitswesen 5, 208–210 (1975).
Hewing, R., Liebermeister, H., Daweke, H., Gries, F. A., Grüneklee, D.: Weight regain after low calorie diet: Long term pattern of blood sugar, serum lipids, ketone bodies and serum insulin levels. Diabetologia 9, 197–202 (1973).
Heyden, S.: Angewandte Epidemiologie der Herz-und Gefäßkrankheiten. Umschau Wissenschaft Technik. 71, 511–515 (1971).
Heyden, S.: Klinische Epidemiologie des Krebses. p. 97. Stuttgart: Thieme 1972.
Heyden, S., Demaria, W., Barbee, S., Morris, M.: Weight reduction in adolescents. Nutr. Metabol. 15, 295–304 (1973).
Heyden, S., Hames, C. G., Bartel, A., Cassel, J. C., Tyroler, H. A., Cornoni, J. C.: Weight and weight history in relation to cerebrovascular and ischemic heart disease. Arch. int. Med. 128, 956–960 (1971).
Himsworth, H. P.: Diet and the incidence of diabetes mellitus. Clin. Sci. 2, 117–148 (1935).
Himsworth, H. P.: Diabetes mellitus. It’s differentiation into insulin sensitive and insulin insensitive types. Lancet I, 127 (1936).
Hippokrates: I. C. E. Grafe: Ernährungs-und Stoffwechselkrankheiten und ihre Behandlung. p. 186. Berlin — Heidelberg: Springer Verlag 1958.
Hirsch, J., Gallian, E.: Methods for the determination of adipose cell size and cell number in man and animals. J. Lipid Res. 9, 110 (1968).
Hirsch, J., Goldrick, R. B.: Serial studies on the metabolism of human adipose tissue. I. Lipogenesis and free fatty acid uptake and release in small aspirated samples of subcutaneous fat. J. clin. Invest. 43, 1776 (1964).
Hirsch, J., Han, P. W.: Cellularity of rat adipose tissue: effects of growth, starvation and obesity. J. Lipid Res. 10, 77–82 (1969).
Hirsch, J., Knittle, J. L.: Cellularity of obese and nonobese human adipose tissue. Fed. Proc. 29, 1516–1521 (1970).
Hirsch, J., Knittle, J. L., Salans, L. B.: Cell lipid content and cell number in obese and nonobese human adipose tissue. J. clin. Invest. 45, 1023 (1966).
Hirsch, J., Van Itallie, T. B.: The treatment of obesity. Am. J. Clin. Nutr. 26, 1039–1044 (1973).
Hochrein, M., Schleicher, I.: Zur Beurteilung, Begutachtung und Behandlung der Fettleibigkeit. Med. Mschr. 9, 649, 730 (1955).
Hoebel, B G Feeding: Neural control of intake Ann. Rev. Physiol. 33, 533 (1971).
Hoffbrand, B. J., Adadevoh, B. K., Reuter, C., Samuel, P., Turner, P.: Fenfluramine and its derivatives. Postgrad. Med. J. 51, Suppl. 1 (1975).
Hofman, G. G., Schneider, G., Strohmeyer, E., Pickardt, C. R., Krick, L.: Thyroid hormones in obesity: thyroid function, effects on isolated fat cells of man and therapeutical application. In: A. Howard (ed.): Recent Advances in Obesity Research Research I p. 383–386. London: Newman Publ., 1975.
Hohlweg-Majert, P., Schwab, H., Wittlinger, H.: Entbindung bei übergewichtigen Frauen. Therapeut. Umschau 32, 571 (1975).
Holland, J., Masling, J., Copley, D.: Mental illness in lower class normal, obese and hyperobese women. Psychosom. Med. 32, 351 (1970).
Hollenberg, C. H., Raben, M. S.: Effect of growth hormone on plasma fatty acids. J. clin. Invest. 38, 484 (1959).
Hollenberg, C. H., Vost, A., Patten, R. L.: Regulation of adipose mass: control of fat cell development and lipid content. Rec. Progr. Hormon Res. 26, 463–503 (1970).
Holley, H. S., Milk, J., Becklake, M. R., Bates, D. V.: Regional distribution of pulmonary ventilation and perfusion in obesity. J. clin. Invest. 46, 475 (1967).
Hollifield, G.: Glucocorticoid-induced obesity — a model and a challenge. Am. J. clin. Nutr. 21, 1471–1474 (1968).
Hollifield, G., Parson, W.: Overweight in the aged. Am. J. clin. Nutr. 7,127–131 (1959).
Hollingsworth, D. R., Amatruda, T. T., Scheig, R.: Quantitative and qualitative effects of L-Triiodothyronine in massive obesity. Metabolism 19, 934–945 (1970).
Hollister, L. E., Beckman, W. G., Baker, M.: Comparative variability of serum cholesterol and serum triglycerides. Amer. J. med. Sci. 248, 329 (1964).
Hollister, L. E., Overall, J. E., Snow, H. L., Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma glucose levels. Amer. J. clin. Nutr. 20,777–782 (1967).
Hollobaugh, S. L., Boshell, B. R.: Direct evidence for increased insulin turnover in obesity. Diabetes 18, 359 (1969).
Hollobaugh, S. L., Rao, B., Kruger, F. A.: Studies on the site and mechanism of action of phenformin. Diabetes 19, 45–49 (1970).
Holtmeier, H. J.: Diät bei Übergewicht und gesunde Ernährung. Stuttgart: Thieme 1966.
Hood, B., Björntorp, P.: Studies on adipose tissue from obese patients with or without diabetes mellitus. III Transformation of U-14C-acetate and 1–14C-glycerol into carbon dioxide and lipid. Acta med. Scand. 179, 349 (1966).
Hood, C. E. A., Goodhart, J. M., Fletcher, R. F., Gloster, J., Bertrand, P. V., Crooke, A. C.: Observations on obese patients eating isocaloric reducing diets with varying proportions of carbohydrate. Brit. J. Nutr. 24, 39–44 (1970).
Horton, E. S., Danforth, E., Sims, E. A. H., Salans, L. B.: Correlation of forearm muscle and adipose tissue metabolism in obesity before and after weight loss. Clin. Res. 20,548 (1972).
Horton, E. S., Runge, C. F., Sims, E. A. H.: Forearm metabolism in human experimental obesity. J. clin. Invest. 49, 45a (1970).
Howard, A. N.: Dietary treatment of obesity. In: Baird, I. M., Howard, A. N. (eds.): Obesity. Medical and Scientific Aspects. p. 96. Edinburgh and London E. u. S. Livingstone Ltd., 1969.
Howard, A. N., Dus, J., Mcmahon, M.: The incidence, cause and treatment of obesity in Leicester School children. Practioner 207, 662–668 (1971).
Huber, E. G.: Formen der kindlichen Fettsucht und ihre Häufigkeit. Hely. paed. acta 2, 114–137 (1962).
Hundley, J. H.: Need for control programs. In: Weight control. p. 1–17. Ames, I a.: Iowa State College Press 1955.
Hundley, J. H.: Diabetes — overweight: U. S. problems. J. Am. diet. Ass. 32, 417–422 (1956).
Hunecke, I., Reuter, W., Ries, W.: Epidemiologische Zusammenhänge zwischen körperlicher Aktivität, Berufstätigkeit und Alter bei Adipösen. Z. Alternsforsch. 29, 219–294 (1975).
Hunt, E. E.: Epidemiologic considerations. In: Reichsman F. (ed.): Hunger and satiety in health and disease. Adv. psychosom. Med. 7, 148–172 (1972).
Hunter, W. M., Friend, J. A. R., Strong, J. A.: The diurnal pattern of plasma growth hormone concentration in adults. J. Endocrinol. 34, 139 (1966).
Hunter, W. M., Willoucxsv, J. M. T., Strong, J. A.: Plasma insulin and growth hormone during 22 hr fasts and after graded glucose loads in six healthy adults. J. Endocrinol. 40, 207 (1968).
Husemann, G.: Dünndarmausschaltung zur Therapie der extremen Adipositas. Dtsch. med. Wschr. 98, 2343–2347 (1973).
Hüter, K. A.: Die Fettsucht in der Gynaekologie und Geburtshilfe. Mtkurse ärztl. Fortbild. 17, 141–146 (1967).
Hüter, K. A., Buchenau, H.: Ernährung der werdenden Mutter. Bundesausschuß für volkswirtschaftl. Aufklärung, Köln 1969.
Huth, K.: Kohlenhydrate in der Diätetik bei Fettsucht. In: K. Jahnke, H. Mehnert, H. Drost (eds.): Metabolische und klinische Aspekte der Kohlenhydrate in der Ernährung. p. 131–135. Mainz: Verlag Kirchheim & Co, 1975.
Hüther, K. J., Ritzl, F.: Selective lack of response of corticosterone to dexamethasone suppression in some obese subjects with asymptomatic diabetes mellitus. Acta endocr. (Kbh) Suppl. 152, 47 (1971).
Imlah, N.: Unusual effect of fenfluramine. Brit. Med. J. 11, 178 (1970).
Innes, J. A., Campbell, J. W., Campbell, C. J., Needle, A. L., Munro, J. F.: Long term follow-up of therapeutic starvation. Brit. Med. J. 11, 356–359 (1974).
Insull, W., Houser, H., Littell, A. S.: Fatty acid composition of human adipose tissue. Relationship to body weight, age and serum cholesterol 58th. Ann. Meeting. Am. Soc. clin. Invest. 54 (1966).
Irie, M., Tsushima, T., Sakuma, M.: Effect of nicotinic acid administration on plasma HGH, FFA and glucose in obese subjects and in hypopituitary patients. Metabolism 19, 972–979 (1970).
Irsigler, K.: Zum Energiehaushalt des menschlichen Organismus. Regulation des Körpergewichtes. Wien. Klin. Wschr. 81, 845–854 (1969a).
Irsigler, K.: Glucoseutilisation und Plasmalipoide bei adipösen Patienten unter dem Einfluß von Dimethylbiguanid (Glucophage). Wien. Med. Wschr. 119, 191–194 (1969b).
Irsigler, K.: Metforminwirkung auf Glucoseverwertung und Körpergewicht. Dtsch. med. Wschr. 95 2169–2171 (1970).
Irsigler, K.: Pathophysiologie und Klinik der Fettleber. Leber-Magen-Darm 3,117 (1971).
Irsigler, K., Schmid, P., Schlick, W., Heitkamp, H.: A new method of measuring body composition using a „buoyancy scale“ and „pressure volumetry”. In: A. Howard (ed.): Recent Advances in Obesity Research I. p. 110. London: Newman Publ., 1975.
Irsigler, K., Waldhäusl, W.: Änderungen einzelner Parameter des Fett-und Kohlenhydratstoffwechsels bei Adipösen durch Abmagerung. Wien. Klin. Wschr. 81, 534–536 (1969).
Isaksson, B., Lindholm, B., S.Iögren, B.: Body composition during long-term administration of cortisone and anabolic steroids in an asthmatic subject. Metabolism 16, 162 (1967).
Issekutz, B. Jr., Bortz, W. M., Miller, H. I., Paul, P.: Turnover rate of plasma FFA in humans and in dogs. Metabolism 16, 1001, (1967a).
Issekutz, B., Bortz, W. M., Miller, H. I., Wroldsen, A.: Plasma — free fatty acid response to exercise in obese humans. Metabolism 16, 492 (1967b).
Issexutz, B. Jr., Paul, P., Miller, H. I., Bortz, W.M.: Oxidation of plasma FFA in lean and obese humans. Metabolism 17, 62 (1968).
Jackson, I. M. D., Mckiddie, M. T., Buchanan, K. D.: Effect of fasting on glucose and insulin metabolism of obese patients. Lancet I, 285 (1969).
Jacobsen, G., Seltzer, C. C., Bondy, P. K., Mayer, J.: Importance of body characteristics in the excretion of 17- ketosteroids and 17-ketogenic steroids on obesity. N. Engl. J. Med. 271, 651 (1965).
Jacot, J. P., Zuppinger, K. A., Joss, E. E., Donath, A.: Evidence for two types of juvenile obesity on the basis of body composition and insulin release following small doses of glucose. Klin. Wschr. 51, 1109–1114 (1973).
Jaffe, H. L., Corday, E., Master, A. M.: Evaluation of the precordial leads of the electrocardiogram in obesity. Amer. Heart J. 36, 911 (1948).
Jahneke, J.: Risikofaktor Hypertonie. p. 41. Studienreihe Boehringer Mannheim 1974.
Jahnke, K.: Oberernährung als Krankheitsursache und die Behandlung der Fettleibigkeit. Regensburger Jahrbuch ärztl. Forth. 11, 253–260 (1963).
Jahnke, K., Daweke, H., Liebermeister, H., Schilling, W., Gruneklee, D.: Ober den Einfluß von Buformin auf das Verhalten von Gewicht und Stoffwechselmetaboliten bei Fettsüchtigen mit und ohne Störung der Glukosetoleranz. In: Oberdisse, K., Daweke, H., Michael G. (eds.): 2. Int. Biguanid Symposium. p. 82–91. Stuttgart: Thieme 1968.
Jahnke, K., Daweke, H., Liebermeister, H., Schilling, W. H., Thamer, G., Preiss, H., Gries, F. A.: Hormonal and metabolic aspects of obesity in humans. In: Ostman, J., Milner, R. D. G., (eds.): Diabetes. p. 533–539. Amsterdam. Exerpta medica foundation, Int. Congress Series No. 172, (1969).
Jahnke, K., Daweke, H., Schilling, W. H., Ruenauver, R., Oberdisse, K.: Der potentielle Diabetes (sog. Praediabetes). Verh. dtsch. Ges. inn. Med. 72, 851 (1967).
Jahnke, K., Englhardt, A., Jung, G. F., Pilger, H.: Die Behandlung der Fettsucht mit Mischkost und Formuladiät. Dtsch. med. Wschr. 88, 2130 (1963).
Jahnke, K., Gabbe, R.: Bedeutung und Methodik von Ernährungsanamnesen. Nutr. et Dieta 2, 115 (1960).
Jahnke, K., Gries, F. A., Wallenfels, H., Schulte, H.: Verhalten von Metaboliten des Fettstoffwechsels im Serum adipöser Personen unter Grundumsatzbedingungen. Klin. Wschr. 42, 1016–1020 (1964).
Jahnke, K., Jahnke, K. A., Reis, H. E.: Ober die Regenerationsfähigkeit der (3-Zellenfunktion bei adipösen Diabetikern nach Gewichtsreduktion. Dtsch. med. Wschr. 101, 73 (1976).
Jahnke, K., Miss, H. D., Drost, H.: Kriterien und Bewertung der Diabeteseinstellung. Bearbeitet im Auftrag der Deutschen Diabetes-Gesellschaft. Dtsch. med. Wschr. 99, 870 (1974).
Jahnke, K. A., Reis, H. E., Jahnke, K.: Zur Beurteilung der Differentialtherapie des Diabetes mellitus durch Bestimmung der endogenen Insulinsekretion nach konsekutiver Glucose-und Tolbutamidstimulation. IV. Internat. Donau-Symposium über Diabetes mellitus, Dubrovnik (1975).
Jansen, M.: Beitrag zur Manifestation des Diabetes 1946. I. c. Ries W. (1970).
Januszewicz, W., Sznasderman-Ciswicka, M., Wocial, B.: Urinary excretion of catech-lamines in fasting obese subjects. I. c. Rath, R., Kujalova, V. (1973).
Jarlmv, E.: The clinical types of abnormal obesity. Copenhagen: NYT Nordisk Forlag 1932.
Jeanrenaud, B., Hepp, D.: Adipose tissue. Regulation and metabolic functions. Horm. metab. Res. Suppl. 2, Stuttgart: Thieme 1970.
Jeliffe, R. W., Hill, D., Tatter, D., Lewis, E. Jr: Death from weight control pills. A case report with objective postmortem confirmation. J. Am. Med. Ass. 208, 1843–1847 (1969).
Jequier, E. (ed.): Regulation of energy balance in man. Edit. Médecine et Hygiène. Genève 1975.
Jequier, E., Pitrel, PH., Gygax, P.-H., Chappnis, PH.: Deficits d’induction de la thermogenese chez l’obese: Etude par calorimetrie directe et indirecte. In: Jequier, E. (ed.): Regulation of energy balance in man. p. 44. Edition Médecine et Hygiène Genève 1975.
John, H. J.: A summary of the findings in 1100 glucose tolerance estimations. Endocrin. 13, 388–392 (1929).
John, H. J.: Statistical study of 6000 cases of diabetes. Ann. Intern. Med. 33, 925–940 (1950).
Johnson, H. J.: A study of 2400 electrocardiograms of apparently healthy males. J. Amer. med. Ass. 114, 561 (1940).
Johnson, M. L., Burke, B. S., Mayer, J.: Relative importance of inactivity and overeating in the energy balance of obese high school girls. Amer. J. clin. Nutr. 4, 37 (1956a).
Johnson, M. L., Burke, B. S., Mayer, J.: The prevalence and incidence of obesity in a cross-section of elimentary and secondary school children. Am. J. clin. Nutr. 4, 231–238 (1956b).
Johnson, P. R., Hirsch, J.: Cellularity of adipose depots in six strains of genetically obese mice. J. Lipid Res. 13, 2–11 (1972).
Johnson, P. R., Zucker, L. M., Cruce, J. A. F., Hirsch, J.: Cellularity of adipose depots in the genetically obese Zucker rat. J. Lipid. Res. 12, 706–714 (1971).
Johnson, S., Karam, J. H., Levin, S. R., Grodsky, G. M., Forsham, P. H.: Hyperinsulin response to oral leucine in obesity and acromegaly. Clin. Endocrinol. Metab. 37, 431–435 (1973).
Jolliffe, N., Rinzler, S. H., Archer, M.: Prudent reducing diet: effect on serum cholesterol, study of 111 obese men 50–59 years old. Arch. intern. Med. 109, 506–572 (1962).
Joossens, J. V.: Kochsalz und Hypertonie, Härte des Wassers und Mortalität bei HerzKreislauf-Erkrankungen. Triangel 12, Nr. 1, 9 (1973).
Jorgensen, K. R.: Evaluation of the double anti-body radioimmunoassay of insulin and the determination of insulin in plasma and urine in normal subjects. Acta Endocrin. 60, 327 (1969).
Joslin, E. P.: The prevention of diabetes mellitus. J. Am. Med. Ass. 76, 76–84 (1921).
Joslin, E. P., Dublin, L. J., Marks, H. H.: Studies in diabetes mellitus IV: Etiology. Part II. Am. J. Med. Sci. 192, 9–23 (1936).
Josun, E. P., Root, H. F., Withe, R., Marble, A.: The treatment of diabetes mellitus. London: H. Kimpton 1959.
Juergens, J. L., Barker, N. W., Hines, E. A.: Arteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 21, 188–195 (1960).
Juhl, E., Christoffersen, P., Baden, H., Quadde, F.: Liver morphology and biochemistry in eight obese patients treated with jejunoiliacal anastomosis. N. Engl. J. Med. 285, 543–547 (1971).
Julkunen, H., Heinonen, O. P., Pyöräla, K.: Hyperostosis of the spine in an adult population. Ann. rheum. Dis. 30, 605 (1971).
Kaeding, A.: Blut-und Gewebszucker beim Stoffwechselgesunden und beim Diabetiker, 1952.1. c. Ries, W. 1970.
Kaeding, A., Hirschlipp, H.: Klinische und emährungsanamnestische Erhebungen bei Norm-und Übergewichtigen. Zschr. ges. inn. Med. 23, 225–228 (1968).
Kaeding, A., Rohmann, H.: Vergleichende Untersuchungen zu den Ernährungsgewohnhei‑ ten bei Norm-und Übergewichtigen. Dtsch. Gesundheitswesen 22 395–398 (1967).
Kahn, C. R., Neville, D. M., Gordon, P., et al.: Insulin receptor defect in insulin resistance: Studies in the obese hyperglycemic mouse. Biochem. Biophys. Res. Comm. 48, 135 (1972).
Kahn, C. R., Neville, D. M., Rom, J.: Insulin receptor interaction in the obese-hyperglycemic mouse — a model of insulin restistance. J. biol. Chem. 248, 244 (1973a).
Kahn, C. R., Neville, D. M., Soll, A.: Deficiency of insulin receptors in the insulin resistant obese hyperglycemic mouse. Excerpta Medica (Amsterdam). Internal. Congr. Series 280, 75 (1973c).
Kahn, C. R., Soll, A., Neville, D. M.: Severe deficiency in insulin receptor: A common denominator in the insulin resistance of obesity. Clin. Res. 21, 628 (1973b).
Kahn, C. R., Soll, A. H., Neville, D. M., Goldfine, I. D., Archer, J. A., Gordon, P., Rom, J.: The insulin receptor in obesity and other states of altered insulin sensitivity. In: Bray, G. A. (ed.): Obesity in perspective DHEW Publication No (NIH) 75–708 p. 301. Washington 1975.
Kalkhoff, R. K.: Hormonal disturbances in obesity. In: Vague, J., Boyer, J. (eds.): The regulation of the adipose tissue mass. p. 271. New York: Exerpta medica American Elsevier, 1974.
Kalkhoff, R. K., Ferrou, C. A.: Metabolic differences between obese overweight and muscular overweight men. N. Engl. J. Med. 284, 1236 (1971).
Kalkhoff, R. K., Gossain, V. V., Matute, M. L.: Plasma glucagon in obesity. response to arginine, glucose and protein administration. N. Engl. J. Med. 289,465–467 (1973).
Kalkhoff, R. K., Kim, H., Cerletty, J., Ferrou, C.: Effects of weight loss on abnormal plasma insulin and growth hormone responses in obese subjects. Diabetes 19, 361–362 (1970).
Kalkhoff, R. K., Kim, H. J., Cerletty, J., Ferrou, C. A.: Metabolic effects of weight loss in obese subjects: changes in plasma substrate levels, insulin and growth hormone responses. Diabetes 20, 83 (1971).
Kallie, N. R., Peters, J. A. M.: Chow, S. C.: Submucous lipoma of the stomach. Canad. J. Surg. 19, 42–45 (1976).
Kalofoutis, A., Jullien, G., Koutselinis, A., Miras, C.: Erythrocyte 2, 3-Diphosphoglycerate as related to diabetes and obesity. Clin. Chem. 21, 1414 (1975).
Kannel, W. B., Brand, N., Skinner, J. J., Dawber, T. R., Mcnamara, P. M.: The relation of adiposity to blood pressure and development of hypertension. Ann. intern. Med. 67, 48–59 (1967a).
Kannel, W. B., Castelli, W. P., Mcnamara, P. M., Mckee, P. A., Feinleib, M.: Role of blood pressure in the development of congestive heart failure. N. Engl. J. Med. 287, 782 (1972).
Kannel, W. B., Gordon, T.: Assessment of coronary vulnerability — the Framingham Study. In: Waldenström, J., Larsson, T., Ljungstedt, N. (eds.): Early phases of coronary heart disease. The possibility of prediction. p. 123. Stockholm: Nordiska Bokhandelns Förlag 1973.
Kannel, W. B., Gordon, T.: Obesity and cardiovascular disease. The Framingham Study. In: Burland, W. L., Samnel, P. D., Yudkin, J. (eds.): Obesity symposium. p. 24 u. 57. London: Churchill Livingstone, 1974.
Kannel, W. B., Gordon, T.: Some determinants of obesity and its impact as a cardiovascular risk factor. In: Howard, A. (ed.) Recent advances in Obesity Research I. p. 14. London: Newman Publ. Ltd. 1975.
Kannel, W. B., Kagan, A., Dawber, T. R., Revotskie, N.: Epidemiology of coronary heart disease. Geriatrics 17, 675–690 (1962).
Kannel, W. B., Le Bauer, E. J., Dawber, T. R., Mcnamara, P. M.: Relation of body weight to development of coronary heart disease. Circulation 35, 734–744 (1967b).
Kannel, W. B., Pearson, G., Mcnamara, P. M.: Obesity as a force of morbidity and mortality in adolescents. In: Heald. (ed.). Nutrition and growth. p. 51 New York: Appleton-Century-Crofts, 1970.
Kannel, W. B., Seidman, J. M., Fercho, W., Castelli, W. P.: Vital capacity and congestive heart failure. Circulation 49, 1160–1166 (1974).
Kapell, R.: Die Syntropie der Adipositas mit der Hypertonie, ihr Vorkommen and ihre Verteilung in einer ländlichen Bevölkerung nach dem Broca-Index and nach dem Optimalgewicht. Dtsch. Gesundheitswesen 26, 2316 (1971a).
Kapell, R.: Zur Epidemiologie der Fettsucht. Med. alternd. Menschen 1, 99–103 (1971b).
Karam, J. H., Grodsky, G. M., Forsham, P. H.: Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12, 197–205 (1963).
Karam, J. H., Grodsky, G. M., Forsham, P. H.: The relationship of obesity and growth hormone to serum insulin levels. Ann. N. Y. Acad. Sci. 131, 374–387 (1965a).
Karam, J. H., Grodsky, G. M., Forsham, P. H.: Weight gain in infancy and development of juvenile diabetes mellitus. Lancet I, 45 (1976).
Karam, J. H., Grodsky, G. M., Pavlatos, F. C., Forsham, P. H.: Critical factors in excessive serum-insulin response to glucose. Lancet 1, 286–289 (1965b).
Karl, H. J., Raith, L.: Cortisolsekretion and Cortisolabbauprodukte im Urin bei Fettsüchtigen im Vergleich zu Normalpersonen. Klin. Wschr. 39, 702–703 (1961).
Karlbero: The development of children in a Swedisch urban community. A prospective longitudinal study. Acta Paed. Scand. Suppl. 187, 9 (1968).
Karpowitz, D. H., Zeis, F. R.: Personality and behavioural differences among obese and non-obese adolescents. In: Howard, A. (ed.): Recent advences in obesity research I. p. 226. London: Newman Publ. 1975.
Kasper, H., Plock, E.: Körpergewicht bei fettreicher kohlenhydratarmer Diät. Med. Klinik 66, 440–445 (1971).
Kasper, H., Thiel, H., Ehl, M.: Response of body weight to a low carbohydrate, high fat diet in normal and obese subjects. Am. J. Clin. Nutr. 26, 197–204 (1973).
Kasperek, R., Englhardt, A., Liebermeister, H., Jahnke, K.: In vitro investigations of the glucose uptake of human adipose tissue in normalweight and obese subjects. Diabetologia 6, 76 (1970).
Kato, Y., Moiumoto, M., Imura, H.: Plasma growth hormone in hyperthyroidism and obesity: Effect of propranolol infusion. Metabolism 19, 406–408 (1970).
Katfermann, R., Köbberling, J.: Serumlipide bei Verwandten ersten Grades von Diabetikern in Abhängigkeit von Körpergewicht and Glukosetoleranz. Dtsch. med. Wschr. 94, 1273 (1969).
Kaufmann, B. J., Ferguson, M. H., Cherniack, R. M.: Hypoventilation in obesity. J. clin. Invest. 38, 500 (1959).
Kaup, J., Forst, T.: Körperverfassung and Leistungskraft Jugendlicher. München u. Berlin: Verlag R. Oldenbourg 1930.
Kazdova, Lfabry, P., Vrna, A.: Adipose tissue hyperplasia induced by small doses of insulin. In: Vague J., Boyer, J. (eds.): The Regulation adipose tissue mass. Exerpta medica. p. 151. New York, American Elsevier 1974.
Kazdova, L., Vrana, A.: Insulin and adipose tissue cellularity. Horm. Metab. Res. 2, 117 (1970).
Keckwick, A., Pawan, G. L. S.: Caloric-intake in relation to body-weight changes in the obese. Lancet II, 155–161 (1956).
Keckwick, A., Pawan, G. L. S.: Metabolic study in human obesity with isocaloric diets high in fat, protein or carbohydrate. Metabolism 6, 447–460 (1957).
Keckwick, A., Pawan, G. L. S.: Body-weight, food and energy. Lancet I, 822–825 (1959).
Keckwick, A., Pawan, G. L. S., Chalmers, T. M.: Resistance to ketosis in obese subjects. Lancet 11, 1157–1159 (1959).
Keen, H.: The incomplete story of obesity and diabetes. In: Howard, A. (ed.): Recent advances in obesity research: I. p. 116. London: Newman Publ. 1975.
Kempner, W., Newborg, C., Peschel, R. L., Skyler, J. S.: Treatment of massive obesity with rice reduction diet programm. Arch. intern. Med. 135, 1575–1584 (1975).
Kennedy, G. C.: The role of depot fat in the hypothalamic control of food inkake in the rat. Proc. Roy. Soc. London (Ser. B) 140, 578 (1953).
Kepp, R., Staemmler, H. J.: Lehrbuch der Gynaekologie. 11. Auflage. p. 208. Stuttgart: Thieme 1974.
Keys, A.: Coronary heart disease-the global picture. Atherosclerosis 22, 149 (1975).
Keys, A., Anderson, J. T., Brozek, J.: Weight gain from simple overeating. Metabolism 4, 427–432 (1955).
Keys, A., Aravanis, C., Blackburn, H., Van Buchem, F. S. P., Buzina, R., Djordjevic, B. S., Fidanza, F., Karvonen, M. J., Menotti, A., Puddu, V., Taylor, H. L.: Coronary heart disease: Overweight and obesity as risk factors. Ann. intern. Med. 77, 15–27 (1972a).
Keys, A., Brozek, J.: Body fat in adult man. Physiol. Rev. 33, 245–325 (1953).
Keys, A., Fidanza, F., Karvonen, M. J., Kimura, N., Taylor, H. L.: Indices of relative weight and obesity. J. Chron. Dis. 25, 329–343 (1972b).
Keys, A., Grande, F.: Body weight, body composition and calorie status. In: Goodhart, R. S., Shils, M. E. (eds.): Modern Nutrition in Health and Disease. p. 1–27. Philadelphia: Lea u. Febiger 1973.
Keys, A., Taylor, H. L., Blackburn, H., Brozek, J., Anderson, J. T., Simonson, E.: Mortality and coronary heart disease among men studied 23 years. Arch. intern. Med. 128, 201–214 (1971).
Keys, A., Taylor, H. L., Mickelsen, O., Henschel, A.: Famine edema and mechanism of its formation. Science 103, 669 (1946).
Khosla, T., Lowe, C. R.: Indices of obesity derived from body weight and height. Brit. J. Prey. Soc. Med. 21, 122–128 (1967).
Khosla, T., Lowe, C. R.: Obesity and smoking habits. Brit. Med. J. 4, 10–13 (1971).
Kimmel, D.: Körpergewicht and Varizen. Diss. Leipzig, 1963.
Kinsell, L. W., Gunning, B., Michaels, G. D., Richardson, J. Cox, S. E., Lemon, C.: Calories do count. Metabolism 13, 195–204 (1964).
Kifnis, D. M., Schalch, D. S.: The impairment of carbohydrate tolerance by elevated plasma free fatty acids. J. clin. Invest. 43, 1283 (1964).
Kifnis, D. M., Stein, M. F.: Insulin antagonism: fundamental considerations. In: M. P. Cameron, M. O’Connot, (eds.): Ciba Foundation Colloquia on Endocrinology 15, Aetiology of Diabetes Mellitus and its Complications. p. 156–191. Boston: Little Brown and Company, 1964.
Kirby, M. J., Turner, P.: Fenfluramine and norfenfluramine on glucose uptake into skeletal muscle. Postgrad. Med. J. 51, (Suppl. 1), 73–76 (1975).
Kirby, M. J., Turner, P.: Do anorectic drugs produce weight loss by appetite suppression? Lancet I, 566–567 (1976).
Kisch, E. H.: Lipogener Diabetes. Munch. med. Wschr. 58, 677–679 (1911).
Kjellberg, J., Reizenstein, P.: Body composition in obesity. Acta Med. Scand. 188, 161–169 (1970).
Klein, B., Cornoni, J.C., Jones, F., Boyle, E.: Overweight indices as correlates of coronary heart diseases and blood pressure. Human Biology 45, 329–340 (1973).
Klein, D., Ammann, F.: The syndrome of Laurence-Moon-Biedl and allied diseases in Switzerland. J. neurol. Sci. 9, 479 (1969).
Klein, R.F., Troyer, W.G., Back, K.W., Hood, T.C., Bogdonoff, M.D.: Lipid mobilization in lean and obese subjects. Ann. NY Acad. Sci. 131, 662 (1965).
Klör, H.U., Ditschuneit, H.: Über die Beziehungen zwischen Glukosetoleranz, Fettstoffwechselstörungen and Adipositas. 7. Kongr. dtsch. Diabetes Gesellschaft, Bad Nauheim 1972.
Knick, B.: Fettleber — Symptomatologie and Therapie. Therapiewoche 20, 1412 (1970).
Knittle, J.L.: Obesity in childhood: a problem in adipose tissue cellular development. J. Pediatrics 81, 1048–1059 (1972).
Knittle, J.L., Ginsberg-Fellner, F.: Effect of weight reduction On in vitro adipose tissue lipolysis and cellularity in obese adolescents and adults. Diabetes 21, 754 (1971).
Knittle, J.L., Hirsch, J.: Effect of early nutrition on the development of rat epididymal fat pads: Cellularity and metabolism. J. clin. Invest. 47, 2091 (1968).
Knorre, G.V.: Ergebnisse einer Diabetes — Reihenuntersuchung in einem Landkreis 1961/1962. Dtsch. Gesundheitswesen 19, 593–598 (1964).
Knorre, G.V., Bode, H., Steigemann, M.: Fettsuchtfrequenz and Diabetesmorbidität. Zschr. inn. Med. 25, 61–66 (1971).
Knowles, H.C.: Prevalence and development of diabetes. Fed. Proc. 27, 945–947 (1968).
Knudsen, K.B., Sparberg, M., Lecocq, F.: Porphyria precipitated by fasting. N. Engl. J. Med. 277,350–351 (1967).
Knussmann, R., Toeller, M., Holler, H.D.: Zur Beurteilung des Körpergewichts. Med. Welt 23, 529–535 (1972).
Koch, J.: Untersuchungen über das Körpergewicht von Patienten mit peripheren Durchblutungsstörungen. Diss. Leipzig 1963.
Kobberling, J., Appels, A., Köbberling, G., Creutzfeldt, W.: Glukosebelastungstest bei 727 Verwandten ersten Grades von Altersdiabetikern. Dtsch. med. Wschr. 94, 416 (1969).
Köbberling, J., Creutzfeldt, W.: Comparison of different methods for the evaluation of the oral glucose tolerance test. Diabetes 19, 870–877 (1970).
Koepp, P.: Laurence-Moon-Biedl syndrome associated with diabetes insipidus neurohormonalis. Europ. J. Pediat. 121, 59–62 (1975).
Kohlrausch, W.: Methodik zur quantitativen Bestimmung der Körperfette in vivo. Arbeitsphysiologie 2,23–45 (1929).
Kohlrausch, W.: Physikalische Therapie der Fettsucht. In: Fettsucht, Pathogenese, Klinik und Therapie. Lochham: Pallas-Verlag 1961.
Kommission Der Deutschen Ges. F. Kreislaufforschung: Empfehlungen zur indirekten Messung des Blutdruckes beim Menschen. Z. Kreisl. Forsch. 60, Heft 6 (1971).
Konishi, F.: The relationship of urinary 17 —hydroxycorticosteroids to creatinine in obesity. Metabolism 13, 847–851 (1964).
Kono, T.: Destruction of insulin effector system of adipose tissue cells by proteolytic enzymes. J. biol. Chem. 244, 1772 (1969).
Kosara, K., Hagura, R., Odagiri, R., Saito, F., Kuzuya, T.: Effect of weight changes on serum insulin response in subjects with normal oral glucose tolerance. J. clin. Endocrinol. Metab. 35, 655–658 (1972).
Koschinsky, Th., Gries, F.A.: Glycerin-Kinase und Lipolyse des menschlichen Fettgewebes in Abhängigkeit vom relativen Körpergewicht. Hoppe-Seyler’s Z. Physiol. Chem. 352, 430–432 (1971).
Koschinsky, Th., Gries, F.A., Herberg, L.: Regulation of glycerol kinase by insulin in isolated fat cells and liver of Bar-Habor obese mice. Diabetologia 7, 316–322 (1971).
Kotchen, J.M., Kotchen, T.A., Schwertman, N.C., Kuller, L.H.: Blood pressure distribution of urban adolescents. Amer. J. Epidemiol. 99, 315 (1974).
Kotilainen, M.: Group therapy for obesity. Ann. Med. intern. Fam. 52, 155 (1963).
Kothhaus, H.: Zur Nahrungsaufnahme Adipöser nach Gewichtsreduktion. Inaugural Diss., Düsseldorf 1975.
Kral, J.G.: Surgical reduction of adipose tissue. Effects of adipectomy and intestinal by-pass on adipose tissue cellularity. Thesis, University of Gothenburg 1976.
Kral, J.G., Sjöström, L.V.: Surgical reducion of adipose tissue hypercellularity. In: A. Howard, (ed.): Recent Advances in Obesity Research I. p. 327–330. London: Newman Publ., 1975.
Kraupp, O.: Pharmacology und Toxikologie der Appetitzügler. Regensburger Jahrbuch ärztl. Fortbildung 211, 354–359 (1971).
Krogman, W.M.: Growth of man. Tabulae Biologicae, vol. XX. Den Haag: Dr. W. Junk 1941.
Krebs, W., Manger, S.: Die Syntropie cardiovasculärer Krankheiten mit der Adipositas. Dtsch. Gesundheitswesen 20, 1040–1047 (1965).
Kreisberg, R.A.: Glucose metabolism in normal and obese subjects. Effect of phenformine. Diabetes 17, 481 (1968).
Kreisberg, R.A., Boshell, B.R., Di Placido, J., Roddam, R.F.: Insulin secretion in obesity. N. Engl. J. Med. 276, 314–319 (1967).
Kreisberg, R.A., Pennington, L.F., Boshell, B.R.: Lactate turnover and gluconeogenesis in normal and obese humans. Effect of starvation. Diabetes 19, 53–63 (1970).
Kremer, G.J., Knick, B., Lange, H.J., Kössling, F.K., Grams, H.: Frühdiabetische Stoffwechselanomalien und bioptisch objektivierter Leberverfettungsgrad bei Gallensteinträgern. Schweiz. med. Wschr. 98, 110–114 (1968).
Kremen, H.J., Linner, J.H., Nelson, C.H.: An experimental evaluation of nutritional importance of proximal and distal small intestine. Ann. Surgery 140, 439 (1954).
Kronenberg, R.S., Grabel, R.A., Severinghaus, J.W.: Normal chemoreceptor function in obesity before and after ileal bypass surgery to force weight reduction. Amer. J. Med. 59, 349–353 (1975).
Krotkiewski, M., Björnrorp, P., Sjöström, L.: Regional variation of fat cell size in young, middle-aged and obese women. In: Howard, A. (ed.): Recent advances in obesity research I. p. 97–100. London: Newman, Publ. 1975.
Krüger, H.H.: Die Therapie der Fettsucht mit Schilddrüsenhormonen und Diuretika. Med. Klinik 59, 217–225 (1964).
Kruskemper, G., Zimmermann, H., Berger, M., Schlegel, S.: Psychological abnormalities associated with obesity and anorexia nervosa. In: Howard, A. (ed.): Recent advances in Obesity Research I. p. 251. London: Newman Publ. Ltd., 1975.
Krzvwicki, H.J., Ward, G.M., Rahman, D.P., Nelson, R.A., Consolazio, C.F.: A comparison of methods for estimating human body composition. Am. J. Clin. Nutr. 27, 1380–1385 (1974
Kuhlo, W., Doll, E.: Beziehungen zentraler und kardiopulmonaler Funktionsstörungen am Beispiel des Pickwick-Syndroms. Zbl. ges. Neurol. Psychiat. 197, 8 (1970).
Kuhlo, W., Dom, E., Franck, M.C.: Erfolgreiche Behandlung eines Pickwick-Syndroms durch eine Dauertrachealkanüle. Dtsch. med. Wschr. 94, 1286 (1969).
Kohnau, J.: Festvortrag. 16. Dtsch. Kongr. f. Ärztl. Fortbildung, Berlin (1967).
Külz, E.: Klinische Erfahrungen über den Diabetes mellitus. (bearbeitet von Th. Rumpff und anderen) Jena 1899.
Kunkel, W., Haupt, E., Fröhlich, A., Schöffling, K.: Der Einfluß einer Gewichtsreduk‑ tion auf Verlauf und Behandlung des Erwachsenendiabetes. Med. Welt 23, 679 (1972).
Kuo, P.T., Feng, L., Cohen, N.N., Fors, W.T., Miller, L.D.: Dietary carbohydrates in hyperlipemia (hyperglyceridemia): hepatic and adipose tissue lipogenic activities. Am. J. clin. Nutr. 26, 116 (1967).
Labia, M., Boulin, R.: Obesity, Part I. L’épreuve de l’hypoglycemie provoquée chez les obéses. Bull. Soc. Méd. Hop. Paris 649–653 (1925).
Labhart, A.: Myatonic Diabetes (Prader-Labhart-Willi Syndrome) Obesity and vascular complications. In: Froesch, E.R., Yudkin, J. (eds): Nutrition and diabetes mellitus. Acta diabet. lat. 9 (Supp1.1) 469–483 (1972).
Lachner, O.: Gesundheitszustand europäischer Jugendlicher. Ärztl. Jugendkunde 56, 282–294 (1965).
Lachnit, V.: Die Fettleibigkeit. Wien: Mandrich 1963.
Lambert, A.E., Hoet, J.J., Ekka, E., Horemans, B.: Plasma insulin levels during pregnancy in obesity and potential diabetes. Diabetologia 2, 260–264 (1966).
Lamki, L., Ezrin, C., Koven, J., Steiner, G.: L-Thyroxine in the treatment of obesity without increase in loss of lean body mass. Metabolism 22, 617–622 (1973).
Lanceraux, E.: Bull. Acad. Méd. Paris, 1215 (1877).
Lanceraux, E.: Etude comparative du diabète maigre et du diabète gras. Union méd. Paris 39, 161 (1880).
Landau, B.R.: Adrenal steroids and carbohydrate metabolism. In: Harris, R.S., Wool, I.G., Loraine, J.A., (eds.): Vitamines and Hormones. p. 2–59. New York: Acad. Press 1965.
Lang, P.D., Vollmar, J., Klemens, K.H. et al.: Lipidsenkende Wirkung von Phenformin bei primärer Hyperlipoproteinämie Typ IV. Dtsch. med. Wschr. 98, 2280 (1973).
Lasagna, L.: Attitudes toward appetite suppressants. J. Amer. Med. Ass. 225, 44–48, (1973).
Laube, H., Köhle, K., Ditschuneit, H., Pfeiffer, E.F.: Klinik und Ergebnisse YOB Fastenkuren bei Fettsucht. Therapiewoche, 3944–3945 (1971).
Laube, H., Köhle, K., Ditschuneit, H., Pfeiffer, E.F.: Dauererfolg von Fastenkuren. Dtsch. med. Wschr. 97, 830–835 (1972a).
Laube, H., Raptis, S., Chrisibu, M., Pfeiffer, E.F.: Der Einfluß verschiedener Reduktionsdiäten auf den Hyperinsulinismus bei Adipositas. Therapiewoche 22, 4535 (1972b).
Laube, H., Raptis, S., Pfeiffer, E.F.: Der Einfluß von Ernährungsfaktoren auf die Entstehung von Fettsucht und Hyperinsulinismus. Dtsch. med. Wschr. 98, 1256 (1973).
Lazlo, J., Klein, R.F., Bogdonoff, M.D.: Prolonged starvation in obese patients: in vitro and in vivo effects. Clin. Res. 9, 183 (1961).
Laurence, J.Z., Moox, R.C.: Four cases of retinitis pigmentosa occuring in the same family, and accompanied by general imperfections of development. Ophth. Rev. London 2, 32–41 (1866).
Lauter, I., Baumann, H.: Ober den Kreislauf beim sogenannten Fettherzen. Klin. Wschr. 7, 741–745 (1928).
Lawlor, T., Wells, D.G.: Metabolic hazards of fasting. Am. J. Clin. Nutr. 22, 1142–1149 (1969).
Lawlor, T., Wells, D.G.: Fasting as a treatment of obesity. Postgrad. Med. Journal. June Suppl.: 452–458 (1971).
Lawson, A.A.H., Roscoe, P., Strong, J.A., Gibson, A., Peattie, P.: Comparison of fenfluramine and metformin in treatment of obesity. Lancet II, 437–440 (1970).
Lazarus, S.S., Volk, B.W.: The effect of protracted glucagon administration on blood glucose and on pancreatic morphology. Endocrinology 63, 359 (1958).
Leelarthaepin, B., Woodhill, J.M., Palmer, A.J., Blacket, R.B.: Obesity diet and type-II hyperlipidaemia. Lancet II, 1217–1221 (1974).
Leevy, C.: Fatty liver: a study of 270 patients with biopsy proven fatty livers. Medicine 41, 249 (1962).
Leger, L., Zara, M., Mouleé, P., Dentan, T.: Coust-circuit jéjuno-ileâl dans le traitment de l’obésité. Clinigie 96, 949–956 (1970).
Lemonnier, D.: Effect of age, sex, and site on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet. J. clin. Invest. 51, 2907–2915 (1972).
Leonhardt, W.: Größenmessung menschlicher Fettzellen mit dem ZG 2 des VEB Transformatoren-und Röntgenwerkes, Dresden. I. Gewinnung der Fettzellen, Messung und Auswertung. Labortechnik 6, 29–32 (1973).
Leonhardt, W., Hanefeld, M., Haller, H.: Die Volumina isolierter Fettzellen — ihre Verteilungsfunktion, Maximalgröße und Beziehung zum Gewichtsindex. Dtsch. Gesundheitswesen 26, 2165–2168 (1971).
Leonhardt, W., Hanefeld, M., Schneider, H., Haller, H.: Human adipocyte volumes: Maximum size, and correlation to weight index in maturity onset-diabetes. Diabetologia 8, 287–291 (1972).
Leonie, R.: Glucagon and the regulation of blood sugar. N. Engl. J. Med. 294, 494 (1976).
Lesser, G.T., Deutsch, S., Markofsky, J.: Use of independent measurement of body fat to evaluate overweight and underweight. Metabolism 20, 792–804 (1971).
Lessof, M.H., Mc Hardy Young, S., Greenwood, F.C.: Growth hormone secretion in obese subjects. Guy’s Hospital Report 115, 65–71 (1965).
Levine, R.: Glucagon and the regulation of blood sugar. N. Engl. J. Med. 294, 494 (1976).
Levin, D., Devesa, S.S., Goowin, J.D., Silverman, D.T.: Cancer rates and risks. US Dept. H.E.W., Public health service, NIH, Washington D.C. (1974).
Levrrz, L.S., Stunkard, A.J.: A therapeutic coalition for obesity behaviour modification and patient self-help. Am. J. Psych. 131, 423–427 (1974).
Lew, E.A.: New data on underweight and overweight persons. J. Am. diet. Ass. 38,323–327 (1961).
Lewis, H.E., Masterton, J.P., Ferres, H.M.: Selection of representive sites for measuring changes in human subcutaneous tissue thickness. Clin. Sci. 17, 369–376 (1958).
Lewis, L.A., Turnbull, R.B. Jr., Page, J.H.: Effects of jéjunocolie shunt on obesity, serum lipoproteins, lipids and electrolytes. Arch. int. Med. 117, 4 (1966).
Lewis, S., Haskell, W.L., Wood, P., Manoogian, N., Bailey, J.E., Pereira, M.B.: Effects of physical activity on weight reduction in obese middleaged women. Am. J. Clin. Nutr. 29, 151 (1976).
Liebelt, R.A., Idimol, S., Nicholson, N.: Regulatory influences of adipose tissue on food intake and body weight. Ann. N.Y. Acad. Sci. 131, 559 (1965).
Liebermeister, H.: Die Therapie der Fettsucht. Ihre Erfolge und ihre Stoffwechseleffekte. Habil. Schrift Düsseldorf (1968).
Liebermeister, H.: Prognose der Fettsucht. Lebensversicherungsmedizin 25, 80–85 (1973).
Liebermeister, H.: Kohlenhydrate in der Diätetik bei Fettsucht. In: Jahnke, K, Mehnert, H., und Drost, H., (eds.): Metabolische und klinische Aspekte der Kohlenhydrate in der Ernährung. p. 135. Mainz: Kirchheim 1975.
Liebermeister, H.: Die Fettsucht als sozialmedizinisches Problem. Medical Tribune 5, 19 (1970).
Liebermeister, H.: Gewichtsreduktion bei Adipositas durch Diät, Medikamente und operative Verfahren. Klin. Wschr. 49, 125–134 (1971).
Liebermeister, H., Daweke, H., Gries, F.A., Schilling, W.H., Gruneklee, D., Probst, G., Jahnke, K.: Einfluß der Gewichtsreduktion auf Metabolite des Kohlenhydrat-und Fettstoffwechsels und auf das Verhalten des Seruminsulins bei Adipositas. Diabetologia 4, 123–132 (1968a).
Liebermeister, H., Daweke, H., Jahnke, K., Grüneklee, D., Preiss, H., Oberdisse, K.: Langzeitbeobachtungen des Kohlenhydratstoffwechsels und des Seruminsulins bei adipösen Diabetikern unter einer Reduktionsdiät. In: Beringer, A., Deutsch, E., (eds.): Diabetes mellitus. Internat. Donau-Symposium über Diabetes mellitus. p. 55. Wien 1969a.
Liebermeister, H., Jahnke, K., Voss, H.J., Englhardt, A., Probst, G.: Initial-und Spätergebnisse der Diätbehandlung bei Fettsucht. Dtsch. med. Wschr. 93, 21491–2155 (1968b).
Liebermeister, H., Probst, G., Jahnke, K.: Erfahrungen mit dem Appetithemmer Fenflurminhydrochlorid bei der Adipositas. Med. Klinik 64, 1201–1207 (1969b).
Liechty, R.D., Alserer, R.N., Burrington, J.: Islet cell hyperinsulinism in adults and children. J. Amer. med. Ass. 230, 1538–1543 (1974).
Lincoln, J.E.: Calorie intake, obesity, and physical activity. Amer. J. clin. Nutr. 25, 390–394 (1972).
Lipinski, B.G.: Life change events as correlates of weight gain. In: Howard A. (ed.): Recent advances in obesity research: I. p. 210. London: Newman Publ. 1975.
Lisch, H.J., Sailer, S., Sandhofer, F., Braunsteiner, H.: Untersuchungen an isolierten menschlichen Fettzellen verschiedener Gewebsregionen. II. Beziehungen zwischen Zellvolumen und basaler Lipolyse. Klin. Wschr. 48, 1352–1356 (1970).
Lw, R.: L’indice ponderale o repporto tra la Statura e il peso. Atti Soc Romano Antrop. 5, 125–153 (1897).
Livingston, J.N., Cuatrecasas, P., Lockwood, D.: Insulin insensitivity of large fat cells. Science 177, 626 (1972).
Lockwood, D.H., Livingston, J.N., Amatruda, J.M.: Relation of insulin receptors to insulin resistance. Fed. Proc. 34, 1564 (1975).
Loeb, H., Ooms, H.A., Wolter, R., Brunet, N.: Study of the glycoregulation in obese children. Diabetologia 5, 47 (1969).
Loew, D., Meng, K. Zum Kochsalzverbrauch in der Bundesrepublik Deutschland. Klin. Wschr. 53, 1131–1132 (1975).
Löhren, D.: Untersuchungen zur Insulinempfindlichkeit des Glukosestoffwechsels menschlicher Adipozyten. Inaugural Diss. 1975.
Londono, J.H., Gallagher, T.F. Jr., Bray, G.A.: Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity. Metabolism 18, 986–992 (1969).
Longler, L.P., Muller, M. The effect of diet and meals and the maximum urea clearance. Am J. med. Sci. 203, 253 (1942).
Loude, S., Bourglognie, J.J., Robson, A.M., Goldring, D.: Hypertension in apparently normal children. J. Pediat. 78, 569–577 (1971).
Lourenco, R.V.: Diaphragm activity in obesity. J. clin. Invest. 48, 1609 (1969).
Lovidan, L., Sadeglie-Nejad, A., Senior, B.: Hypersecretion of insulin after administration of 1-leucine to obese children. J. Pediat. 78, 53 (1971).
Lowenstein, F.W., Abraham, S.: Obesity in adults in the USA: Preliminar findings. In: A. Howard, (ed.): Recent advances in obesity research: I. p. 52. London: Newman Publ. Ltd. 1975.
Lowy, C., Rubenstein, A.H., Wright, A.D., Martin, T.J., Fraser, T.R.: Urinary immunochemical insulin in normal obese, and obese diabetic subjects during oral glucose test and starvation. Diabetologia 2, 209 (1966).
Lufr, R., Cerasi, E., Andersson, B.: Obesity as an additional factor in the pathogenesis of diabetes. Acta endocr. (Kbh) 59, 344 (1968).
Luft, R., Ikkos, D., Palmieri, G., Ernster, L., Afselius, B.: A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control. J. clin. Invest. 41, 1776–1804 (1962).
Luhanova, Z.: Durch Fettsucht behinderte Kinder. Off. Gesundheitswesen 31, 209–214 (1969).
Lutz, W.: Das endokrine Syndrom des adipösen Jugendlichen. Wien. med. Wschr. 114, 459–462 (1964).
Luycxx, A., Lefèbvre, P.: Evidence d’une réduction de la sécrétion d’insuline dans le diabète avec ou sans obésité. Discussion de l’emploi thérapeutique des biguanides. Ann. Endocr. (Paris) 30, 717–730 (1969).
Luyckx, A.S., Lefèbvre, P.: Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc. Soc. exp. Biol. Med. 133, 524–528 (1970).
Lyons, H.A., Huang, C.T.: Therapeutic use of progesterone in alveolar hypoventilation associated with obesity. Amer. J. Med. 44, 881 (1968).
Maaser, R., Droese, W., Whrtenberger, H.: Die Beurteilung des Ernährungszustandes. Ein Vergleich zwischen Ultraschall und Calipermessung. Klin. Wschr. 50, 925–926 (1972).
Mackay, E.M., Sherril, J.W.: A comparison of the ketosis developed during fasting by obese patients and normal subjects. Endocrinology 21, 677–680 (1937).
Mackay, E.M., Callaway, J.W., Barnes, R.H.: Hyperalimentation in normal animals produced by protamine insulin. J. Nutr. 20, 59–66 (1940).
Maddox, G.L., Anderson, C.F., Bogdanoff, M.D.: Overweight as a problem of medical management in a public outpatient clinic. Amer. J. med. Sci. 252, 394–402 (1966).
Maddox, G.L., Back, K.W., Liedermann, V.R.: Overweight as social deviance and disability. J. Health Social Behaviour 9, 287–298 (1968).
Madelung, O.: Über den Fetthals (diffuses Lipom des Halses). Arch. klin. Chir. 37, 106–130 (1888).
Madison, L.L., Seyffert, W.A., Unger, R.H., Barker, B.: Effect of plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism 17, 301–304 (1968).
Mahler, R.: The relationship between eating and obesity. Acta diabet. lat. 9, (suppl. 1), 449–465 (1972).
Mahler, R.J.: The cause of insulin resistance in obesity. Excerpts Medica (Amsterdam) Internat. Congr. Series 280, 156 (1973).
Mahler, R.J.: The pathogenesis of pancreatic islet cell hyperplasia and insulin insensitivity in obesity. Adv. metab. disorders 7, 213 (1974).
Mahler, R.J., Szabo, O.: Amelioration of insulin resistance obese mice. Am. J. Physiol. 221, 980 (1971).
Malaisse, W., Lavaux, J.P., Franckson, J.R.M., Bastenie, P.A.: Diabetes in bearded women (Achard-Thiers-Syndrome). A clinical and metabolic study of 20 cases. Diabetologia 1, 155 (1965).
Malina, R.M.: Quantification of fat, muscle and bone in man. Clin. Orthop. rel. Res. 65, 9–38 (1969).
Malins, J.M.: Diabetes in the population. Clin. Endocrinol. Metab. 1, 645–672 (1972).
Mandell, F., Berenberg, W.: The Mauriac Syndrome. Amer. J. Dis. Child. 127, 900–902 (1974).
Mann, G.V.: The influence of obesity on health. N. Engl. J. Med. 291, 178–185 und 226–232 (1974).
Mann, G.V., Teel, K., Hayes, O., Mc Nally, A., Bruno, D.: Exercise in the disposition of dietary calories. Regulation of serum lipoprotein and cholesterol levels in human subjects. N. Engl. J. Med. 253, 349–355 (1955).
Marchionni, M., Costabello, E.: Primary obesity at school age. Minerva Pediat. 21, 805 (1969).
Marco, J., Calle, C., Roman, D., Diaz-Fierros, M., Villaneva, M.L., Valverde, I.: Hyperglucagonism induced by glucocorticoid treatment in man. N. Engl. J. Med. 288, 128–131 (1973).
Marks, H.H.: Influence of obesity on morbidity and mortality. Bull. N.Y-Acad. Med. 36, 296 (1960).
Marks, H.H., Krall, L.P., Whrre, P.: Epidemiology and detection of diabetes In: Marble, A., White, P., Bradley, R.F., Krall, L.P. (eds.): Joslin’s Diabetes mellitus. p. 10. Philadelphia: Lea & Febiger 1971.
Maranon, G.: Praediabetische Zustände. Abh. Grenzgeb. inn. Sekret (Budapest) 1927 1. c. Ries, 1970.
Marston, A.F., London, P., Cooper, L., Cohen, N.: In vivo observations of the eating behaviour of obese and non-obese subjects. In: Howard, A. (ed.): Recent advances in obesity research: I. p. 207. London: Newman Publ. 1975.
Martin, D.G., Hawryluk, G.A., Gerson, A.: Obesity, conditionability and perceived locus of control. In: Howard, A. (ed.): Recent advances in obesity research: I. p. 215. London: Newman Publ. 1975.
Martin, E.: L’hyperostose frontale interne, Syndrome de Morgagni-Morel, un état de diabète latent. Praxis 58,1068 (1969).
Martin, L.: Effect of weight reduction on normal and raised blood pressures in obesity. Lancet II, 1051–1053 (1952).
Martin, R.: Lehrbuch der Anthropologie. 2. Auflage, G. Fischer 1928.
Marx, J.L.: Estrogen Drugs: Do they increase the risk of cancer. Science 191, 838 (1976).
Mason, E.E., Ito, C.: Gastric bypass in obesity. Surg. Clin. North. Am. 47, 1345–1351 (1967).
Masoro, E.: Effect of cold on metabolic use of lipids. Physiol. Rev. 46, 67 (1966).
Masson, J.K.: Lipectomy: The surgical removal of excess fat. Postgrad. Med. 32, 481–488 (1962).
Master, A.M., Jaffe, H.L., Chesky, K.: Relationship of obesity to coronary disease and hypertension. J. Am. Med. Ass. 153, 1499–1501 (1953).
Matsuki, S., Kataoka, K., Suzuki, Y., Takabayashi, Y.: Lipogenesis and frequency of feeding: enhanced serum insulin response and sparing of specific dynamic action by 2-meals-per day feeding in man. In Vague, J., Boyer, J., (eds.): The regulation of the adipose tissue mass. p. 198. New York: Exerpta Medica American Elsevier 1974.
Matzkies, F., Baumbauer, E., Pensel, W., Kori-Lindner, C., Berg, D., Sailer, D., GrabNer, W., Bergner, D.: Erfahrungen mit einer Minimalernährung zur ambulanten Behandlung des Übergewichts. Medizin und Ernährung 13, 97–99(1972).
Mauriac, P.: Gros ventre, hepatomegalie, troubles de la croissance chez les enfants diabétiques traites blepuis plurieus années par l’insuline. Gaz. hebd. Sci. Med. Bordeaux 26, 402–410 (1930).
Maxwell, J.G., Richards, R.C., Auto, D. Jr.: Fatty degeneration of the liver after intestinal bypass for obesity. Am. J. Surg. 116; 648–652 (1968).
Mayer, J.: Genetic, traumatic and environmental factors in the etiology of obesity. Physiol. Rev. 33, 472 (1953).
Mayer, J.: Some advances in the study of the physiologic basis of obesity. Metabolism 6,435 (1957).
Mayer, J.: Zur Physiologie der Adipositas und ihren Beziehungen zur Ernährung. Int. Z. Vitaminforsch. 29, 87 (1958).
Mayer, J.: Overweight: Causes, costs and control. Englewood Cliffs N.J. Prentice-Hall 1968.
Mayer, J.: Obesity. In: Goodhart, R. S., Shils, M. E. (eds.): Modern nutrition in health and disease. p. 625–644. Philadelphia: Lea and Febiger 1971.
Mayer, J., Thomas, D.W.: Regulation of food intake and obesity. Science 156,328 (1967).
Mayer, J., Roy, P., Mrrsa, K.P.: Relation between caloric intake, body weight and physical work: Studies in an industrial male population in West Bengal. Amer. J. clin. Nutr. 4, 169–175 (1956).
Mccuish, A.C., Munro, J.F., Dunean, L.J.S.: Follow — up study of refractory obesity. Brit. Med. J. I, 91–92 (1968).
Medalie, J.H., Papier, C.M., Goldbourt, N., Herman, J.B.: Major factors in the development of diabetes mellitus in 10000 men. Arch. intern. Med. 135, 811–817 (1975). Medical Letter: 16, 54 (1974).
Medico Actuarial Mortality Investigation, Vol. II. Ass. Life Insurance Medical Div. America, Actuarial Soc, Amer. (N. Y.). 1913.
Medley, D.R.K.: The relationship between diabetes and obesity: a study of suscebtibility to diabetes in obese people. Quart. J. Med. 34, 111–132 (1965).
Meek, J.D., Doffing, K.M., Bolinger, R.E.: Radioimmunoassay of insulin A and B chains in normal and diabetic human plasma. Diabetes 17, 61 (1968).
Mehnert, H.: Aktuelle Diabetesprobleme in Klinik und Praxis. Dtsch. med. Wschr. 91, 744–750 (1966).
Mehnert, H., Pelikan, L., Zöllner, N.: Ober die Konzentration der freien Fettsäuren im Serum von Diabetikern und Fettsüchtigen. Klin. Wschr. 39,888–891 (1961).
Mehnert, H., Schöffling, K.: Diabetologie in Klinik und Praxis. Stuttgart: Thieme 1974.
Mehnert, H., Sewering, H., Reichstein, W., Vogt, H.: Früherfassung von Diabetikern in München 1967/68. Dtsch. med. Wschr. 93, 2044–2050 (1968).
Meier, E.: Ober die Variation von Körpergrößen und Körpergewichten bei Erwachsenen nach Untersuchungen an der Berliner Bevölkerung. Arch. Hygiene (Berlin) 140, 304–319 (1956).
Meinicke, K.H., Olsen, J.M., Bansi, H.W.: Erhöhte Aldosteronausscheidung bei Adiposi-tas. Klin. Wschr. 36, 539 (1958).
Melani, F.: Critical considerations regarding the obesity-hyperinsulinism concept. Acta Diab. Latina 5 (Suppl. 1), 332–340 (1968).
Melani, F., Lawecki, J., Bartelt, K.M., Pfeiffer, E.F.: Immunologisch meßbares Insulin (IMI) bei Stoffwechselgesunden, Fettsüchtigen und adipösen Diabetikern nach intravenöser Gabe von Glukose, Tolbutamid und Glucagon. Diabetologia 3, 422 (1967).
Melani, F., Rubenstein, A.H., Steiner, D.F.: Human serum proinsulin. J. clin. Invest. 49, 49 (1970).
Mellich, W., Benke, A.: Adipositas und Emphysem. Ein ernstes Narkoserisiko bei akuten abdominellen Eingriffen. Wien. med. Wschr. 113, 415 (1963).
Mendelson, M.: Psychological aspects of obesity. Med. Clin. North. Amer. 48,1373 (1964).
Mertz, D.P.: Gicht. Grundlagen, Klinik und Therapie. Stuttgart: G. Thieme 1971.
Mertz, D.P., Scriba, P.C., Schwarz, K.: Hormonjod im Serum bei alimentärer Fettsucht. Diskussionsbemerkungen. Klin.Wschr. 46, 1058 (1968a).
Mertz, D.P., Stelzer, M., Heinzmann, M.: Hormonjod im Serum bei alimentärer Fettsucht. Klin. Wschr. 46, 157–158 (1968b).
Meyer, J.E., Tuchelt-Gallwitz, A.: Psychiatrisch-psychologische Untersuchungen an weiblichen Fettsüchtigen. Z. psychosomat. Med. und Psychoanalyse 13, 73–106 (1967).
Meyerrowitz, B.R., Gruber, R.P., Laub, D.R.: Massive abdominal panniculectomy. J. Am. Med. Ass. 225, 408–409 (1973).
Micheels, K.H.: Adipositas und vorzeitige Invalidität. Z. ges. inn. Med. 20, 203–207 (1965).
Michel, D., Seraphim, P.H., Eigler, E.: Übergewichtigkeit, Herz-und Kreislaufsystem. Ärztl. Praxis 9, 4403 (1968).
Migeon, C.J., Green, Se., Eckert, J.P.: Study of adrenocortical function in obesity. Metabolism clin. exp. 12, 7181(1963).
Mietfinen, T.: Cholesterol production in obesity. Circulation 44, 842–850 (1971).
Miller, A., Granada, M.: In-hospital mortality in the Pickwickiansyndrome. Amer. J. Med. 56, 144 (1974).
Miller, D.S., Mumford, P.M.: Obesity: physical activity and nutrition. Proc. Nutr. Soc. 25, 100–107 (1966).
Miller, D.S., Mumford, P.: Gluttony. L. An experimental study of overeating low-or high-protein diets. Am. J. clin. Nutr. 20, 1212–1222 (1967).
Miller, D.S., Mumford, P., Stock, M.J.: Gluttony. 2. Thermogenesis in overeating man. Am. J. clin. Nutr. 20, 1223 (1967).
Minemura, G.: Epidemiology of diabetes in Asia espicially in Japan. In: Rodriguez, R.R., Vallance-Owen, J. (eds.): Diabetes. p. 331–344. Amsterdam: Excepta Med. Found 1971.
Mlynaryk, P., Gillies, R.R., Beverly, M. Pattee, C.J.: Cortisol production rates in obesity. J. clin. Endocrinol. 22, 587 (1962).
Möhr, M.: Antropometrische Untersuchungen zur Kennzeichnung des Ernährungszustandes. Dtsch. Gesundheitswesen 22, 1853–1859 (1967).
Möhr, M.: Ernährungszustand und Körperzusammensetzung bei Werktätigen der Industrie. Z. inn. Med. 24, 907–910 (1969).
Montegriffo, V.M.E.: 1968 zitiert nach Baird, M.I.: Obesity in adults. In: Baird, Howard, A.N., (eds.). Obesity medical and scientific aspects. p. 13–24. London: Livingstone LTD. 1969.
Montegriffo, V.M.E.: A survey of the incidence of obesity in the United Kingdom. Postgrad. Med. J. Jun-Suppl. 418–422 (1971).
Montenegro, M.R., Solberg, L.A.: Obesity, body weight, body length, and atherosclerosis. Lab. Invest. 18, 594 (1968).
Monti, M.: Redcell 2,3-Diphosphoglycerate in obese patients. Acta med. Scand. 195, 287–289 (1974).
Montoye, H.J., Epstein, F.A., Kjelsberg, M.O.: The measurement of body fatness. Am. J. clin. Nutr. 16, 417–427 (1965).
Montoye, H.J., Epstein, F.H., Kjelsberg, M.O.: Relationship between serum cholesterol and body fatness. Amer. J. clin. Nut. 18, 397–406 (1966).
Moore, F.D., Olesen, K.H., Mcmurrey, J.D., Parker, H.V., Ball, M.R., Boyden, C.M.: The body cell mass and its supporting environment. Body composition in health and disease. Philadelphia-London: W.B. Saunders Co. 1963.
Moore, M.E., Stunkard, A., Srole, L.: Obesity social class and mental illness. J. Amer. med. Ass. 181, 962–966 (1962).
Moore, N.S., Young, C.M., Maynard, L.A.: Blood lipid levels as influenced by weight reduction in women. Amer. J. Med. 17, 348–354 (1954).
Moore, N.S., Fryer, J.H., Young, C.M., Maynard, L.A.: Blood lipid levels as influenced by weight reduction in men. Amer. J. clin. Nutr. 3, 397–402 (1955).
Morel, F.: L’hyperostose frontale interne. Syndrome de l’hyperostose frontale interne avec adipose et troubles cérébraux. Gaston Doin, Paris 1930.
Morris, H.G., Jorgensen, LR., Elrick, H., Goldsmith, R.E.: Metabolic effects of human growth hormone in corticoid-treated children. J. clin. Invest. 47, 436 (1968).
Morse, W.I., Mahabar, R.: Changes in glucose tolerance and plasma free fatty acids after fasting in obesity. Diabetes 13, 286–290 (1964).
Morse, W.I., Sidorov, J.J., Soeldner, J.S., Dickson, R.C.: Oberservations on carbohydrate metabolism in obesity. Metabolism 9, 666 (1960).
Morse, W.I., Soeldner, J.S.: The non-adipose body mass of obese women: evidence of increased muscularity. Can. med. Ass. J. 90, 723–725 (1964).
Mosinger, B., Kühn, E., Kujalova, V.: Action of adipokinetic hormones on human adipose tissue in vitro. J. lab. clin. Med.66, 380–389 (1965).
Mühlbauer, W.: Die plastisch-chirurgische Behandlung der Fettleibigkeit. Munch. Med. Wschr. 117, 747–750 (1975).
Müller, F., Paul, I.: Epidemiologische und familiäre Untersuchungen zum Auftreten von Fettsucht und Diabetes mellitus. In: A. Beringer (ed.): Diabetes mellitus. p. 159–164. Wien: E. Deutsch 1970.
Müller, F., Paul, J., Wrrng, J.: Untersuchungen zur Fettsuchthäufigkeit in einem Landkreis Ostmecklenburgs. Teil I: Fettsuchthäufigkeit und Schweregrad der Fettsucht in Abhängigkeit von Geschlecht und Alter. Z. inn. Med. 22, 789–796 (1967).
Müller, F., Paul, J., Brasch, C., Kapell, R., Knorre, G.V., Grimmberger, E., GrimmberGer, M., Wrrrio, J.: Zur Verbreitung der Fettsucht in der Deutschen Demokratischen Republik. Z. ges. innere Medizin 25, 1001–1009 (1970).
Müller, M.M., Fuchs, H., Schwarjmeier, I.D., Obiditsch-Mayer, I., Freilinger, G., Frank, O.: Zur Biochemie der benignen symmetrischen Lipomatose (Adenolipomatose Launois-Bensaude, Madelung’sche Krankheit). Wien. Klin. Wschr. 88, 94–101 (1976).
Müller, W.A., Falona, G.P., Unger, R.H.: The influence of the antecedent diet upon glucagon and insulin secretion. N. Engl. J. Med. 285, 1450–1454 (1971).
Muir, G.G., Chamberlain, D.A., Pedoe, D.T.: Effects of ß-sympathetic blockade on non-esterified-fatty-acids and carbohydrate metabolism at rest and during exercise. Lancet II, 930 (1964).
Muxcx, A.: Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms, and physiological significance. Perspect. Biol. Med. 14, 265–289 (1971).
Munro, H.N.: The energy metabolism of man during overfeeding. Brit. J. Nutr. 4, 316–322 (1950).
Munro, J.F., Mccuish, A.C., Marshall, A., Wilson, E.M., Duncan, L.J.P.: Weight reducing effect of diguanides in obese nondiabetic women. Brit. med. J. 2, 13–15 (1969).
Munro, J.F., Mccuish, A.C., Goodall, , Fraser, J., Duncan, L.J.S.: Further experience with prolonged therapeutic starvation in gross refractory obesity. Brit. med. J. IV, 712–714 (1970).
Munro, J.F., Seaton, D.A., Duncan, L.J.P.: Treatment of refractory obesity with fenfluramine. Brit. med. J. 2, 624–625 (1966).
Murphy, R.: Obesity and diabetes mellitus. J. Mich. med. Soc. 55, 1209 (1956).
Muting, D., Fischer, R., Koin, U., Reikowski, J.: Pathogenese, Klinik und Biochemie der Fettleber. Dtsch. med. Wschr. 98, 733–737 (1973).
Muting, D., Kaufmann, M.: Störungen der Glukosetoleranz bei 2600 histologisch gesicherten akut und chronisch Leberkranken. Munch. med. Wschr. 117, 1689–1694 (1975).
Naeye, R.: Human obesity, cell size and number in visceral organs. Fed. Proc. 28, 493 (1969).
Naimark, A., Cherniak, R.M.: Compliance of the respiratory system and its components in health and obesity. J. appl. Physiol. 15, 377 (1960).
Naunyn, B.: Der Diabetes mellitus. p. 105. 2. Aufl. Wien: Hölder 1906.
Nestel, P.: Turnover of plasma esterfied cholesterol: influence of dietary fat and carbohydrate and relation to plasma lipids and body weight. Clin. Sci. 38, 593–600 (1970).
Nestel, P. J., Canoll,K.F., Silverstein, M.S.: Influence of free-fatty acid metabolism on glucose tolerance. Lancet II, 115 (1964).
Nestel, P.J., Schreibman, P.H., Ahrens, E.A.: Cholesterol metabolism in human obesity. J. clin. Invest. 52, 2389–2397 (1973).
Nestel, P.J., Wfirre, H.M.: Plasma free fatty acid and triglyceride turnover in obesity. Metabolism 17, 1122 (1968).
Neuenschwander-Lemmer, N.: Über Ausnutzungsversuche bei fettsüchtigen und normalen Menschen. Z. exper. Medizin 99, 394–398 (1936).
Neumann, M.: Hormonale Regulation der Lipolyse des subcutanen menschlichen Fettgewebes in vitro. Inaugural Diss. Düsseldorf (1970).
Neumann, M., Berger, M., Englhardt, A., Gries, F.A.: Einfluß von Glukose, Noradrenalin, Theophyllin und DB-cyclo-AMP auf die Lipolyse menschlicher Fettzellen in vitro bei Adipositas. 5. Kongr. dtsch. Diabetes-Ges. Bad Godesberg (1970).
Neumann, R. O.: Experimentelle Beiträge zur Lehre von dem täglichen Nahrungsbedarf des Menschen unter besonderer Berücksichtigung der notwendigen Eiweißmenge. (Selbstversuche) Arch. Hyg. 45, 1–87 (1902).
Neumann, I., Michaelis, D., Schulz, B., Michael, R., Schneider, H., Hanefeld, M.: Beeinflussung hormonell-metabolischer und morphologischer Parameter der Adipositas durch Gewichtsreduktion. 2. Mitteilung: Verhalten des Kohlenhydratstoffwechsels und der Insulinsektretion. Dtsch. Gesundheitswesen 29, 1172 (1974).
Newburgh, L.H.: Control of the hyperglycemia of the obese „diabetics“ by weight reduction. Ann. int. Med. 17,935–942 (1942a).
Newburgh, L.H.: Obesity. Arch. intern. Med. 70, 1033–1096 (1942b).
Newburgh, L.H.: Obesity I. Energy metabolism. Physiol. Rev. 24, 18 (1944).
Newburgh, L.H., Conn, J.W.: New interpretation of hyperglycemia in obese middleaged persons. J. Amer. med. Ass. 112, 7 (1939).
Nicholsen, W.J.: Emotional factors in obesity. Am. J. med. Sci. 211, 443–447 (1946).
Nicoloff, J. T., Drenick, E. J.: Altered peripheral thyroxine metabolism in severe obesity. Clin. Res. 14, 148 (1966).
Nikkilä, E. A., Taskinen, M. R.: The insulin secretion rate in obesity. Postgrad. Med. J. (June Suppl.) 412–417 (1971).
Nielsen, J H , Hansen, F. M.: Studies on the influence of cell size and rat weight on the lipogenic action of insulin in isolated adipozytes. In Vague, J., Boyer, J. (eds.): The regulation of the adipose tissue mass. p. 93. Amsterdam: Excerpta Medica, 1974.
Nisbett, R. E.: Determination of food intake in human obesity. Science 159, 1254–1255 (1968a).
Nisbett, R. E.: Taste deprivation and weight determinants of eating behavior. J. Personality social Psychol. 10, 107–116 (1968b).
Nisbetr, R. E.: Eating behavior and obesity in men and animals. In: Reichsman F. (ed.): Hunger and satiety in health and disease. Ado. psychosom. Med. 7, 173–193 (1972).
Nissen, R.: Die Operation des Fettleibigen. Munch. med. Wschr. 102, 2205–2207 (1960).
Nolte, D.: Druck-Strömungs-Diagramm der Lungen bei Adipositas. Klin. Wschr. 47,1119(1969).
Noorden, C. V.: Die Fettsucht. Wien: Alfred Hölder 1900.
Noorden, C. V.: Metabolism and practical medicine. Chicago: W. T. Keener 1907. Noorden, C. v.: Die Fettsucht. 2. Aufl. Leipizig: Hölder, 1910.
Noorden, C. V.: Pathologie des Stoffwechsels, 1893 1. c. NOORDEN, C. v. und ISAAC, S. Die Zuckerkrankheit und ihre Behandlung. Berlin 1927.
Noorden, C. V., Isaac, S.: Die Zuckerkrankheit und ihre Behandlung. 8. Aufl. p. 87. Berlin: Springer 1927.
Noorden, C. V., Salomon, H.: Handbuch der Ernährungslehre I. 1. Auflage. p. 994–995. Berlin: Springer 1920.
Oberdisse, K.: Die Fettsucht und die Magersucht. Therapiewoche 10, 556–562 (1960).
Oberdisse, K.: Bignaniole. In: Oberdisse, K. (ed.): Handbuch d. inneren Medizin. 5. Aufl. Bd. VII, 2 B. Berlin, Springer, im Druck.
Oberwittler, W., Schulte, H., Paravassiliov, K.: Vergleich verschiedener Indices zur Beurteilung des relativen Körpergewichtes. Med. Welt 25, 1269–1271 (1974).
O’connell, M., Danforth, E., Horton, E. S., Salans, L., Sims, E. A. H.: Experimental obesity in man. III. Adrenocortical function. J. clin. Endocrinol Metab. 36, 323–329 (1973).
Oeder, S.: Die Fettpolsterdicke als Index des Ernährungszustandes bei Erwachsenen. Med. Klinik 17, 657–662 (1910).
Östman, J., Backman, L., Hallberg, D.: Cell size and lipolysis by human subcutaneous adipose tissue. Acta med. Scand. 193, 469–475 (1973).
Östman, J., Backman, L., Hallberg, D.: Cell size and the antilipolytic effect of insulin in human subcutaneous adipose tissue. Diabetologia 11, 159 (1975).
Ogilvie, R.: Sugar tolerance in obese subjects: A review of 65 cases. Quart. J. Med. 28, 345–358 (1935).
Olefsky, J., Reaven, G.: Clin. Res. 22, 476A (1974).
Olefsky, J. M., Reaven, G. M.: Effects of age and obesity on insulin binding. Endocrinology 96, 1486 (1975).
Olefsky, J., Reaven, G. M., Farquhar, J. W.: Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subject. J. clin. Invest. 53, 64–76 (1974).
Olson, N. S., Nuetzel, J. A.: Resistance to small doses of insulin in various clinical conditions. J. clin. Invest. 29, 862 (1950).
Opie, L. H., Walfish, P. G.: Plasma free fatty acid concentrations in obesity. N. Engl. J. Med. 268, 757–760 (1963).
Opitz, K.: Die medikamentöse Behandlung der Adipositas. Therapiewoche 18,2031–2034 (1968).
Opttz, K., Loeser, A.: Pharmakologie der appetitmindernden Substanzen. In: Fettsucht, Pathogenese, Klinik and Therapie. Lochham: Pallas 1961.
Orth, R. D., Williams, R. H.: Response of plasma NEFA levels to epinephrine infusions in normal and obese women. Proc. Soc. exp. Biol. Med. 104, 119 (1960).
Oscai, L. B.: The role of exercise in weight control. In: Wilmore, J. H. (ed.): Exercise and Sport Sciences Reviews, Vol. 1. p. 103. New York: Academic Press 1973.
Oscai, L. B., Holloszy, J. O.: Effects of weight changes produced by exercise, food restriction or overeating on body composition. J. clin. Invest. 48, 2124 (1969).
Ostrander, L. O., Lamphiear, D. E.: Coronary risk factors in an community. Findings in Tecumseh, Michigan. Circulation 53, 152–156 (1976).
Ostrander, L. D., Lamphiear, D. E., Block, W. D., Johnson, B. C., Epstein, F. H.: Biochemical precursors of atherosclerosis. Studies in apparently healthy men in a general population, Tecumseh, Michigan. Arch. intern. Med. 134, 224 (1974).
O’sullivan, J. B.: Population retested for diabetes after 17 years: new prevalence study in Oxford, Massachusetts. Diabetologia 5, 211–214 (1969).
O’sullivan, J. B., Mahan, C. M.: Blood sugar levels, glycosuria, and body weight related to development of diabetes mellitus. J. Amer. med. Ass. 194, 587–592 (1965).
Orr, H.: Normalgewicht and Optimalgewicht. Ernährungsumschau 10, 49 (1963).
Otto, H.: Diabetes and Pyelonephritis. In: Losse, H., Kienitz, M. (eds.): Die Pyelonephritis. p. 265. Stuttgart: Thieme 1966.
Owen, J. A., Lindsay, R. W., Gaskin, J. H., Hollifield, G.: Response of human adipose tissue to endogenous serum insulin — like activity in vitro. Metabolism 16, 47–56 (1967).
Owen, O. E., Felig, P., Morgan, A. P., Wahren, J., Cahill, G. F.: Liver and kidney metabolism during prolonged starvation. J. clin. Invest. 48, 574 (1969).
Owen, O. E., Morgan, A. P., Kemp, H. S., Sullivan, I. M., Herrera, M. G., Cahill, G. F. Jr.: Brain metabolism during fasting. J. Clin. Invest. 46, 1589–1595 (1967).
Owen, O. E., Reichard, G. A.: Ketone body metabolism in normal, obese and diabetic subjects. Israel. J. med. Sci. 11, 560 (1975).
Paffenbarger, R. S., Wing, A. L.: Chronic disease in former college students. XII. Early precursors of adult-onset diabetes mellitus. Amer. J. Epidemiol. 97, 314–322 (1973).
Parker, D. C., Mace, J. W., Gotlin, R. W., Rossman, G.: Nychthemeral variation of human growth hormone in plasma. J. clin. Invest. 47, 76a (1968).
Parmeggiani, A., Bowman, R. H.: Regulation of phosphofructokinase activity by citrate in normal and diabetic muscle. Biophys. Res. Comm. 12, 268–273 (1963).
Parizkova, J., Rom, Z.: The assessment of depot fat in children from skinfold thickness measurements by Holtain (Tanner/Whitehouse) Caliper. Human Biology 44, 613 (1972).
Parnell, R. W.: Behaviour and Physique. London: Arnold 1958.
Parra, A., Schultz, R. B.: Metabolic response to simultaneous infusion of epinephrine and propranolol in obese adolescents. Metabolism 18, 497–508 (1969).
Passaro, E., Drenick, E. J., Wilson, S. E.: Bypass enteritis-new complication of jejunoileal bypass for obesity. Amer. J. Surg. 131, 169 (1976).
Passmore, R., Durmin, J. V. G. A.: Human energy expenditure. Physiol. Rev. 35, 801–840 (1955).
Pastan, I., Rom, J., Maechia, V.: Binding of hormone to tissue: The first step in polypeptide hormone action. Proc. Natl. Acad. Sci. 56, 1802 (1966).
Patel, M. S., Owen, O. E., Goldman, L. I., Hanson, R. W.: Fatty acid synthesis by human adipose tissue. Metabolism 24, 161 (1975).
Patel, D. P., Srowers, J. M.: Phenformin in weight reduction of obese diabetics. Lancet II, 282–284 (1964).
Paul, P., Bortz, W.: Turnover and oxidation of plasma glucose in lean and obese humans. Metabolism 18, 570 (1969).
Paulin, I. E., Sauls, H. C.: A study of the glucose tolerance in the obese. South. med. J.15, 249 (1922).
Paulsen, E. P., Lawrence, A. M.: Glucagon hypersecretion in obese children. Lancet II, 110 (1968).
Paulsen, E. P., Richendorfer, L., Ginsberg-Fellner, F.: Plasma glucose, free fatty acids, and immunoreactive insulin in sixty-six obese children. Diabetes 17, 261–269 (1968).
Pawan, G. L. S.: Some aspects of metabolism of the obese. Proc. Nutr. Soc. 18, 155–162 (1959).
Payne, J. H.: Obesity. Am. J. Surgery 120, 513 (1970).
Payne, J. H., Dewind, L. T.: Surgical treatment of obesity. Am. J. Surg. 118, 141–147 (1969).
Payne, J. H., Dewind, L. T.: Metabolic observations in patients with jéjunocolic shunt. Am. J. Surg. 106, 273–289 (1963).
Peckham, C. H., Christianson, R. E.: The relationship between pre-pregnancy weight and certain obstetric factors. Amer. J. Obstet. Gynecol. 111, 1–7 (1971).
Pedersen, J., Olesen, E. S.: Observations on the mechanism of increased weight loss during metformin administration in obesity. Acta endocrinol. 57, 683–688 (1968).
Pelkonen, R., Nikkila, E. A., Taskinen, M. R., Miettinnen, T.: Plasma insulin (IRI) response to small doses of intravenous glucose: Influence of obesity and fasting. Scand. J. clin. lab. Invest. 21, (Suppl. 101), 25, (1968).
Pell, S.: The identification of risk factors in employed populations. Trans. N. Y. Acad. Sci. 36, 341–356 (1974).
Pell, S., D’alonzo, C. A.: Chronic disease morbidity and income level in an employed population. Amer. J. publ. Health 60, 116–129 (1970).
Penick, S. B., Filion, R., Fox, S., Stunkard, A. J.: Behavior modification in the treatment of obesity. Phychosomat. Med. 33, 49–55 (1971).
Penick, S. B., Hinkle, L. E.: Depression of food intake induced in healthy subjects by glucagon. N. Engl. J. Med. 264, 893–897 (1961).
Pennington, A. W.: Treatment of obesity. Developments of the past 150 years. Amer. J. digest. Dis. 21, 65–69 (1954).
Pennington, A. W.: Pyruvic acid metabolism in obesity. Am. J. dig. Dis. 22, 33–37 (1955).
Perley, M. J., Kipnis, D. M.: Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 15, 867–874 (1966).
Perley, M. J., Kipnis, D. M.: Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. clin. Invest. 46, 1954–1962 (1967).
Perlstein, I. B., Premachandra, B. N., Blumenthal, H. T.: Studies on obesity II: Altered serum protein binding of thyroxine in human obesity. J. Am. Med. Ass. 204, 533 (1968).
Perlstein, I. B., Premachandra, B. N., Blumenthal, H. T.: Effect of triiodothyronine on thyroid autoantibodies and abnormal thyroxine binding in human obesity. Clin. Pharmacol. Ther. 12, 298–299 (1971).
Persson, J., Andersen, V., Deckert, T.: Treatment of obesity with fenfluramine. Europ. J. Clin. Pharmacol. 6, 93–97 (1973
Petzold, A., Ries, W., Schmidt, W.: Untersuchungen über die Pregnandiolausscheidung von Fettsüchtigen. Endokrinologie 47, 271–277 (1965).
Pfeiffer, E. F.: Obesity islet function and diabetes mellitus. Horm. metab. Res. Suppl. 4, 143–151 (1974).
Pflanz, M.: Medizinisch-soziologische Aspekte der Fettsucht. Psyche 16, 575–591 (1962/63).
Pflanz, M.: Soziokulturelle Faktoren und innere Erkrankungen. Internist 3, 80–85 (1962a).
Pflanz, M.: Sozialer Wandel und Krankheit. Stuttgart: F. Enke Verlag 1962 b.
Phear, D. N.: The normal and diabetic patterns of insulin response to glucose. Lancet II, 955–958 (1962).
Piguet, M. CH.: Du coefficient de rostisticité. p. 33. Bull. méd. (Paris) 1901.
Pilkington, T. R. E., Gainsborough, H., Roseover, V. M., Carey, M.: Diet and weight-reduction in the obese. Lancet I, 856–858 (1960).
Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., Avery, G. S.: Fenfluramine: A review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10, 241–323 (1975).
Pinter, E. J., Pattee, C. J.: Fat-mobilizing action of amphetamine. J. clin. Invest. 47, 394–402 (1968a).
Pinter, E. J., Pattee, C. J.: Some data on the metabolic function of the adrenergic nervous system in the obese and during starvation. J. clin. Endocr. Metab. 28, 206 (1968b).
Piorkowski, P.: Medizinische und ökonomische Aspekte der Fettsucht. Dtsch. Gesundheitswesen 25, 1740–1746 (1970).
Piondexter, C. A., Bruger, M.: Effect of low calorie diets and resultant weight loss on plasma cholesterol in the obese. Arch. intern. Med. 56, 884–890 (1935).
Poisnick Di Rarmonelo, V.: Adrenocortical function in obese women. J. clin. Endocrinol. 16, 957 (1956).
Poldinger, W.: Psychosomatische Aspekte der Fett-und Magersucht. Monatsk. ärztl. Fortb. 21, 360 (1971).
Pomerleau, O., Bass, F., Grown, V.: Role of behavior modification in preventive medicine. N. Engl. J. Med. 292, 1277–1282 (1975).
Popper, H., Schaffner, F.: Nutritional cirrhosis in man? N. Engl. J. Med. 285, 577–578 (1971).
Porte, D. Jr., Bagdade, J. D., Bierman, E. L.: The critical role of obesity in the interpretation of serum insulin levels. In: Camerini-Daralos, R. A., Cole, H. (eds.): Advances in metabolic disorders. Suppl. 1, Early diabetes, p. 191. New York: Academic Press 1970.
Potter, H. P. Jr., Bassett, D. R.: Extensive jéjunoileal resection. Pennsylvania Med. 69, 27 (1966).
Prader, A., Labhart, A., Willi, H.: Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. Schweiz. med. Wschr. 86, 1260 (1956).
Preble, W. E.: Obesity: Observations on one thousand cases. Boston Med. Surg. J. 188, 617–621 (1923).
Preiss, H., Thamer, G., Gries, F. A., Solbach, H. G., Jahnke, K.: Der Einfluß von Noradrenalin auf die Lipidmobilisation aus subcutanem menschlichen Fettgewebe in vitro bei normgewichtigen und adipösen Personen. Verh. dtsch. Ges. inn. Med. 74, 950 (1968).
Premachandra, B. N., Perlstein, I. B., Blumenthal, H. T.: Studies on Obesity. II. Slowmoving thyroxine binding globulin in the sera of normal and obese subjects. J. clin. Endocr. 30, 752 (1970).
Pressman, B. C., Lardy, H. A.: Effect of surface active agents on the latent ATP ase of mitochondria. Biochim., Biophys. Acta 21, 458 (1956).
Prezio, J. A., Careon, G., Clerkin, E., Meloni, C. R., Kyle, Ch., Canary, J. J.: Influence of body composition on adrenal function in obesity. J. clin. Endocrinol 24, 481 (1964).
Price, J. M., Sheposch, J. P., Tiano, F. E.: A direct test of Schachters internal-external theorey of obesity in a naturalistic setting. In: Howard A. (ed.): Recent advances in obesity research: I. p. 204. London: Newman Publ. 1975.
Printen, K. J., Mason, E. E.: Gastric surgery for relief of morbid obesity. Arch. Surg. 106, 428–437 (1973).
Prior I, A. M., Rose, B. S., Harvey, H. P. B., Davidson, F.: Hyperuricemia, gout and diabetic abnormality in polynesian people. Lancet I, 333 (1966).
Prodder, S. H., Dennig, H.: A study of the circulation in obesity. J. clin. Invest. 11,789–806 (1932).
Pudel, V.: Der Einfluß vorgetäuschter Kalorien auf das Sättigungsgefühl Übergewichtiger. Ztschr. exp. angew. Psychologie 20, 653–662 (1973).
Pudel, V.: Psychological observations on experimental feeding in the obese. In: Howard A. (ed.): Recent advances in obesity research: I. p. 217. London: Newman Publ. 1975.
Pudel, V., Metzdorff, M., Oetting, M.: Zur Persönlichkeit Adipöser in psychologischen Tests unter Berücksichtigung latent Fettsüchtiger. Z. psychosomat. Med. Psychoanalyse 21,345–361 (1975).
Pudel, V., Meyer, J. E.: Die Fettsucht als Störung des Appetitverhaltens. Dtsch. med. Wschr. 99, 618–628 (1974).
Puts, W., Keup, V.: Influence of an a-amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man. Diabetologia 9, 97–101 (1973).
Puls, E., Keuf, V.: Metabolic studies with an amylase inhibitor in acute starch loading tests in rat and men and its influence on the amylase content of the pancreas. In: Howard, A. (ed.): Recent advances in obesity research: I. p. 391. London: Newman Publ., 1975.
Putnam, L., Jenicek, J. A., Allen, C. R., Wilson, R. D.: Anesthesia in the morbidly obese patient. South. med. J. 67, 1411–1417 (1974).
Pyke, D. A., Please, N. W.: Obesity, parity, diabetes. J. Endocrinol. 15, 26–33 (1957).
Quaade, F.: Obese children. Anthropology and environment. Danish Science Press Copenhagen 1955.
Quaade, F.: Insulination in leanness and obesity. Lancet II, 429–432 (1963).
Quaade, F.: The Scandinavian obesity shunt project. In: Howard, A. (ed.): Recent advances in obesity Research: I. p. 323. London: Newman Publ., 1975.
Quabbe, H. J., Helge, H.: Verhalten der STH-Sekretion bei der Fettsucht. Verh. dtsch. Ges. inn. Med. 73, 89–94 (1967).
Quabbe, H. J., Schilling, E., Helge, H.: Pattern of growth hormone secretion during a 24-hour fast in normal adults. J. clin. Endocrinol. 26, 1173 (1966).
Quetelet, A.: Anthropométrie ou mesure des différentes facultés de l’homme. Bruxelles, 1870.
Rabinowitz, D.: Hormonal profile and forearm metabolism in human obesity. Amer. J. clin. Nutr. 21, 1438–1444 (1968).
Rabinowitz, D.: Some endocrine and metabolic aspects of obesity. Ann. Rev. Med. 21, 241–258 (1970).
Rabinowitz, D., Merimee, T. J., Nelson, J. K., Schultz, R. B., Riggs, L.: The hormonal profile in obesity. Trans. Ass. Am. Physicians 80, 190 (1967).
Rabinowitz, D., Zierler, K. L.: Forearm metabolism in obesity and its response to intra-arterial insulin. „Evidence for adaptive hyperinsulism“. Lancet II, 690 (1961).
Rabinowitz, D., Zierler, K. L.: Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J. clin. Invest. 41, 2173–2181 (1962a).
Rabinowitz, D., Zierler, K. L.: Role of free fatty acids in forearm metabolism in man quantitated by use for insulin. J. clin. Invest. 41, 2191–2197 (1962b).
Radovanovic, M.: Epidemiology of obesity of population in VOrvoDINA. In: Vague, J. (ed.): Physiopathology of adipose tissue. p. 335–339. Amsterdam: Exerpta Medica Found. 1969.
Randle, P. J., Garland, P. B., Newsholme, E. A., Hales, C. N.: The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I, 785 (1963).
Randle, P. J., Garland, P. B., Newsholme, E. A., Hales, C. N.: The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann. N. Y. Acad. Sci. 131, 324 (1965).
Rapoport, A., From, G. L. A., Husdon, H.: Metabolic studies in prolonged fasting. I. Inorganic metabolism and kidney function. Metabolism 14, 31–46 (1965).
Raptis, S., Schröder, K. E., Telb, M., Pfeiffer, E. F.: Unterschiede in der Wirkung des Sekretins bei Normalgewichtigen and Adipösen. Wien. Zschr. inn. Med. 49, 423–429 (1968).
Rath, R., Kujalova, V.: Catecholamines and obesity. In: Symposium über Lipidstoffwechselerkrankungen. Dresden, Vol. II, 514 (1973).
Ratzmann, K. P., Männchen, E., Meyer, L. W., Baufeld, M.: Interrealtionen zwischen Blutglukose, peripheren IRI-Konzentrationen and Lipidparametern bei Adipositas mit normaler Glukosetoleranz. Dtsch. Gesundheitswesen 30, 538–543 (1975).
Reaven, G., Miller, R.: Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17, 560–569 (1968).
Reaven, G. M., Olefsicy, J. M.: Increased plasma glucose and insulin responses to high-carbohydrate feedings in normal subjects. J. clin. Endocrinol. Metab. 38, 151 (1974).
Reed, L. J., Love, A. G.: Biometric studies on U. S. Army officers somatological norms in disease. Human Biol. 5, 61 (1933).
Reh, H.: Die Fettzellgröße beim Menschen and ihre Abhängigkeit vom Ernährungszustand. Virchows Archiv 324, 234 (1953).
Rehfeld, J. F., Juhl, E., Quadde, F.: Effect of jèjunoileostomy on glucose and insulin metabolism in ten obese patients. Metabolism 19, 529–538 (1970).
Reichlin, S.: Neuroendocrinology. In: Williams R. H. (ed.): Textbook of Endocrinology. p. 774. Philadelphia: Saunders 1974.
Reichsman, F. (ed.): Hunger and satiety in health and disease. Adv. Psychosomatic Med. 7 (1972).
Reid, D. D., Brett, G. Z., Hamilton, P. J. S., Jarrett, R. J., Keen, H., Rose, G.: Cardiorespiratory disease and diabetes among middle-aged male civil servants. A study of screening and intervention. Lancet I, 469–473 (1974).
Reinheimer, W., Davidson, P. C., Albrink, M. J.: Effect of moderate exercise on plasma glucose insulin and free fatty acids during oral glucose tolerance tests. J. Lab. clin. Med. 71, 429 (1968).
Reitsma, W. D.: The relationship between serum free fatty acids and blood sugar in nonobese and obese diabetics. Acta med. Scand. 182, 353 (1967
Renold, A. E., Cahill, G. F. (eds.): Adipose tissue. Handbook of Physiology No. 5 Washington D. C., American Physiological Society 1965 a.
Renold, A. E., Cahill, G. F.: Preface. In: Renold A. E., Cahill G. F., (eds.): Handbook of Physiology. Section 5: Adipose tissue. p. 1. Baltimore: Williams u. Wilkins 1965 b.
Report: On the health of the school child by the chief medical officer of the Ministry of Education 1962. London, H. M. Stationary office.
Rezek, M., Kroeger, E. A.: Glucose antimetabolites and hunger. J. Nutr. 106, 143–157 (1976).
Richardson, G. O.: The obese diabetic. Diabetes 2, 454–456 (1953).
Richer, P.: Du rôle de la graisse dans la conformation extérieure du corps humaine. Nouvelle Iconographie de la Salpetriere 3, 20–26 (1890).
Ries, W.: Kritische Stellungnahme zur Behandlung der Fettsucht mit Preludin. Munch. med. Wschr. 35, 1138–1142 (1956).
Ries, W.: Fettsucht. Leipzig: Verlag J. A. Barth 1970.
Ries, W., Schröder, B.: Körpergewicht und Cholezystopathie. Z. ges. inn. Med. 14, 165 (1959).
Rimm, A. A., Werner, L. H., Yserloo, B., Bernstein, R. A.: Relationship of obesity and disease in 73532 weight-conscious women. Pupl. Health Rep. 90, 44–51 (1975).
Rivlin, R.: Therapy of obesity with hormones. N. Engl. J. Med. 292, 26–29 (1975).
Robinson, S. C., Brucer, M., Mass, J.: Hypertension and obesity. A statistical and clinical study of 10883 individuals. J. Lab. clin. Med. 25, 807–822 (1940).
Rochester, D. F., Enson, Y.: Current concepts in the pathogenesis of the obesity hypoventilation syndrome. Mechanical and circulatory factors. Amer. J. Med. 57, 402 (1974).
Rodin, J.: Obesity and external responsiveness. In: Howard A. (ed.): Recent advances in obesity research: I. p. 191. London: Newman Publ. 1975.
Rodin, L.: Schwangerschaftskomplikationen bei Fettsüchtigen. 1. c. Ries, W. 1970.
Roginski, M. S., Sandler, J.: Phenformin in human obesity. Ann. N. Y. Acad. Sci. 148, 892–896 (1968).
Rohmann, H., August, J., Hubel, A., Mahlan, G.: Zur Entwicklung eines großen poliklinischen Krankengutes von 1948–1963 unter besonderer Berücksichtigung von Blutdruck und Gewichtsverhalten. Dtsch. Gesundheitswesen 22, 1256–1260 (1967).
Rohrer, F.: Die Kennzeichnung der allgemeinen Bauverhältnisse des Körpers durch Indexzahlen. Munch. med. Wschr. 68, 580 (1921).
Romani, J.-D., Albeaux-Fernet, M.: Etude du metabolism hydrosodique au cours du l’obésité. La Semaine des Hôpitaux 41, 829–833 (1965).
Romani, J. D., Boutier, M., Bernheim, R., Loo, H., Reyes, F., Albeaux-Fernet, M.: Obésité et maladie diabétique. La Semaine des Hôpitaux 44, 275–286 (1968).
Rony, H. R.: Obesity and leanness. Philadelphia: Lea & Febiger 1940.
Rooth, G., Carlström, S.: Therapeutic fasting. Acta med. Scand. 187, 455–463 (1970).
Rosenfeld, G.: Die äußeren Symptome des Diabetes. Berliner Klin. Wschr. 55, 494–495 (1918).
Rosenman, R. H., Brand, R. J., Jenkins, C. D., Friedman, M., Straus, R., Wurm, M.: Coronary heart disease in the Western Collaborative Group Study. Final follow-up experience of 81/2 years. J. Am. med. Ass. 233, 872 (1975).
Rose, R. H.: Weight reduction and its remarkable effect on high blood pressure. N. Y. Med. J. Med. Res. 21, 752–755 (1922).
Ross, M. H.: Length of life and nutrition in the rat. J. Nutr. 75, 197 (1961).
Rosselin, G. E., Claude, J. R., Eschwege, E. P., Patios, E., Warnet, J. M., Richard, J. L.: Diabetes Survey. Plasma insulin during 0–2 oral glucose tolerance test systematically carried out in a professional group. Diabetologia 7, 34–45 (1971).
Rosselin, G., Tchobroutsky, G., Assan, R., Freychet, P.: Intern. Symp. Growth Hormone Amsterdam: Excerpta Med. 1967.
Rout, J.: Peptide hormone binding to receptors: A review of direct studies in vitro. Metabolism 22, 1059 (1973).
Rom, J., Guck, S. M., Yalow, R. S., Berson, S. A.: Secretion of human growth hormone: physiologic and experimental experimentation. Metabolism 12, 577 (1963).
Roth, J., Gordon, P., Pastan, I.: „Big Insulin“: A new component of plasma insulin detected by immunoassay. Proc. Nat. Acad. Sci. (U. S.) 61, 138 (1968).
Rozental, P., Biava, C., Spencer, H.: Liver morphology and function tests in obesity and during total starvation. Amer. J. dig. Dis. 12, 198–208 (1967).
Ruderman, N. B.: Muscle amino acid metabolism and gluconeogenesis. Ann. Rev. Med. 26, 245 (1975).
Rudnick, P. A., Taylor, K. W.: Effect of prolonged carbohydrate restriction on serum insulin levels in mild diabetes. Brit. med. J. I, 1225–1228 (1965).
Ruffer, W. A.: Two simple indexes for identifying obesity compared. J. Am. diet Ass. 57, 326–334 (1970).
Runcie, J., Thomson, T. J.: Total fasting, hyperuricaema and gout. Postgrad. med. J. 45, 251–253 (1969).
Runcie, J., Thomson, T. J.: Prolonged starvation — a dangerous procedure. Brit. med. J. 3, 432–435 (1970).
Russel, G. F. M.: The effect of diets of different composition on weight loss, water and sodium balance in obese patients. Clin. Sci. 22, 2691(1962).
Rynearson, E. H., Gastineau, C. F.: Obesity. Springfield: Thomas 1949.
Sabeh, G., Corredor, D. G., Mendelsohn, L. V., Morgan, C. R., Sieracki, J. C., Sunder, J. H., Wingert, J. P., Danowski, T. S.: Growth hormone and insulin levels in newly discovered glucose intolerance. Metabolism 18, 741–747 (1969).
Said, D.: Abnormalities of pulmonary gas exchange in obesity. Ann. intern. Med. 53, 1121 (1960).
Sailer, S., Sandhofer, F., Braunsteiner, H.: Overweight and triglyceride level in normal persons and patients with diabetes mellitus. Metabolism 15, 135–137 (1966).
Sailer, S., Sandhofer, F., Lisch, H.-J., Braunsteiner, H.: GIöße der Fettzellen and relatives Körpergewicht in verschiedenen Regionen des Menschen. Wien. Z. inn. Med. Grenzgeb. 50, 374–381 (1969).
Sakurai, H., Doses, R. E., Unger, R. H.: The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus. Metabolism 24, 1287 (1975).
Salans, L. B., Bray, G. A., Cushman, S. W., Danforth, E., Glennon, I. A., Horton, E. S., Sims, E. A. H.: Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effect of dietary composition and adipose cell size. J. clin. Invest. 53, 848 (1974).
Salans, L. B., Cushman, S. W.: Cellular consequences of obesity. In: Bray, G. A., (ed.): Obesity in Perspective DHEW publication No (NIH) 75–708. p. 245. Washington 1975.
Salans, L. B., Cushman, S. W., Weisman, R. E.: Studies of human adipose tissue adipose cell size and number in non-obese and obese patients. J. clin. Invest. 52, 929–941 (1973).
Salans, L. B., Danforth, E., Horton, E. S., Sims, E. A. H.: Dissociation of the effects of adiposity and diet on glucose, insulin and adipose tissue metabolism in human obesity. J. clin. Invest. 51, 84 a (1972).
Salans, L. B., Dougherty, J. W.: The effect of insulin upon glucose metabolism by adipose cells of different size: Influence of cell lipid and protein content, age, and nutritional state. J. clin. Invest. 50, 1399 (1971).
Salans, L. B., Horton, E. S., Sims, E. A. H.: Experimental obesity in man: Cellular character of adipose tissue. J. clin. Invest. 50, 1005–1011 (1971).
Salans, L. B., Knittle, J. L., Hirsch, J.: The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J. clin. Invest. 47, 153–165 (1968).
Salans, L. B., Wise, J. K.: Metabolic studies of human obesity. Med. Clin. N. Amer. 54, 1533 (1970).
Salans, L. B., Zarnowski, M. J., Segal, R.: Effect of insulin upon the cellular character of rat adipose tissue. J. Lipid Res. 13, 616 (1972).
Saller, K.: Lehrbuch der Anthropologie. Band II. Stuttgart: Gustav-Fischer Verlag 1959.
Salmon, P. A.: The results of small intestinal bypass operations for the treatment of obesity. Surg. Gynecology Obstetrics 132, 965 (1971).
Saltiel, H.: L’obésité-Syndrome: classification psychodynamique et conduite thérapeutique. Sem. Höp. Paris 49, 3629 (1973).
Samaan, N., Brown, J., Fraser, R., Trayner, I.: Effect of obesity and of starvation on insulin activity. Brit. med. J. 1, 1153–1156 (1965).
Sanbar, S. S., Martin, J. M.: Stimulation by octanoate of insulin release from isolated rat pancreas. Metabolism 16, 482–484 (1967).
Sanders, G. B.: Diskussionsbemerkung. Ann. Surg. 177, 733–734 (1973).
Sandhofer, F., Dienstl, F., Bolzano, K., Schwingshackl, H.: Severe cardiovascular complications associated with prolonged starvation. Brit. Med. J. I, 462–463 (1973).
Sapeika, N.: Drugs in obesity. South African Med. J. 48, 2027–2030 (1974).
Sapir, D. G., Owen, O. E., Pozefski, T., Walser, M.: Nitrogen sparing induced by a mixture of essential animoacids given chiefly as their keto-analogues during prolonged starvation in obese subjects. J. clin. Invest. 54, 974 (1974).
Sarles, H., Hauton, J., Planche, N. E.: Diet, cholesterol gallstones, and composition of bile. Amer. J. dig. Dis. 15, 251 (1970).
Schachter, S.: Obesity and eating. Science 161, 751–756 (1968).
Schachter, S., Gross, L.: Manipulated time and eating behavior. J. Personality and social Psychol. 10, 98–106 (1968).
Schachter, S.: Some extraordinary facts about obese humans and rats. Amer. Psychol. 26, 129–144 (1971a).
Schachter, S.: Emotion, obesity and crime. New York: Academic Press (1971 b).
Schachter, S.: Appetite regulation in obese subjects. Horm. metab. Res. Suppl. 4, 88–90 (1974).
Schachter, S., Rodin, J.: Obese humans and rats. Washington D. C. Erlbaum/Wiley, 1974.
Schade, D. S., Eaton, R. P.: Rôle of insulin and glucagon in obesity. Diabetes 23, 657–661 (1974).
Schalch, D. S.: Changes in carbohydrate tolerance in obese diabetics during starvation: Relationship to alterations in the secretion of insulin, glucagon and growth hormone. Diabetes 15, 527 (1966).
Schalch, D. S., Kipnis, D. M.: The impairment of carbohydrate tolerance by elevated plasma free fatty acids. J. clin. Invest. 43, 1283 (1964).
Schatz, D. L., Sheppard, R. H., Palter, H. C.: Fasting in obese females. Can. med. Assoc. J. 99, 190 (1968).
Schatz, D. L., Sheppard, R. H., Palter, H. C., Jaffri, M.H.: Thyroid function studies in fasting obese subjects. Metabolism 16, 1075–85 (1967).
Scheffers, H.: Preludin in der Behandlung der Adipositas beim Diabetes mellitus. Dtsch. med. Wschr. 81, 939–940 (1956).
Schenck, E. G., Mellinghopf, C. H.: Der Diabetes mellitus als Volkskrankheit und seine Beziehung zur Ernährung. Darmstadt: Dr. Dietrich Steinkopf Verlag 1960.
Scherrer, M., Liechti, D.: Adipositas und Lungenfunktion. In: Blankart R. (ed.): Adipositas, Kreislauf p. 29. Bern: Huber 1974.
Scheugl, H., Adanos, F.: Show freaks and monster. 2. Aufl., p. 125. Köln: Du Mont Schauberg 1975.
Schilling, W. H., Oberdisse, K., Huther, K. A., Blank, K.: Vergleichende Untersuchungen mit der oralen und intravenösen Glukosebelastung zur Erfassung einer verminderten Kohlenhydrattoleranz. Diabetologia 1, 187–194 (1965).
Schimert, G. C.: Kardiovaskuläre Folgen der Obesitas. Triangel 13, Nr. 2,31–40 (1974).
Schlegel, S.: Die Persönlichkeitsstruktur adipöser Frauen und deren Einfluß auf die Therapie. Eine Untersuchung mit dem MMPI. Diss. Düsseldorf (1976).
Schlegel, S., Berger, M., Berchtold, P., Zimmermann, H.: unpubliziert 1975.
Schless, G. L., Duncan, G.G.: The benefical effect of intermittent total fasts on the glucose tolerance in obese diabetic patients. Metabolism 15, 98–102 (1966).
Schlick, W., Schmid, P., Irsigler, K.: Körperzusammensetzung bei Normalgewichtigen und Fettsüchtigen. Dtsch. med. Wschr. 101, 67–72 (1976).
Schlomka, G., Blankett: Über den Elektrokardiogrammtyp von Fettleibigen. Z. Wien. Med. 134, 435 (1938).
Schneider, H., Leonhardt, W., Hanefeld, M., Haller, H., Neumann, J., Michaelis, D.: Beeinflussung hormonell-metabolischer und morphologischer Parameter der Adiposi-tas durch Gewichtsreduktion. 1. Mitteilung: Veränderung von Triglyceriden, Cholesterol, freien Fettsäuren und Harnsäure. Dtsch. Gesundheitswesen 29, 1117 (1974).
Schrade, W., Böhle, E., Biegler, R., Kirst, H.: Untersuchungen über die unveresterten Fettsäuren des Blutes. Munch. med. Wschr. 101, 2062–2067 (1959).
Schreibman, P. H.: Increased cholesterol-synthesis as a consequence of overeating. Circulation 51/52 suppl. II, 11–81 (1975).
Schröckert, L.: Adipositas und Fettleber. Mainz: Dissertation 1969.
Schteingart, D. E., Conn, J. W.: Characteristics of the increased adrenocortical function observed in many obese patients. Ann. N. Y. Acad. Sci. 131, 388–403 (1965).
Schteingart, D. E., Conn, J. W.: Cortisol secretion, turnover, and metabolism in obesity. In: Vague, J. (ed.): Physiopathology of adipose tissue. p. 178. Amsterdam: Excerpta Med. Found. Monograph. 1968.
Schteingart, D. E., Gregerman, E. I., Conn, J. W.: A comparison of the characteristics on increased adrenocortical function in obesity and in cushing’s syndrome. Metabolism 12, 484 (1963).
Schubert, R., Peters, H., Stewens, G.: Klinische Wandlungen des Diabetes mellitus im Verlauf des Lebens. Z. Altersforschung 10, 205–221 (1957).
Schultz, R. B., Parra, A.: Relationship between body composition and insulin and growth hormone responses in obese adolescents. Diabetes 19, 492–501 (1970).
Schwab, D., Rubulis, A., Lim, E. C., Sherman, C. D., Faloon, W. W.: Effects of neomycin in obese patients with jéjunoileostomy. Am. J. clin. Nutr. 25, 987–991 (1972).
Seltzer, C. C.: Some re-evaluations of the build and blood pressure study, 1959 as related to ponderai index, somatotype and mortality. N. Engl. J. Med. 274, 254–259 (1966).
Seltzer, C. C.: Genetics and obesity. In: Vague, J. (ed.): Physiopathology of adipose tissue. p. 325–334. Amsterdam: Exerpta Medica Found., 1968.
Seltzer, C. C., Mayer, J.: Body build and obesity. Who are the obese? J. Am. med. Ass. 189, 677–684 (1964).
Seltzer, C. C., Mayer, J.: Body build (Somatotype) distinctiveness in obese women. J. Am. diet. Ass. 55, 454 (1969).
Seltzer, C. C., Stoudt, H. W. Jr., Bell, B., Mayer, J.: Reliability of relative body weight as a criterion of obesity. Am J. Epidemiology 92, 339–350 (1970).
Seltzer, H. S., Allen, W. E., Herron, A. L. Jr., Brennan, M. T.: Insulin secretion in response to glycemic stimulus. Relation of delayed inital release to carbohydrate intolerance in mild diabetes mellitus. J. clin. Invest. 46, 323–355 (1967).
Seltzer, H. S., Smith, W. L.: Plasma insulin activity after glucose. An index of insulinogenic reserve in normal and diabetic man. Diabetes 8, 117–124 (1959).
Seyffert, W. A. Jr., Madison, L.L.: Physiologic effects of metabolic fuels on carbohydrate metabolism. I. Acute effect of elevation of plasma free fatty acids on hepatic glucose output, peripheral glucose utilization, serum insulin, and plasma glucagon level. Diabetes 16, 765 (1967).
Shagrin, J. W., Frame, B., Duncan, H.: Polyarthritis in obese patients with intestinal bypass. Ann. int. Med. 75, 377–380 (1971).
Sharp, J. T., Henry, J. P., Sweany, S. K., Meadows, W. R., Pietras, R. J.: Total respiratory inertance and its gas and tissue components in normal and obese men. J. clin. Invest. 43, 503 (1964a).
Sharp, J. T., Henry, J. P., Sweany, S. K., Meadows, W. R., Pietras, R. J.: The total work of breathing in normal and obese men. J. clin. Invest 43, 728–738 (1964b).
Shatney, C. H., Grage, T. B.: Diagnostic and surgical aspects of insulinoma. Amer. J. Surgery 127, 174–184 (1974).
Shaw, W. N., Chance, R. E.: Effect of porcine proinsulin in vitro on adipose tissue and diaphragm of the normal rat. Diabetes 17 737 (1968).
Sheldon, W. H., Stevens, S. S., Tucker, W. B.: The varieties of human physique. New York: Harper 1940.
Shepard, Diehl: 1924 I. c. PFLANZ, M. 1962 b.
Sherman, C. D. Jr., May, A. G., Nye, W., Waterhouse, C.: Clinical and metabolic studies following bowel by-passing for obesity. Ann. Natl. Acad. Sci. 131, 614 (1965).
Sherwin, R. S., Fisher, M., Hendler, R., Felig, P.: Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N. Engl. J. Med. 294, 455 (1976).
Shibata, H. R., Mackenzie, J. R., Long, R. C.: Metabolic effects of controlled jéjunocolic bypass. Arch. Surg. 95, 413 (1967).
Shima, K., Price, S., Foa, P. P.: Serum insulin concentration and birth weight in human infants. Proc. Soc. exper. Biol. Med. 121, 55–59 (1966).
Short, I. J.: The increase of elektrocardiographic changes with obesity. Proc. life. ext. exam. 1, 82 (1939).
Shrago, E., Glennon, J. A., Gordon, E. S.: Enzyme studies in human liver and adipose tissue. Nature (London) 1, 1263 (1966).
Shrago, E., Glennon, J. A., Gordon, E. S.: Studies on enzyme concentration and adaptation in human liver and adipose tissue. J. clin. Endocr. 27, 679 (1967).
Shrago, E., Glennon, I. A., Gordon, E. S.: Comparative aspects of lipogenesis in mammalian tissues. Metabolism 20, 54–62 (1971).
Shreeve, W. W.: Transfers of carbon- 14 and tritium from substrates to CO2, water, and lipids in obese and diabetic subjects in vivo. Ann. N. Y. Acad. Sci. 131, 464 (1965).
Shreeve, W. W., Hoshi, M., On, N.: Oxydation of glucose-1-14C, 1-3H to 14CO2 and 3HOH after oral glucose load in obese patients. Diabetes 18, 372 (1969).
Shreeve, W. W., Hoshi, M., Oji, N., Shigeta, Y., Abe, H.: Insulin and the utilisation of carbohydrates in obesity. Am J. clin. Nutr. 21, 1404–1418 (1968).
Shreeve, W. W., Tashjian, A. J., Oji, N., Slavinski, R. H., Hoshi, M.: Formation of 14CO2 and 3HOH from glucose-1-14C, -1-3H during oral glucose tolerance tests in obese patients. Metabolism 20, 280–292 (1971).
Shukla, A., Forsyth, H. A., Anderson, C. M., Marwah, S. M.: Infantile overnutrition in the first year of life: a field study in Dudley, Worcestershire. Brit. med. J. 4, 507–515 (1972).
Sigg, K.: Varicen-Ulcus cruris und Thrombose, neue Wege zur nichtoperativen Behandlung. Berlin: Springer 1962.
Silverstone, J. T.: Obesity. Proc. Royal Soc. Med. 61, 371–375 (1968).
Silverstone, J. T.: Psychological factors in obesity. In: I. M. Baird, N. Howard, (eds.): Obesity-Medical and Scientificaspect. p. 45. Edinburgh und London: E. u. S. Livingstone Ltd., 1969.
Silverstone, J. T.: Psychological and social factors in the pathogenesis of obesity. In: Burland, W. L., Samuel, P. D., Yudkin, J. (eds.): Obesity symposium. p. 105. London: Churchill Livingstone 1974.
Silverstone, J. T., Buckle, R. M.: Obesity in diabetes: some considerations on treatment. Am. J. clin. Nutr. 19, 158–162 (1966).
Silverstone, J. T., Cooper, R. M., Begg, R. R.: A comperative trial of fenfluramine and diethylpropion in obesity. Brit. J. clin. Pract. 24, 423–425 (1970).
Silverstone, J. T., Gordon, R. P., Stunkard, A. J.: Social factors in obesity in London. Practitioner 202, 682–688 (1969).
Silverstone, J. T., Solomon, T.: Psychiatric and somatic factors in the treatment of obesity. J. psychosom. Res. 9, 249–255 (1965).
Simeons, A. T. W.: The action of chorionic gonadotropin in the obese. Lancet II, 946–947 (1954).
Simeons, A. T. W.: Pounds and inches. 7. Auflage, Rom 1971 Privat-Druck A. T. W. Simeons.
Simkin, B.: Urinary 17-ketosteroid and 17-ketogenic steroid excretion in obese patients. N. Engl. J. Med. 264, 974–977 (1961).
Simkin, B., Arce, R.: Steroid excretion in obese patients with colored abdominal striae. N. Engl. J. Med. 266, 1031–1035 (1962).
Sills, E. A. H., Horton, E. S., Salans, L. B.: Inducible metabolic abnormalities during development of obesity. Ann. Rev. Med. 22, 235–250 (1971).
Sims, E. A. H., Bray, G. A., Danforth, E., Glennon, J. A., Horton, E. S., Salans, L. B., O’connell, M.: Experimental obesity in man VI: the effect of variation in intake of carbohydrate on carbohydrate, lipid and cortisol metabolism. Horm. Metab. Res. Suppl. 4, 70 (1972).
Sims, E. A. H., Danforth, E.: Role of insulin in obesity. Israel J. med. Sci. 10, 1222–1229 (1974).
Sims, E. A. H., Goldman, R. F., Gluck, C. M., Horton, E. S., Kelleher, P. C., Rowe, D. W.: Experimental obesity in man. Trans. Ass. Am. Physicians 81, 153–170 (1968).
Sims, E. A. H., Horton, E. S.: Endocrine and metabolic adaption to obesity and starvation. Am. J. clin. Nutr. 21, 1455–1470 (1968).
Sims, E. A. H., Kelleher, P. E., Horton, E. S., Glueck, C. M., Goldman, R. F., Rowe, D.W. In: Vague, J. (ed.): Pathophysiology of adipose tissue. Amsterdam: Excerpta med. Found. 1969.
Suo, W. E.: NCRL Publication No 3349’. Donner Laboratory of Biophysics and Medical Physics, University of California 1956.
Sive, P. H., Medalie, J. H., Kahn, H. A., Neufeld, H. N., Riss, E.: Correlation of weight - height index with diastolic and with systolic blood pressure. Brit. J. prey. soc. Med. 24, 201–204 (1970).
Sjöström, L.: Adult human adipose tissue cellularity and metabolism with special reference to obesity and fatty acid synthesis de novo. Acta med. Scand. (Suppl. 544) 1–52 (1972).
Sjöström, L., Björntorp, P.: Body composition and adipose tissue cellularity in human obesity. Acta med. Scand. 195, 201–211 (1974).
Sjöström, L., Björntorp, P., Vrana, J.: Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determination of osmium-fixed fat cells. J. Lipid Res. 12, 521–530 (1971).
Sjöström, L., Smith, U., Krotkiewski, M., Björntorp, P.: Cellularity in different regions of adipose tissue in young men and women. Metabolism 2, 1143–1153 (1972).
Sjövall (1956): 1. c. Pflanz, 1962 b.
Skamenova, B., Sottner, L.: Die Spinnenfettleibigkeit bei Frauen in Bezug zum Diabetes mellitus. In: G. Mohnicke, (ed.): III. Intern. Symp. über Diabetesfragen. p. 84–91. Karlsburg DDR: Institut für Diabetes-Forschung und -Behandlung. „G. Katsch“, 1964.
Skinner, W., Madison, L. L.: A further role of epinephrine and glucagon in producing their counterregulatory response to hypoglycemia. Clin. Res. 8, 60 (1960).
Slany, J., Mösslacher, H., Irsicler, K.: Beeinflußt Adipositas die Herzfunktion? Z. Kardiol. 64, 851–862 (1975).
Smekal, P. v., Standfuss, K., Rau, G.: Zunahme der primär vaskulären pulmonalen Hypertonie im Zusammenhang mit der Zunahme von Appetitzüglern? Fragen der Atemregulation. Zschr. f. Kreislaufforschung 59C, 892–897 (1970).
Smith, M., Levine, R.: Obesity and Diabetes. Med. Clin. North. Amer. 48, 1387–1397 (1964).
Smith, R. E.: Thermogenesis and thyroid action. Nature 204, 1311–1312 (1964).
Smith, R. G., Innes, J. A., Munro, J. F.: Double blind evaluation of mazindol in refractory obesity. Brit. med. J. 3, 284 (1975).
Smith, U.: Effects of glucose and insulin on lipolysis in human fat cells of different sizes. FEBS Letters 11, 8–10 (1970a).
Smith, U.: Insulin responsiveness and lipid synthesis in human fat cells of different sizes: effect of the incubation medium. Biochim. Biophys. Acta. 218, 417 (1970b).
Smith, U.: Effect of cell size in lipid synthesis by human adipose tissue in vitro. J. Lipid Res. 12, 65 (1971a).
Smith, U.: Morphological studies of human subcutaneous adipose tissue in vitro. Quat. Res. 169, 97–104 (1971b).
Smith, U., Sjöström, L., Björntorp, P.: Comparison of two methods for determining human adipose cell size. J. Lipid Res. 13, 822–824 (1972).
Snodgrass, P. J.: Obesity small-bowel bypass and liver disease. N. Engl. J. Med. 282, 870–871 (1970).
Soc. of Actuaries: Build and blood pressure study. Chicago (1959).
Soeldner, J. S., Steinke, J., Herrera, M. G., Cahill, G. F.: Effect of seven-day-fast on glucose-tolerance and serum insulin of six normal males. Endocrin. Society June 17, 66 (1965) abstr.
Sohar, E., Sneh, E.: Follow-up of obese patients: 14 years after a successful reducing diet. Am. J. clin. Nutr. 26, 845–848 (1973).
Solomon, J., Mayer, D.: Effect of alloxan on obese hyperglycaemic mice. Nature (London) 193, 135–137 (1962).
Solomon, S. S., Ensinck, J. W., Williams, R. H.: Effect of starvation on plasma immunoreactive insulin and non-suppressible insulin-like activity in normal and obese humans. Metabolism 17, 528 (1968).
Solow, C., Silberfarb, P. M., Swwr, K.: Psychosocial effects of intestinal bypass surgery for severe obesity. N. Engl. J. Med. 290, 300–304 (1974).
Souter, W. A.: Bolus obstruction of gut after use of hydrophilic colloid laxatives. Brit. med. J. I, 166–168 (1965).
Spahn, V., Plenert, W.: Veränderungen der Körperzusammensetzung adipöser Kinder bei akuter Nahrungskarenz. Z. Kinderheilkunde 115, 59–65 (1973).
Spencer, J. O. B.: Death during therapeutic starvation for obesity. Lancet I, 128E-1290 (1968).
Spranger, J.: Phentermin-Resinat bei Fettsucht. Munch. med. Wschr. 107, 1833–1834 (1965).
Stahelin, H. B.: Beobachtungen zum Problem der Übergewichtigkeit an der Basler Studie III. In: Brühacher, G., Ritzel, G. (eds.): Zur Ernährungssituation der schweizerischen Bevölkerung. p. 251. Bern: Huber 1975.
Stalley, S., Garrow, J. S.: Photographic and ultrasonic methods for measuring change in subcutaneous fat distribution. In: Howard, A. (ed.): Recent Advances in obesity Research I. p. 66–68. London: Newman Publ., 1975.
Stamler, J. et al.: (1960) I. c. Pflanz, M. 1962 b.
Stamler, J., Stamler, R., Rhomberg, P., Dyer, A., Berkson, D. M., Reedus, W., Wanna Maker, J.: Multivariate analysis of the relationship of six variables to blood pressure: Findings from Chicago community surveys 1965–1971. J. chron. Dis. 28, 499–525 (1975) a.
Stamler, J., Rhomberg, P., Schoenenberger, J. A., Shekelle, R. B., Dyer, A., Shekelle, S., Stamler, R., Wannamaker, J.: Multivariate analysis of the relationship of seven variables to blood pressure: Findings of the Chicago heart association detection project in industry 1967–1972. J. chron. Dis. 28, 527–548 (1975) b.
Steel, J. M., Briggs, M.: Withdrawal depression in obese patients after fenfluramine treatment. Brit. med. J. III, 26 (1972).
Stefanini, P., Carboni, M., Patrassi, N., Basoli, A.: Beta-islet cell tumors of the pancreas: results of a study on 1067 cases. Surgery 75, 597–609 (1974).
Stegmann, H., Wagner, D., Lau, A.: Schwangerschaft, Geburtsverlauf and Nachgeburtsperiode bei adipösen Frauen. Med. Welt 2195 (1964).
Stein, I. F., Leventhal, M. L.: Amenorrhea associated with bilateral polycystic ovaries. Amer. J. Obstetr. Gynec. 29, 181–191 (1935).
Steiner, D. F., Cunningham, D.: Insulin biosynthesis: Evidence for a precursor. Science 157, 697 (1967).
Steiner, D. F., Hallund, O., Rubenstein, A. H., Cho, S., Bayliss, C.: Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin. Diabetes 17, 725 (1968).
Steinkamp, R. C.: Body composition in relation to disease. Am. J. publ. Health. 58, 473 (1968).
Steinke, J., Camerini, R., Marble, A., Renold, A. E.: Elevated levels of serum insulin like activity as measured with adipose tissue in early untreated diabetes and prediabetes. Metabolism 10, 707 (1961).
Steinke, J., Soeldner, J. S., Renold, A. E.: Insulin-like activity of extracts from large sarcomatous tumors associated with hypoglycemia. J. clin. Invest. 41, 1403 (1962).
Stepanek, P., Krizek, V., Stadilek, L.: Die Anwendung von Trijodthyronin and Dianabol bei Abmagerungskuren. Med. Welt 17, 2393–2395 (1966).
Stephan, F., Reville, PH., Thierry, R., Schlienger, J. L.: Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus. Diabetologia 8, 196–201 (1972).
Stern, J. S., Batchelor, B. R., Hollander, N., Cohn, C. K., Hirsch, J.: Adipose cell size and immunoreactive insulin levels in obese and normal weight adults. Lancet II, 948 (1972).
Stern, J. S., Greenwood, M. R. C.: A review of development of adipose tissue cellularity in man and animals. Fed. Proc. 33, 1952 (1974).
Stern, M., Olefsky, J., Farquhar, J., Reaven, G.: Relationship between fat cell size and insulin resistance in vivo. Clin. Res. 20, 557 (1972).
Stern, M. P., Olefsky, J., Farquhar, J. W., Reaven, G. M.: Relationship between fasting plasma lipid levels and adipose tissue morphology. Metabolism 22, 1311 (1973).
Stern, M., Wood, P., King, A., Osann, K., Farquhar, J., Silvers, A.: Morphological and temporal characteristics of obesity as determinants of plasma triglycerides in a free living population. In: Vague, J., Boyer, J. (eds.): The regulation of the adipose tissue mass. p.316–319. Amsterdam: Excerpta Med., 1974.
Stewart, W. K., Fleming, L. W.: Relationship between plasma and erythrocyte magnesium and potassium concentrations in fasting obese subjects. Metabolism 22, 535–547 (1973).
Stiles, J. W., Francendese, A. A., Masoro, E. J.: Influence of age on size and number of fat cells in the epididymal depot. Ann. J. Physiol. 229, 1561–1568 (1975).
Stirling, J. L., Stock, M. J.: Metabolic origins of thermogenesis induced by diet. Nature 220, 801–802 (1968).
Stirling, J. L., Stock, M. J.: Nonconservative mechanisms of energy metabolism in thermogenesis. In: Energy balance in man. Paris: Masson 1973.
Stock, M. J.: Letter to the editor. Nature 223, 213 (1969).
Strandell, B.: On influence of exercise on blood sugar especially in connection with glucose ingestion. Acta med. Scand. Suppl. 55, 1–245 (1934).
Strong, J. A., Shirling, D., Passmore, R.: Some effects of overfeeding for four days in man. Brit. J. Nutr. 21, 909–919 (1967).
Stuart, R. B.: Behavioral control of overeating. Behay. Res. and Therapy 5, 357–365 (1967).
Stucklikova, E., Hruskova, J., Tenorava, M., Novotna, B., Komarkova, A., Riedl, O.: Some changes in intermediary metabolism in obese patients. Clin. Chim. Acta 6, 571 (1961).
Stunkard, A. J.: The dieting depression. Am. J. Med. 23, 77–86 (1957).
Stunkard, A. J.: Eating pattern and obesity. Psychiat. Quart. 33, 284 (1959).
Stunicard, A. J.: Hunger and satiety. Amer. J. Psychiat. 118, 212 (1961).
Stunicard, A. J.: Environment and obesity: recent advances in our understanding of regulation of food intake in man. Fed. Proc. 27, 1367–1373 (1968).
Stunicard, A. J.: New therapies for the eating disorders. Arch. Gen. Psychiat. 26, 391–398 (1972a).
Stunkard, A. J.: The success of Tops, a self-help group. Postgrad. Med. 51,143–147 (1972b).
Stunkard, A. J.: Obesity. In: Freedman, A. M., Kaplan, H. I., Sadock, B. J. (eds.): Comprehensive textbook of psychiatry. Baltimore: Williams and Wilkins 1975a.
Stunkard, A. J.: From explanation to action in psychosomatic medicine: The case of obesity. Psychosomat. Med. 37, 195–236 (1975b).
Stunkard, A. J., D’acquili, E., Fox, S.: The influence of social class on obesity and thinness in children. J. Amer. med. Ass. 221, 579–584 (1972).
Stunkard, A. J., Grace, W. J., Wolff, H. G.: The night eating syndrome. Amer. J. Med. 19, 78 (1955).
Stunkard, A. J., Levine, H., Fox, S.: The management of obesity. Patient self-help and medical treatment. Arch. Int. Med. 125, 1067–1072 (1970).
Stunkard, A., Mclaren-Hume, M.: The results of treatment for obesity. Arch. Int. Med. 103, 79’-85 (1959).
Stunkard, A. J., Mendelson, M.: Obesity and the body image. Amer. J. Psychio1.123,1296 (1967).
Stunkard, A. J., Rickew, K., Hesbacher, P.: Fenfluramine in the treatment of obesity Lancet I, 503–505 (1973).
Stunkard, A. J., Rush, J.: Dieting and depression reexamined. Ann. intern. Med. 81, 526–533 (1974).
Suryanarayana, B. V., Kent, J. R., Meister, L., Parlow, A., Florsheim, W. H.: Some endocrine consequences of prolonged total starvation. Clin. Res. 16, 116 (1968).
Sussmann, K. E.: Effect of prolonged fasting on glucose and insulin metabolism in exogenous obesity. Arch. intern. Med. 117, 343–347 (1966).
Sutton, F. D., Zwillich, C. W., Creagh, C. E., Pierson, D. J., Weil, J. V.: Progesterone for outpatient treatment of Pickwickian syndrome. Ann. intern. Med. 83, 476 (1975).
Sumo, M.: Pickwickian syndrome and endocardial fibroelastosis. Amer. J. Med. 53, 123 (1972).
Swaner, J. C., Connor, W. E.: Hypercholesterolemia of total starvation: its mechanismus via tissue mobilisation of cholesterol. Amer. J. Physiol. 229, 365–369 (1975).
Swanson, D. W., Dinello, F.: Therapeutic starvation in obesity. Dis. nerv. syst. 669–674 (1969).
Swanson, D. W., Dinello, F. A.: Follow-up of patients starved for obesity. Psychosom. Med. 32, 209–214 (1970).
Szenas, P., Pattee, C. J.: Studies of adrenal cortical function in obesity. J. clin. Endocrinol. 19, 344 (1959).
Täljedal, I. B.: The structure and metabolism of the pancreatic islets. In: Kalkner, S., Hellman, B., Täljedal, I. B. (eds.): p. 238. Oxford: Pergamon 1970.
Taggart: Diet, activity and body-weight. A study of variations in a woman. Brit. J. Nutr. 16, 223–235 (1962).
Taller, H.: Calories don’t count. New York: Simson and Schuster 1961.
Taller, H.: Dietary management of obesity. Ann. J. Obstet. Gynec. 83, 62–72 (1962).
Talso, P. J., Miller, C. E., Carballo, A. J.: Exchangeable potassium as a parameter of body composition. Metabolism 9, 456–471 (1960).
Tashev, L., Balabanski, L., Apostolov, I., Ekimova, S., Milev, N.: Studies on the intestinal resorption of fats, the intermediary lipid metabolism and the lipase activity in obese persons. Pol. Arch. Med. Wewn. 42, 553 (1969).
Tattersall, R. B., Pyke, D. A.: Growth in diabetic children-studies in identical twins. Lancet II, 1105–1109 (1973).
Tchobroutsky, G., Rosselin, G., Assan, R., Freychet, P., Derot, M.: In Vague, J. (Ed.): Physiopathology of adipose tissue. p. 269–288. Amsterdam: Excerpta Med. 1968.
Tell, G. P. E., Krug, F., Cuatrecasas, P.: Insulin receptor interactions and the action of insulin. In: Hasselblatt A., Bruchhausen, F. V. (eds.): Insulin Part 2, p. 249. Berlin-Heidelberg: Springer 1975.
Tepperman, J.: Etiologic factors in obesity and leanness. Perspect. Biol. Med. 1, 293 (1958).
Terry, A. H.: Obesity and hypertension. J. Amer. med. Ass. 81, 1283–1284 (1923).
Thaler, H.: Kritische Betrachtungen der Grundlagen unserer Lebertherapie. Dtsch. med. Wschr. 95, 526 (1970).
Theodoridis, C. G., Chance, G. W., Brown, G. A., Rayner, P. H. W.: Growth hormone response to oral glucose in children with simple obesity. Lancet I, 1068–1069 (1969).
Theuer, D.: Zur Problematik der Fettleber. Dtsch. Gesundheitswesen 23, 2113 (1968).
Thomson, A. M., Black, A. E.: Nutritional aspects of human lactation. Bull. World Health Organ. 52, 163–176 (1965).
Thomson, T. J., Runcie, J., Miller, V.: Treatment of obesity by total fasing for up to 249 days. Lancet II, 992–996 (1966).
Thum, Ch., Laube, H., Schröder, K. E., Raptis, S., Pfeiffer, E. F.: Das kontinuierliche Blutzuckertagesprofil in Korrelation zum Seruminsulin bei idealgewichtigen und normalgewichtigen Stoffwechselgesunden. Dtsch. med. Wschr. 100, 1595–1599 (1975).
Tibblin, G.: High blood pressure in men aged 50. — A population study of men born in 1913. Acta med. Scand. Suppl. 470 (1967).
Tibblin, G., Aurell, E., Hjortzberg-Nordlund, H., Paulin, S., Risholm, L., Sanne, H., Wilhelmsen, L., Werkö, L.: A general health examination of a random sample of 50-year old men in Göteborg. Acta med. Scand. 177, 739 (1965).
Tompkins, W. T., Wiehl, D. G.: The promotion of maternal and newborn health. New York 1955.
Tracey, V. V., De N. C., Harper, J. R.: Obesity and respiratory infection in infants and young children. Brit. med. J. 1, 16–18 (1971).
Tunis, J. F.: Rational diet construction for mild and grand obesity. J. Amer. med. Assoc. 226, 70–71 (1973).
Turell, D. J., Austin, R. C., Alexander, J. K.: Cardiorespiratory response of very obese subjects to treadmill exercise. J. lab. clin. Med. 64, 107 (1964).
Turner, P.: Drugs in the treatment of obesity. In: Obesity, Medical and Scientific aspects. Mc Lean Baird, J., Howard, A. N. Edinburgh und London: E. und S. Livingstone Ltd. 1969.
Turtle, J. R., Burgess, J. A.: Hypoglycemic action of fenfluramine in diabetes mellitus. Diabetes 22, 858–867 (1973).
Turtle, J. R., Burgess, J. A., Bauckham, S.: The metabolic effects of fenfluramine. S. Afr. med. J. 45, Suppl. 22–23 (1971).
Tyner, J. D.: The prediabetic state: its relation to obesity and to diabetic mercedity. Am. J. med. Sci. 185, 704–710 (1933).
Umber, F.: Die Stoffwechselkrankheiten in der Praxis. 3. Auflage, p. 203. München und Berlin: Lehmann 1939.
Unger, R. H., Aguilar-Parada, E., Muller, W. A., Eisentraut, A. M.: Studies of pancreatic alpha cell function in normal and diabetic subjects. J. clin. Invest. 49, 837–848 (1970).
Unger, R. H., Eisentraut, A. M., Madison, L. L.: The effects of total starvation upon the levels of circulating glucagon and insulin in man. J. clin. Invest. 42, 1031–1039 (1963).
Unger, R. H., Madison, L. L., Müller, W A Abnormal alpha cell function in diabetes response to insulin. Diabetes 21, 301–307 (1972).
Unger, R. H., Orci, L.: The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet I, 14–16 (1975).
University Group Diabetes Programm: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of phenformin treatment. Diabetes 24, Suppl. 1, 65–184 (1975).
Vague, J.: The degree of masculine differentiation of obesities. Am. J. clin. Nutr.4, 21–34 (1956).
Vague, J.: Origines, évolution et traitement des obésités. Editions Sandoz, Rueil-Malmaison 1968a.
Vague, J.: Adipositas. Med. Prisma (Boehringer, Ingelheim) 6. (1968b).
Vague, J., Vague, PH.: Obesity and atherosclerosis. In: Greten, H., Levine, R., Pfeiffer, E. F., Renold, A. E. (eds.): Lipidmetabolism, obesity, and diabetes mellitus: Impact upon atherosclerosis. Horm. metab. Res. Suppl. 4, p. 164. Stuttgart: Thieme 1974.
Vague, J., Vague, PH., Boyer, J., Cloix, M. C.: Anthropometry of obesity diabetes, adrenal and beta-cell functions. In: Rodrigues, R. R., Valiance-Owen, J. (eds.): Diabetes, p. 517–525. Excerpta Med. Found, Amsterdam 1971.
Vague, J., Boyer, J., Jubelin, J., Nicolino, C., Pinto, C.: Adipomuscular ratio in human subjects. In: Vague, J. (ed.): Physiopathology of adipose tissue. p. 360. Amsterdam: Exerpta Medica, 1969.
Vague, J., Rubin, PH., Jubelin, J., Vague, PH.: Die verschiedenen Formen der Fettsucht. Triangel 13,41–50 (1974a).
Vague, J., Rubin, P., Jubelin, J., Lam-Van, G., Aubert, F., Wassermann, A. M., Fon-Darai, J.: Regulation of the adipose mass: histometric and anthropometric aspects. In: Vague, J., Boyer, J. (eds.): The regulation of the adipose tissue mass. p. 296. Amsterdam: Excerpta Medica 1974b.
Vague, PH., Boeuf, G., Depieds, R., Vague, J.: Plasma insulin levels in human obesity. In: Vague, J., (ed.): Physiopathology of adipose tissue. p. 203. Amsterdam: Excerpta Med. Found. 1969.
Vague, P., Depieds, R., Boeuf, G., Leroy, C., Perrimond, D., Codaccioni, J. L., Vague, J.: Appréciation de l’efficacité de l’insuline chez les obèses parla réponse insulinémique et glycémique à la tolbutamide intraveineuse. Ann. d’Endocr. 27, 820–829 (1966).
Vague, P., Lombardi, G., Minozzi, M., Valette, A., Oliver, C.: Corticotropic function in human obesity. In: Vague, J. U., Boyer, J., (eds.): The Regulation of the adipose tissue mass. p. 283. New York: Excerpta Medica American Elsevier (1974).
Vague, PH., Pierron, H., Rouvier-Leroy, CL., Jaquet, PH., Vague, J.: L’insulinémie au cours d’une charge orale en glucose chez 43 enfants obèses. Ann. d’Endocr. (Paris) 30, 556–579 (1969).
Vague, PH., Scomavachi, J. C., Rouvier-Leroy, C.: Variation des acides gras libres plasmatiques après administration orale de glucose ches les obèses. Ann. d’Endocr. (Paris) 28, 787 (1967).
Vajda, B., Heald, F. P., Mayer, J.: -Intravenous glucose tolerance in obese adolescents. Lancet I, 902–903 (1964).
Vallance-Owen, J., Hurlock, B., Please, N. W.: Plasma insulin activity in diabetes mellitus measured by the rat diaphragm technique. Lancet II, 583 (1955).
Vallance-Owen, J., Lilley, M. D.: Insulin antagonism in the plasma of obese diabetics and prediabetics. Lancet I, 806 (1961).
Van Buchem, F. S. P.: Coronary heart disease in seven countries: VIII. Zutphen a town in the Netherlands. Circulation 41, 42 (Suppl. 1) 76–86 (1970).
Van Dellen, J. R., Van Den Heever, C. M.: Intraspinal lipoma: a case report. S. Afr. med. J. 50, 49–51 (1976).
Van Der Linden, W.: Some biological traits in female gallstone-disease patients. Acta clin. Scand. Suppl. 269 (1961).
Vetter, K., Nohuike, G., Schicht, J.: Untersuchungen bei Fettsucht. Dtsch. Z. Verdau.- u. Stoffwechselkrkh. 24, 215–228 (1964).
Vilain, R.: Chirurgie de l’obésité et des lipodystrophies. In: Klotz, H. P. und Trémolieres, J. (eds.): Expansion Scientifique Francaise, Paris 1963.
Virtanen, A. J.: Gegenwärtige Ernährungsprobleme. Dtsch. med. J. 14, 788 (1963).
Vischer, D., Labhart, A., Prager, A., Ginsberg, J.: Das Prader-Labhart-Willi-Syndrom (myatonischer Diabetes). In: Pfeiffer, E. F. (ed.): Handbuch des Diabetes mellitus, Bd. II, p. 631. München: Lehmanns 1971.
Vlastovsxu, V. G.: (1964) 1. c. Luhanova, 1969.
Vogelberg, K. H., Berchtold, P., Berger, H., Gries, F. A., Klinger, H., Kubler, W., Stolze, TH.: Primary hyperlipoproteinemias as risk factors in peripheral artery disease, documented by arteriography. Atherosclerosis 22, 271 (1975).
Waal-Manning, H. J., Simpson, F. O.: Fenfluramine in obese patients on various antihypertensive drugs. Double blind controlled trial. Lancet II; 1392–1395 (1969).
Wadhwa, P. S., Young, E. A., Schmidt, K., Elson, C. E., Pringle, D. J.: Metabolic consequents of feeding frequency in man. Am. J. clin. Nutr. 26, 823–830 (1973).
Wahren, J.: Die Bedeutung des BROCA-Index für die Beurteilung der Körpergewichtsverhältnisse einer größeren Population im Rahen einer Reihenuntersuchung. Dtsch. Gesundheitswesen 30, 173–175 (1975a).
Wahren, J.: Epidemiologische Aspekte der Fettsucht. Dtsch. Gesundheitswesen 30, 226–229 (1975b).
Wahren, J.: Die Körpergewichtsverhältnisse einer ländlichen Bevölkerung. Dtsch. Gesundheitswesen 30, 472–476 (1975c).
Wahren, J.: Die Bedeutung des Übergewichtes für die Entstehung von Krampfadern und venösen Unterschenkelgeschwüren. Dtsch. Gesundheitswesen 30, 666–669 (1975d).
Waldhäusl, W., Huber, E. G.: Immunologisch reagierendes Insulin bei adipösen Kindern. Z. Kinderheilk. 104, 128 (1968).
Waldhäusl, W., Irsigler, K.: Über die Insulinfreisetzung bei Patienten mit Fettleber. Wien. klin. Wschr. 81, 544 (1969).
Walker, H. C.: Obesity. Its complications and sequelae. Arch. intern. Med. 93, 951–966 (1954).
Wands, J. R., Lamont, J. T., Mann, E., Isselbacher, K. J.: Arthritis associated with intestinalbypass procedure for morbid obesity. N. Engl. J. Med. 294,121–124 (1976).
Wauters, J. P., Busset, R., Dayer, A., Farre, H.: Effects de divers traitement amaigrissant sur la composition corporelle dans l’obésité simple. Analyse par dissection isotopiques. Schweiz. med. Wschr. 100, 1272–1278 (1970).
Weber, B.: Plasmainsulin bei Kindern, klinische Studien bei stoffwechselgesunden, adipösen und diabetischen Probanden. Arch. Kinderheilk. Beiheft 65 (1971).
Wegener, H.: Ästhetische Chirurgie im Stammbereich. In: Gohrbrandt, E., Gabka, J., Erndorfer, A. B. (eds.): Handbuch der Plastischen Chirurgie Band II. Spezielle Plastische Chirurge. 50, 50/1–50/19 (1973).
Wegienka, L. C., Grodsky, G. M., Karam, J. H., Grasso, S. G., Forsham, P. H.: Comparison of insulin and 2-deoxy-D-glucose-induced glucopenia as stimulators of growth hormone secretion. Metabolism 16, 245 (1967).
Weinges, K. F.: Ist eine Neuorientierung der oralen Diabetesbehandlung nötig? Med. Welt 23 N. F. 949 (1972).
Weisenberg, M., Fray, E.: What’s missing in the treatment of obesity by behavior modification? J. Amer. diet. Ass. 65, 410–414 (1974).
Weisinger, J. R., Kempson, R. L., Eldridge, F. L., Swenson, R. S.: The nephrotic syndrome: a complication of massive obesity. Ann. int. Med. 81, 440 (1974).
Weissbecker, L.: Die Fettsucht (Adipositas). In: Heylmeyer, L. (ed.): Lehrbuch der Inneren Medizin. 2. Auflage, p. 1105–1111. Berlin, Göttingen, Heidelberg: Springer Verlag 1961.
Weisswange, A. F., Cuendet, G. S., Marliss, E. B.: Hormonal and metabolic response to a hypocaloric protein diet in normal working subjects. In: Jequier, E. (ed.): Regulation of energy balance in man. p. 117. Edit. Médicine et Hygiène, Genève, 1975.
Welham, W. C., Behnke, A. R. Jr.: Specific gravity of healthy men. J. Am. med. Ass. 118, 498 (1942).
Welsh, G. W., Henley, E. D., Williams, R. H., Cox, R. W.: Insulin I-131 metabolism in man. Am. J. Med. 21, 324 (1956).
Weser, E.: Intestinal adaptation to small bowel resection. Am. J. clin. Nutr. 24, 133–136 (1971).
Wessels, M., Gries, F. A., Irmscher, K., Liebermeister, H., Buchenau, H., Viehweger, I.: Metabolische Konsequenzen einer kohlenhydratarmen Diät („Punktdiät“) bei Normalpersonen. Dtsch. med. Wschr. 95, 382 (1970).
West, K. M.: Epidemiologic evidence linking nutrional factors to the prevalence and manifestations of diabetes. Acta diabet. lat. 9, 405 (1972).
West, K. M.: Epidemiology of adiposity. In: Vague, J., Boyer, J. (eds.): The regulation of the adipose tissue mass. p. 201. Amsterdam: Excerpta Med. 1974.
West, K. M.: Epidemiology of diabetes. In: Fajans, S. S., Sussman, K. G. (eds.): Diabetes mellitus: Diagnosis and Treatment Volume III. p. 121–126. New York: Amer. Diabetes Ass., 1971.
West, K. M., Kalbfleisch, J. M.: Glucose tolerance, nutrition and diabetes in Uruguay, Venezuela, Malaya and Est Pakistan. Diabetes 15, 9–18 (1966).
West, K. M., Kalbfleisch, J. M.: Influence of nutritional factors on prevalence of diabetes. Diabetes 20, 99–108 (1971).
Westwater, J. O., Fainer, D.: Liver impairment in the obese. Gastroenterology 34, 686–693 (1958).
Whitelaw, A. G. L.: The accociation of social class and sibling number with skinfold thickness in London schoolboys. Human Biol. 43, 414 (1971).
Widdowson, E. M., Shaw, W. T.: Full and empty fat cells. Lancet II, 905 (1973).
Wiley, F. H., Newburgh, L. H.: The doubtful nature of „Luxuskonsumption“. J. clin. Invest. 10,733–744 (1931).
Williams, R. H.: Disorders in carbohydrate und lipid metabolism. Philadelphia: Sounders 1962.
Williams, R. H., Palmer, J. P.: Farewell to phenformin for treating diabetes mellitus. Ann. intern. Med. 83, 567–568 (1975).
Williamson, J. R., Browning, E. T., Scholz, R., Kreisberg, R. A., Fritz, I. B.: Inhibition of fatty acid stimulation of gluconeogenesis by (+ )-decanoylcarnitine in perfused rat liver. Diabetes 17, 194 (1968).
Willms, B., Böttcher, M., Wolters, V., Sakamoto, N., Soling, H. D.: Relationship between fat and hebene body metabolism in obese and nonobese diabetics and nondiabetics during norepinephrine infusion. Diabetologia 5, 88 (1969).
Wilmore, D. W., Pruitt, B. A.: Fat boys get burned. Lancet II, 631 (1972).
Wilson, R. H. L., Wilson, N. L.: Obesity and respiratory stress. J. Amer. diet. Ass. 55,465 (1969).
Windorfer, A.: Das Mauriac-Syndrom. Ergeb. inn. Med. Kinderheilk. 4, 392 (1953).
Winkelmann, E. J., Schumacher, O. P., Hermann, R. E., Esselstyn, C. B.: Result of the jéjunoileal shunt in the treatment of morbid obesity. Proceedings of the meetings of the „Organisation Mondiale de Gastroentérologie“, Mexico City, 1974.
Wirths, W.: Über den Einfluß von Industriezeitalter und geänderten Arbeitsbedingungen auf die Entwicklung der Fettsucht. In: Fettsucht. Gefahren, Prophylaxe, Therapie. München: J. F. Lehmann 1968.
Wirths, W.: Bedeutung der Gemeinschaftsverpflegung für den arbeitenden und heranwachsenden Menschen. In: Wirths, W. (ed.): 1. Wiss.-techn. Ernährungsforum (WTE) Herborn ‘72 „Verpflegung Heute-Morgen“ p. 5. Herborn 1972.
Wise, J. K., Hendler, R., Felig, P.: Obesity: evidence of decreased secretion of glucagon. Science 178, 513–514 (1972).
Wise, J. K., Hendler, R., Felig, P.: Evaluation of alpha-cell function by infusion of alanine in normal diabetic and obese subjects. N. Engl. J. Med. 288, 487–490 (1973).
Wise, P. H., Chapman, M., Thomas, D. W., Edwards, J. B.: Phenformin and lactic acidosis. Brit. med. J. 1, 70–72 (1976).
Wolf, L. M., Courtois, H., Javet, H., Schrub, J. C.: Physical training associated with semistarvation in the treatment of obesity. In: Howard, A. (ed.): Recent Advances in obesity research: I. p. 281. London: Newman Publ. 1975.
Wollenweber, J., Doenecke, P., Greten, H., Hild, R., Nobbe, F., Schmidt, F. H., Wagner, E.: Zur Häufigkeit von Hyperlipidaemie, Hyperurikaemie, Diabetes mellitus, Hypertonie und Übergewicht bei arterieller Verschlußkrankheit. Dtsch. med. Wschr. 96, 103–107 (1971).
Wolpe, J.: Reciprocal inhibition as the main basis of psychotherapeutic effects. Arch. Neurol. Psychiat. 72, 205 (1954).
Wood, P. D. S., Stern, M. P., Silvers, A., Raeven, G. M., Von Der Groeben, J.: Prevalence of plasma lipoprotein abnormalities in a free living population in the Central Valley, California. Ciruclation 45, 114 (1972).
Woodward, E. R.: Diskussionsbemerkung. Ann. Surgery 177, 734 (1973).
World health organisation: Energy and protein requirements. WHO techn. series No. 522 and FAO Nutrition meeting report series, p. 34. Geneva 1973.
Wynder, E. L., Escher, G. C., Mantel, N.: An epidemiologic investigation of cancer of the endometrium. Cancer 19, 489–520 (1966).
Wyngaarden, J. B., Kelley, W. N.: Gout. In Stanbury J. B., Wyngaarden, J. B., Fredrickson, D. S. (eds.): The metabolic basis of inherited disease. p. 889. New York: Mc Graw Hill Book Co. 1972.
Yalow, R. S., Glicx, S. M., Roth, J., Berson, S. A.: Plasma insulin and growth hormone levels in obesity and diabetes. Ann. N. Y. Acad. Sci. 131, 357–373 (1965).
York, D. A., Bray, G. A.: Dependence of hypothalamic obesity on insulin, the pituitary and the adrenal gland. Endocrinology 90, 885–894 (1972).
Yorke-Davies, N. E.: Thyroid tabloids in obesity. Brit. med. J. II, 42 (1894).
Yuncker, B.: Calories do count. New York, New York Post, April 23–29 (1962) zit. Astwood (1962).
Zeidler, H. P.: Die Physiologie der oralen Befriedigung. Psychologie heute 3, 18–22 (1976).
Zeilhofer, R.: Fettsucht und Atmung. Fortschr. Med. 86, 861 (1968).
Zelman, S.: The liver in obesity. Arch. intern. Med. 90, 141–156 (1952).
Ziegler, A.: Die Therapie der Fettsucht mit Redukal. Dtsch. Gesundheitsw. 26, 1247 (1971).
Zilker, TH., Kränzlin, TH., Ermler, R., Bottermann, P.: Die Bedeutung der radioimmunologischen Seruminsulinbestimmung für die Diabetestherapie. IV. Internat. Donau-Symposium über Diabetes mellitus, Dubrovnik (1975).
Zimmer, G., Gries, F. A., Jahnke, K.: Das Verhalten von Metaboliten des Fettstoffwechsels im Serum adipöser und nichtadipöser Personen bei oraler Kohlenhydratzufuhr und kurzfristiger Nahrungskarenz. Klin. Wschr. 42, 1020–1024 (1964).
Zimmermann, H.: Klinik und Differentialdiagnose des Cushing-Syndroms. 11. Symposium dtsch. Ges. Endokr. p. 108. Berlin: Springer 1964.
Zinder, O., Bray, G. A.: Lipoprotein lipase activity in human adipose tissue in obesity. In: Bray G. A. (ed.): Obesity in Perspective, DHEW Publication No. (NIH) 75–708, p. 263. Washington 1975.
Zinder, O., Arad, R., Shapiro, B.: Effect of cell size on the metabolism of isolated fat cells. Israel. J. med. Sci. 3, 787 (1967).
Zondek, H.: Ober hypophysär-cerebral-peripherische Fettsucht (Salz-Wasser-Fettsucht). Dtsch. med. Wschr. 51, 1267 (1925).
Zondek, H.: Die Krankheiten der endokrinen Drüsen. 2. Auflage, Berlin: Julius Springer Verlag, 1926.
Zwillich, C. W., Sutton, F. D., Pierson, D. J., Creagh, E. M., Weil, J. V.: Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome Amer. J. Med. 59, 343 (1975).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gries, F.A., Berchtold, P., Berger, M. (1976). Literatur. In: Adipositas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66450-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-66450-2_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-07873-9
Online ISBN: 978-3-642-66450-2
eBook Packages: Springer Book Archive